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Abstract 
UROGENITAL FISTULA:  STUDIES ON EPIDEMIOLOGY AND TREATMENT 
OUTCOMES IN HIGH-INCOME AND LOW- AND MIDDLE-INCOME COUNTRIES 
It has long been recognised that urogenital fistulas in low- and middle-income 
countries are predominantly of obstetric aetiology, whereas those in high-income 
countries usually follow pelvic surgery.  This disparity was confirmed in systematic 
review (included as paper 1) and in large cohort studies undertaken in Nigeria (paper 2) 
and the UK (paper 3).  Whilst there is no standardisation of outcome measures, the 
same studies report treatment ‘success’ in approximately 80-90% of cases in low- and 
middle-income countries (papers 1 & 2) and 95% in high-income countries (papers 1 & 3). 
It is recognised that obstetric fistula patients commonly suffer debilitating stress 
urinary incontinence even after successful closure of their fistula (paper 1).  
Urodynamic investigation in a cohort of fistula patients in UK also showed a high 
incidence of functional abnormalities (paper 4).  Many of these resolved after repair, 
and most women reported minimal impact on quality of life in the long-term (paper 5). 
Success rates were found to be lower following second operations than first in cohort 
studies from Nigeria (paper 2) and UK (paper 3), and in a UK national cohort study 
(paper 8).  This latter study also found idiosyncratic patterns of care, with re-operation 
rates related to workload, varying between 0% and 50% (paper 8). 
Evidence is presented to support an increase in risk of iatrogenic (post-hysterectomy) 
fistulas in high-income countries (papers 6 & 7).  There also is a growing perception by 
colleagues in low- and middle-income countries of an increase in urogenital fistulas 
that may be, in part, iatrogenic in nature.  These trends may reflect supervision and 
surgical experience accrued in training and workload maintained in independent 
practice.  In both situations, it behoves those responsible for training and workforce 
planning in healthcare to ensure an appropriately trained and supervised workforce is 
maintained in the correct working environment. 
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Chapter 1: Background literature 
Introduction 
CATEGORISATION OF COUNTRIES 
The classification of countries on the basis of the level of development of their 
economic, political and healthcare systems has varied over the last few decades, with 
terms often used in a purely descriptive sense, or for statistical convenience and not 
necessarily conveying any objective judgement about the stage reached by a 
particular country in the processes of human development.  Numerous terms have 
been used with varying degrees of acceptance, acceptability and usefulness (table 1). 
A developing country (otherwise described as a low- or middle-income country 
(LMIC), less developed country, less economically developed country (LEDC), or 
underdeveloped country (UDC)) is a country with a less developed industrial base and 
a low Human Development Index (HDI) relative to other countries (United Nations 
Development Programme, 1990; United Nations Statistics Division, 2017).  However, 
this definition is not universally agreed upon; nor is there any clear agreement over 
which countries fit this category. 
The term ‘developing’ describes a currently observed situation and not a changing 
dynamic or expected direction of progress.  Since the late 1990’s, many developing 
countries have tended to demonstrate higher growth rates than developed countries.  
Developing countries include, in decreasing order of economic growth: newly 
industrialized countries, emerging markets, frontier markets, and least-developed 
countries; the latter being the poorest of the developing countries (United Nations 
Department of Economic and Social Affairs - Development Policy and Analysis 
Division, 2018). 
Developing countries tend to have some characteristics in common.  In particular, 
with regards to health risks, they commonly have: low levels of access to safe drinking 
water, sanitation and hygiene; energy poverty; high levels of pollution (e.g. air 
pollution, indoor air pollution, water pollution); high proportion of people with 
tropical and infectious diseases; high number of road traffic accidents.  Often, there is 
also widespread poverty, low educational levels, corruption at all government levels 
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and a lack of good governance.  Effects of global warming (climate change) are 
expected to impact developing countries more than wealthier countries, as most of 
them have a high ‘climate vulnerability’. 
The so-called ‘three-world’ model was used after the second world war to define 
countries aligned with NATO (the first world), the Communist Bloc (the second 
world), or neither (the third world) (Leonard, 2006).  Since the mid- 1970’s the 
concept has been extended to include stateless, poor, and marginal nations, ancient, 
indigenous tribal, and non-industrial nations and nation-states (the fourth world) 
(Manuel and Posluns, 1974).   
Hence, the ‘third world’ was originally a political, rather than an economic, grouping.  
Since the end of the Cold War, the term ‘third world’ has been used interchangeably 
with developing countries, although the concept no longer represents the true 
political or economic state of the world. 
The concept of an HDI was introduced by the United Nations Development 
Programme in 1990 (United Nations Development Programme, 1990; United Nations 
Development Programme, 2016).  It is a summary measure of average achievement in 
key dimensions of human development e.g. health (the ability to lead a long and 
healthy life as evidenced by average life expectancy at birth), education (the ability to 
acquire knowledge as evidenced by mean years of schooling), and standard of living 
(as evidenced by the gross national income (GNI) per capita).  Hence, the focus of HDI 
represents a move away from the narrow and misleading attention on a single 
dimension of human life, whether social, political or economic, to a more holistic 
approach (figure 1).  The most recent UNDP report extends the concept of the HDI 
further, with additional composite indices, covering inequalities, gender, gender-
inequality (highlighting women’s empowerment), and non-income dimensions of 
poverty (United Nations Development Programme, 2016).   
The relationship between the dimensions of HDI and the occurrence of obstetric 
urogenital fistula is self-evident, and the concordance is illustrated in figures 1 and 2.  
The papers submitted describe (and/or compare) epidemiology and treatment 
outcomes of urogenital fistulas from the UK (in the highest quartile of HDI), and 
Nigeria and other countries in sub-Saharan Africa (in the lowest quartile of HDI).  
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Table 1: Matrix of classifications of well- and poorly-resourced countries
Source (reference)
Scale
Well-resourced                                                           Poorly-resourced
United Nations (1)
Descriptive
developed developing
developed newly industrialised emerging markets under-developed/least-developed
NATO & Warsaw pact (2)
Political (post-WWII)
1st world
NATO aligned
2nd world
Soviet Union, China and their allies
3rd world
Non-aligned
George Manuel (3)
Political
1st world
NATO aligned
2nd world
Soviet Union, China and their allies
3rd world
Non-aligned
4th world
sub-populations excluded 
from global society
World Bank (4)
Gross national income (GNI) per 
capita (US$)
high-income
≥ $12,056
upper middle-income
$3896 to $12,055
lower middle-income
$996 to $3895
low-income
≤ $995
UNDP (5)
Human development index (HDI) highest 25% HDI > median HDI < median HDI lowest 25% HDI
UNDP (6)
Adjusted versions of HDI
Inequality-
adjusted HDI
Gender-development 
Index
Gender Inequality 
Index
Multidimensional 
Poverty Index
1. Millennium development indicators: world and regional groupings. (2017) United Nations Statistics Division. https://unstats.un.org/unsd/mi/worldmillennium.htm 
2. Leonard TM. (2006). ”Third World”.  Encyclopedia of the Developing World. 3. Taylor & Francis.
3. Manuel G, Posluns M. (1974) The Fourth World: An Indian Reality.  University of Michigan, Free Press.
4. Fantom N, Khokhar T, Purdie E. (2016). The 2016 edition of World Development Indicators is out: three features you won't want to miss. The Data Blog. The World Bank.
5. United Nations Development Programme (1990) Human Development Report.  http://hdr.undp.org/sites/default/files/reports/219/hdr_1990_en_complete_nostats.pdf.
6. United Nations Development Programme (2016) Human Development Report. http://hdr.undp.org/sites/default/files/HDR2016_EN_Overview_Web.pdf
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Figure 1: World map of the Human Development Index by country, grouped by 
quartiles (based on 2015 and 2016 data) (Wikipedia, 2018). 
 
 
Figure 2: World map of fistula surgeries (based on 2014 and 2016 data) (Fistula 
Foundation et al., 2018) 
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Whilst seeking to avoid the pejorative nature of some earlier and simpler terms, yet 
recognising the, as yet, limited application of more recent composite taxonomy, the 
terms ‘high-income country’ (HIC) and ‘low- and middle-income countries’ (LMICs) will 
be used henceforth throughout this submission, to include the general descriptive, 
political, economic and developmental categorisations of global society.  Hence, they 
embrace such terms as ‘developed’ and ‘developing’, ‘well-resourced’ and ‘poorly 
resourced’, ‘first world’ and ‘third world’ etc., respectively. 
 
QUALITY OF AVAILABLE EVIDENCE 
Although there is a large body of literature on urogenital fistula, most is of low 
scientific quality (Abrams et al., 2012; de Ridder et al., 2013; Hillary et al., 2016; Bodner-
Adler et al., 2017).  The majority of published articles are case series or simple 
observational data, and would be classified as level III and IV evidence, based on the 
International Consultation on Urological Diseases (ICUD) modified version of the 
Oxford Centre for Evidence-based Medicine (OCEBM) grading system (Abrams and 
Khoury, 2010; Howick et al., 2011a; Howick et al., 2011b) (table 2a).  Only seven 
randomised controlled trials (RCTs) have been identified, concerning causation 
(Meeks et al., 1997), perioperative antibiotic prophylaxis (Tomlinson and Thornton, 
1998; Muleta et al., 2010b), surgical techniques (Safan et al., 2009; Shaker et al., 2011), 
and duration of postoperative catheterisation (Nardos et al., 2012; Barone et al., 2015).  
As a result, there are few evidence-based guidelines, and recommendations for 
practice are limited to grade C, or even D (i.e. ‘no recommendation possible’) (Abrams 
and Khoury, 2010; Howick et al., 2011a; Howick et al., 2011b) (table 2b).  Recent World 
Health Organisation (WHO) guidance on the duration of bladder catheterisation after 
surgical repair of simple obstetric urinary fistula, whilst based on two RCTs and 684 
treated women (Nardos et al., 2012; Barone et al., 2015), described their outcomes as 
reflecting low or very low quality evidence (World Health Organization, 2018).   
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Table 2: (a) Summary of IUCD modified OCEBM systems for levels of evidence (above) 
and (b) grades of guideline recommendation (below). 
 
Epidemiology of urogenital fistulas 
AETIOLOGY 
Urogenital fistulas rarely occur congenitally (Dolan et al., 2004), and are most often 
acquired from obstetric, iatrogenic (surgical), radiation and malignant causes.  Most 
reports suggest that whilst approximately 70% of fistulas reported from HICs are of 
iatrogenic aetiology (Moir, 1973; Lawson, 1978; Hilton, 2001), less than 10% of those 
reported from LMICs follow pelvic surgery.  In contrast, over 90% of fistulas reported 
from LMICs are of obstetric aetiology (most following neglected obstructed labour) 
(Waaldijk, 1989; Danso et al., 1996; Hilton, 2003), whereas less than 10% of cases 
reported from HICs are associated with pregnancy (most of those following some 
obstetric surgical intervention).  Whilst genital trauma is uncommon as a cause of 
fistula in HICs, vaginal pessaries for the management of pelvic organ prolapse (POP) 
or other foreign bodies used for sexual purposes are occasionally seen as aetiological 
factors.  In areas of the world where extreme gender-based violence is used as a 
strategy of war (Mukwege and Nangini, 2009; Mukwege et al., 2010), fistula may be 
Level 
of evidence Description
I Meta-analysis of RCTs or high quality RCT
II Low quality RCT or good quality prospective cohort study
III Good quality retrospective case-control study or cohort study
IV Expert opinion
Grade of 
recommendation Description
A Usually consistent with level I evidence
B Consistent with level II or III evidence or ‘majority evidence’ from RCTs
C Level IV evidence or ‘majority evidence’ from level II or III studies
D No recommendation possible because of inadequate or conflicting evidence 
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seen as part of the broad complex of medical, psycho-social and socio-economic 
consequences for survivors (Onsrud et al., 2008; Mukwege and Berg, 2016). 
 
INCIDENCE AND PREVALENCE 
Obstetric fistula – in low- and middle-income countries 
Current estimates of the global prevalence of untreated obstetric fistulas vary from 
654,000 to 3,500,000 (Muleta et al., 2012).  National and regional community-based 
estimates of prevalence are more consistent at between 1.2 and 1.7 per 1,000 women 
surveyed in Ethiopia (Muleta et al., 2007), Malawi (Kalilani-Phiri et al., 2010), 
Bangladesh (Walz et al., 2003) and south-east Asia (Adler et al., 2013).  Reports of the 
incidence of obstetric fistula show much greater variation, with a difference between 
estimates of approximately ten-fold.  The only prospective population-based study 
found an overall incidence of 0.10 per 1,000 births, and an incidence in rural areas of 
1.24 per 1,000 births in West Africa (Vangeenderhuysen et al., 2001).  On the basis of 
this work these authors estimated a minimum of 33,451 (95 % confidence interval (CI) 
4,050 – 120,413) new cases annually in rural sub-Saharan Africa.  Whilst the global 
incidence of obstetric fistula has been expressed as 0.1 to 1.5 per 1000 births (de 
Ridder et al., 2013), hospital-based reports give figures approximately four times 
higher, at between 0.4 and 6.5 per 1,000 births (Muleta et al., 2012). 
Non-obstetric fistula – in high-income countries 
There are few robust data available on the prevalence of non-obstetric fistula in HICs.  
Data from Hospital Episode Statistics (HES) for England over the last 25 years indicate 
an average of 104 (95% CI 100.0, 107.5) procedures for the treatment of VVF, and 13 
(95% CI 12.0, 14.4) for urethrovaginal fistula (UVF) annually.  These are for procedures 
undertaken as the patient’s ‘main procedure’; the equivalent figures for ‘all’ 
procedures are 127 (95% CI 122.4, 132.4) and 18 (95% CI 16.3, 19.0), giving a national 
annual incidence of 145 operations for lower urogenital fistula (figure 3).  Assuming a 
population of 20,000,000 women aged 15-64 years, this gives an incidence of 0.73 
fistula per 100,000 women per year, or approximately 1 in 140,000 – candidate’s own 
calculations based on HES downloaded 1992-2017 from (Department of Health, 2018). 
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Figure 3: ‘Main’ and ‘all’ annual procedures for VVF (OPCS P25.1) and UVF (OPCS 
P25.2) repair in NHS in England, 1990-91 to 2015-16. 
 
RISK OF LOWER URINARY TRACT FISTULA AFTER HYSTERECTOMY 
Although injury to the lower urinary tract and subsequent fistula formation can occur 
at any pelvic surgery, it is with hysterectomy that the risks appear to be greatest, and 
have been reported to be between 0.1% and 4% (Forsgren and Altman, 2010).  In a 
national study from Sweden the rate of women undergoing fistula surgery of any type 
was reported as 0.26% in women who had undergone hysterectomy, compared to 
0.0007% in those not exposed to hysterectomy, the ‘number needed to harm’ being 
estimated at 5700 (Forsgren et al., 2009).   
The previous largest series describing bladder injury and/or fistula in association with 
hysterectomy is that from Harkki-Siren et al., examining 62,379 hysterectomies in 
Finland (Harkki-Siren et al., 1998), although it is highly likely that this significantly 
underestimates the rate of cystotomy, since they describe only 30 (0.05%) 
cystotomies, yet 52 (0.08%) fistulas.  A number of other studies have reported the rate 
of unintentional cystotomy at pelvic surgery and the subsequent rate of fistula 
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formation (Hadley et al., 1994; Mehra et al., 1996; Mathevet et al., 2001; Duong et al., 
2011).  Meta-analysis of these series indicates an average rate of cystotomy of 1.9% 
with 7% of those, i.e. 0.13% or approximately 1 in 750 overall, going on to develop a VVF 
(de Ridder et al., 2013). 
 
RISK OF URETERIC INJURY AFTER HYSTERECTOMY 
Ureteric injury is an uncommon but serious complication of gynaecological surgery; 
iatrogenic trauma is the commonest cause of ureteric injury.  In the Finnish series 
cited above the incidence of ureteric injury associated with hysterectomy for benign 
disease was 0.2%, with the lowest rate being associated with vaginal hysterectomy 
(Harkki-Siren et al., 1998).  A registry study from the USA found the overall incidence 
of ureteric injury during radical hysterectomy to be 0.8% (Likic et al., 2008).  Recent 
systematic reviews have reported that gynaecological and colorectal surgery may be 
associated with ureteric injury in up to 6% of cases (Brandes et al., 2004; Summerton 
et al., 2012; de Ridder et al., 2013). 
It is often stated that the majority of iatrogenic ureteric injuries follow what was 
thought at the time to have been straightforward operations.  Presumed risk factors 
include those contributing to abnormal anatomy, abnormal tissue adhesion or major 
intraoperative haemorrhage.  Risks are higher in surgery for pelvic malignancies, and 
this may reflect one or more of these factors.  
Injury to the ureter at hysterectomy most typically occurs in the lower third, the most 
common mechanisms being, in descending order of frequency, ligation, kinking by 
suture, transection/avulsion, partial transection, crush, and devascularization 
(Brandes et al., 2004).  It is perhaps because of these mechanisms that the diagnosis 
of iatrogenic ureteric injury is often delayed, and identified only after the index 
procedure, in 65–80% of cases.  The delay in diagnosis results in more common and 
serious complications including renal unit loss. 
 
 10 
Patterns of care for fistula 
Although attempts have been made to formulate treatment algorithms for lower 
urinary tract and ureterovaginal fistula of both surgical and radiation aetiologies (de 
Ridder et al., 2013), there have never been widely accepted national or international 
pathways for the care of women with urogenital fistula. 
 
OBSTETRIC FISTULA – IN LOW- AND MIDDLE-INCOME COUNTRIES 
Women with obstetric fistula commonly report delay or difficulty in accessing 
essential healthcare services both for emergency obstetric care and for obstetric 
fistula services.  This may reflect long distances to reach care, difficult terrain, poor 
transportation networks, lack of money, lack of family support or permission, the 
view that parturition is something that can be managed at home, or the wish to try 
traditional remedies before recourse to modern medicine (de Vries et al., 2012).  These 
delays, in the decision to seek care, in arrival at a health-care facility, and in the 
provision of adequate care in hospital have been termed ‘Maine’s delays’ (Thaddeus 
and Maine, 1991).  Amongst reported series of obstetric fistula patients, up to 96% of 
women laboured for more than 24 hours (Ndiaye et al., 2009), and 24% for more than 
96 hours (Muleta et al., 2010a). 
Whilst there may be specific local or regional beliefs and practices influencing access 
to emergency obstetric care, similar issues may also affect women’s access to fistula 
care.  In keeping with this conjecture, one study from northern Nigeria found that 
women with a longer duration of suffering with fistula also had a longer duration of 
labour (Tahzib, 1983).  In other reports the median length of time living with obstetric 
fistula varies between eight months (Muleta et al., 2010a) and eight years, being 
longer in more rural environments (Muleta et al., 2007; Bangser et al., 2011). 
 
NON-OBSTETRIC FISTULA – IN HIGH-INCOME COUNTRIES 
In high income settings, whilst waiting times for treatment vary by country, by region, 
and by specialty, in general the development of a urogenital fistula would be seen as 
justifying urgent care.  Delays in seeking or obtaining care, as described for obstetric 
fistula, would be most unusual.   
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In UK, although over 80% of urogenital fistulas develop following gynaecological 
surgery, 75% of fistula repair procedures carried out in the 1990s were undertaken by 
urologists (Hilton, 1997).  Although only 150 fistula repair procedures were reported in 
HES annually at that time, over 80 hospitals returned data on repair procedures, 
undertaken by surgeons who, in most cases, carried out between one procedure 
every 5 years (gynaecologists) and one procedure per year (urologists) (Hilton, 1997).  
Such idiosyncratic patterns of care are contrary to what is known about the 
relationship between workload and outcome of treatment.   
Although the evidence on surgical and other interventional procedures tends to 
suggest that higher procedure volume is associated with better outcomes, the 
consistency and size of the effect varies for different procedures.  A systematic review 
of 135 studies found a significant association between higher volume (hospital or 
surgeon) and better outcomes in about 70% of studies; none of the studies found a 
significant association between higher volume of any type of surgery and poorer 
outcome (Halm et al., 2002).  In these studies, the definition of low or high volume 
varied between procedures, with median low volumes of up to 100–200 for coronary 
angioplasty or coronary artery bypass graft surgery; and median low volume values 
ranging from 1 to 73 for other procedures described (mainly in the region of 10–30). 
No previous studies have reported the outcomes of fistula surgery according to the 
volume of surgery undertaken, although there are some comparable data in relation 
to other continence surgery.  One case series of retropubic ‘bottom-up’ mid-urethral 
tapes considered the cure rates for each of the ten surgeons who undertook the 
retropubic ‘bottom-up’ tape procedure, which ranged from 72% to 92% and were not 
significantly associated with the number of procedures performed (11–250 per 
surgeon) (Holmgren et al., 2005).  From Finnish national data on retropubic ‘bottom-
up’ tapes, it was estimated that the incidence of complications was 40% in hospitals 
where 15 or fewer operations had been undertaken, and 14% in centres performing 
more than 15 operations (Kuuva and Nilsson, 2002). 
Although the UK retropubic ‘bottom-up’ mid-urethral tape (TVT™)/colposuspension 
RCT (Ward and Hilton, 2002; Ward and Hilton, 2004; Ward and Hilton, 2008), was not 
powered for subgroup analysis, evaluation of recruitment numbers and outcome was 
undertaken (Hilton, 2002).  It is difficult to put the numbers into context because 
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recruited cases may have represented only a proportion of the continence surgery 
undertaken in respective centres.  Notwithstanding, objective cure rates were higher 
for centres recruiting more patients; the categories analysed being more than 30 
patients, 21–30, or fewer than 20.  While it must be conceded that the effect of drop-
outs on an intention-to-treat analysis is greater on units recruiting small numbers of 
patients, it was felt nevertheless that there may be a minimum workload consistent 
with optimal surgical outcome (Hilton, 2002). 
Other studies have reflected on the ‘learning curve’ with the retropubic ‘bottom-up’ 
mid-urethral tape procedure, each showing that the complication rate, or specifically 
bladder injury, was relatively higher during the surgeon’s training period, the 
threshold/definition for which differed across the studies, from the first 5, 10–20, 50 or 
100 procedures (Lebret et al., 2001; Neuman, 2004; McLennan and Melick, 2005; 
Schraffordt Koops et al., 2005; Maguire et al., 2013; Hilton and Rose, 2016). 
With these latter data in mind, the pattern of care provided to women with urogenital 
fistula in the UK described above, with a large number of surgeons each undertaking 
small numbers of procedures annually, might be seen as idiosyncratic, and likely to be 
associated with suboptimal outcomes. 
 
Outcomes of treatment for lower urinary tract fistula 
DEFINITION OF CURE 
There is no universally accepted definition of success or scale of outcome in the 
treatment of urogenital fistula, and definitions applied vary considerably between 
studies.  Historically, outcomes have been evaluated dichotomously on the basis of 
‘success’ or ‘failure of anatomical closure’ of the fistula.  In most LMICs this has been 
based on observed or patient-reported leakage, or on vaginal examination findings at 
the time of catheter removal or discharge from hospital.  In HICs it has been common 
practice to perform imaging, using cystography or video-cystourethrography, prior to 
catheter removal following surgery, and to use this as a measure of immediate 
outcome. 
The definition of success may be different when seen from the patient perspective, 
and a woman whose fistula is closed but who remains incontinent may be just as 
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debilitated as a woman whose repair failed.  Estimates of persistent urinary 
incontinence (UI) after successful closure of obstetric fistula are likely to be 
significantly underestimated in epidemiological literature, but range from 16% to 33% 
depending on the sample size and case complexity (Mourad et al., 2012). 
With the recognition of this so-called ‘continence gap’ (Wall and Arrowsmith, 2007), 
authors have expanded outcome scales to include functional in addition to structural 
outcomes.  Hence, a scale incorporating ‘anatomical closure of fistula without residual 
incontinence’, ‘anatomical closure with residual incontinence’, and ‘failed repair’, is seen 
as more appropriate.   
The need for further surgery – either repeat fistula repair, or secondary urinary 
diversion – has been used to imply failure of initial surgical management.  Perhaps 
such a scale could usefully be expanded to include the need for surgery for urgency 
urinary incontinence (UUI) or stress urinary incontinence (SUI), thus incorporating the 
concept of the ‘continence gap’ into a surgical outcome scale. 
In the evaluation of treatment outcome for other causes of UI there has been an 
increasing move towards the incorporation of patient-defined treatment goals 
(Elkadry et al., 2003).  Although little used to date in surgical or fistula literature, the 
use of composite outcomes, reflecting the overall worth of treatment and the 
patient’s individual experience and interaction with the healthcare system, should 
also be considered (Hilton and Robinson, 2011).  In the context of the obstetric fistula 
patient this might include not only the achievement of urinary and/or faecal 
continence, but also social re-integration, economic stability, role definition, 
restoration of fertility and/or sexual function, and the attainment of pregnancy and 
motherhood, as desired by the woman (de Ridder et al., 2013). 
The WHO published a classification of obstetric fistula that divided fistula in simple or 
complex fistula (de Bernis, 2007); this has been adapted by adding radiation fistula to 
the complex fistula group (de Ridder et al., 2013) (table 3). 
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Table 3: Adapted WHO fistula classification (de Bernis, 2007; de Ridder et al., 2013) 
 
 
The categorical and continuous definitions of cure and scales of outcome are 
summarised overleaf (table 4). 
 
 
Simple fistula with good prognosis Complex fistula with uncertain prognosis
• Single fistula • Multiple fistulae
• Fistula <4cm diameter • Fistula >4cm diameter
• Vesicovaginal fistula • Rectovaginal or cervical fistula
• Closing mechanism not involved • Closing mechanism involved
• No circumferential defect • Circumferential defect
• Minimal tissue loss +/- scarring • Extensive tissue loss +/- scarring
• Ureters not involved • Intravaginal ureters
• No previous attempt at repair • Failed previous repair/s
• Radiation fistula
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Table 4: Summary of outcome measures for fistula treatment 
Scale (categories/sub-groups) Success Failure
Anatomical Visual (2)
Successful anatomical closure Failure of anatomical closure
Imaging (2) Negative cystourethrogram Positive cystourethrogram
Anatomical/functional (2/3)
Successful anatomical closure Failure of anatomical closure
No incontinence Residual incontinence Residual leakage via fistula
Surgical (2/4)
Successful closure Failure of repair
No further surgery Surgery for UUI or SUI Repeat fistula repair Secondary diversion
Symptomatic/PROM (2/4)
No leakage Leakage persists
Urgency UI Stress UI Continuous UI
Quality of life (continuous)
Improvement in individual domain                                                        No improvement in scores
scores and/or total score
Patient-defined goals (PDG’s)
(continuous)
Achievement of PDG’s e.g. urinary and faecal continence; 
reintegration into society;  restoration of sexual function              Failure to reach any or all PDG’s
and fertility; achievement of pregnancy and motherhood
Scale (continuous) Success Failure
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CLASSIFICATION OF FISTULA AND TREATMENT OUTCOME 
Historically, classification systems for fistula have been based largely on the size and 
site of the fistula (Moir, 1967; Lawson, 1968), with Moir particularly recognising the 
importance of circumferential tissue loss.  More recent classification systems have 
incorporated position in relation to fixed reference points (as opposed to an 
anatomical description), the extent of scarring and urethral involvement, and type of 
surgical intervention or anticipated surgical difficulty (Goh et al., 2009).  The most 
widely used systems for classification of obstetric fistulas in LMICs have been those 
described by Waaldijk (Waaldijk, 1989) and Goh (Goh, 2004).   
Classification of fistula might be said only to be useful if it can be shown to determine 
aspects of treatment (e.g. optimal surgical approach) or outcome.  A significant 
increase in post-fistula repair UI has been found in association with both 
circumferential fistula (Bird, 1967), and the markedly stenosed vagina (Gray, 1970).  In 
a postoperative follow-up study of 987 women assessed preoperatively by the Goh 
classification, those women with high (type 1) or small (type a) fistulas were more 
likely to be continent after repair, whereas those with circumferential fistulas or with 
previous unsuccessful repair (type iii) were more likely to have failed closure or post-
fistula repair UI (Goh et al., 2008).   
In the initial description of his classification system, Waaldijk documented the 
occurrence of SUI after repair of fistulas of varying types, describing 1% incidence 
where there was no sphincter involvement in the fistula, and 16% where there was 
both sphincter involvement and tissue loss (Waaldijk, 1989).  More recently the same 
author has reported the rates of fistula closure and postoperative SUI in a consecutive 
series of 1716 women undergoing early repair of obstetric fistula, and confirmed these 
to show rank association with the degree of urethral involvement (Waaldijk, 2009) 
(table 5).   
It should be noted that these two classification systems (Waaldijk, 1989; Goh, 2004), 
with their focus on the urethra and bladder neck (i.e. the area at greatest risk from 
compression in labour), are appropriate for the evaluation of obstetric fistulas in 
LMICs; they are however of limited value in the grading of fistulas in HICs, where the 
largest proportion involve the vaginal vault, reflecting the predominance of iatrogenic 
surgical (especially post-hysterectomy) aetiology. 
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Table 5: Waaldijk classification of obstetric fistula showing postoperative closure and 
incontinence rates in 1716 consecutive women undergoing early closure of type I & II 
fistulas (Waaldijk, 2009; de Ridder et al., 2012). 
 
 
URINARY TRACT FUNCTION IN ASSOCIATION WITH FISTULA AND FISTULA REPAIR 
In the above seminal works on classification by Waaldijk and Goh, sphincter 
involvement was determined on a purely anatomical basis (Waaldijk, 1989; Goh, 
2004), and treatment outcome on a purely symptomatic basis (Goh et al., 2008; 
Waaldijk, 2009).  Waaldijk has emphasised the importance of functional assessment 
prior to repair, especially in those patients with a long delay between fistula 
development and treatment, where bladder compliance is at risk.  However, given the 
resource-poor settings in which he practices, and lack of available dynamic 
Waaldijk
classification
Diagrammatic N Closed at 1st operation Incontinent
I 243 238 (98%) 1 (0%)
IIAa 888 868 (97% 11 (1%)
IIAb 366 333 (91%) 30 (9%)
IIBa 87 80 (96%) 14 (16%)
IIBb 132 114 (86%) 59 (49%)
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assessments, he has described measurement of bladder length as a surrogate for 
bladder capacity, indicating poorer outcome in women with a longitudinal bladder 
diameter of <6cm. (Waaldijk, 2008).  
The application of cystometry in the evaluation of women with residual symptoms 
after surgical closure of obstetric fistula (Schleicher et al., 1993; Murray et al., 2002; 
Goh et al., 2013) confirms the high rate of urodynamic stress incontinence (USI) and 
mixed USI and detrusor overactivity (DOA) postoperatively, the latter authors in 
particular emphasising the need for greater consideration of medical treatment.  
Whilst not carrying out urodynamic investigations, Ekwedigwe et al., reported on the 
high incidence (45%) of bladder spasm in women immediately following repair of 
obstetric fistula, and found this symptom to be associated with poor outcome from 
surgery (Ekwedigwe et al., 2017). 
The application of urethral pressure measurement, and identification of intrinsic 
sphincter deficiency in association with UVF has been reported previously (Sand and 
Ostergard, 1995), although its clinical usefulness remains in doubt (Hilton, 1990).  
There are no previous reports of cystometry in fistula patients before repair surgery.  
Recording detrusor pressure during cystometry depends on the ability to record 
intravesical pressure as distinct from intra-abdominal pressure.  Conventionally the 
latter is determined from rectal or vaginal pressure.  The feasibility of carrying out 
cystometry in patients with communication between the urinary and the genital tract 
may therefore be questioned (Abrams and Hilton, 2002). 
 
TREATMENT OUTCOMES 
Conservative management 
Before epithelialisation is complete an abnormal communication between viscera will 
tend to close spontaneously, provided that the natural outflow is unobstructed.  
Normal urinary continence mechanisms, however, involve the physiological 
contraction and intermittent relaxation of urethral sphincter mechanisms (or anal 
sphincters in the case of anal continence).  As a result, although completely 
spontaneous closure of genital tract fistulas does occur, it is the exception rather than 
the rule.  Bypassing the sphincter mechanisms, or diverting flow around the fistula, 
for example by urinary catheterisation or percutaneous nephrostomy (or by 
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colostomy in the case of colo- or recto-vaginal fistula), may however encourage 
closure.  Recent systematic and non-systematic reviews found closure with catheter 
drainage alone in 13% (95%CI 0%, 36%) and 31% (95%CI 7%, 81%) of included surgical 
fistulas, respectively (Bazi, 2007; de Ridder et al., 2013).  
In large series of obstetric fistulas where a consistent approach to conservative 
management has been applied, spontaneous healing has been reported in 15-28% of 
cases (Waaldijk, 1997; Waaldijk, 2004).  Patients with ongoing, continuous vaginal 
leakage despite a functioning indwelling catheter are unlikely to have resolution of a 
VVF without surgery.  Such patients should be spared prolonged catheter drainage 
and proceed with more definitive repair as soon as medically appropriate.   
Within their systematic review of the management of VVF following benign 
gynaecological surgery, Bodner-Adler and colleagues evaluated the outcomes from 
‘conservative’ treatments (Bodner-Adler et al., 2017).  Only 16% women were reported 
to have undergone prolonged catheter drainage, with only 8% resolving.   
The same authors also included what might be more appropriately considered as 
minor surgical treatments e.g. endovaginal application of cyano-acrylic glue or 
platelet-rich fibrin glue, transvaginal injection of fibrin sealant, neodymium/holmium 
yttrium-aluminium-garnet (YAG) laser welding, electrocoagulation/fulguration, 
curettage of the track and the use of a rubber/metal ball.  They described success 
rates between 67% and 100%, although a total of only 50 women were included, with 
between 1 and 18 highly selected women being treated by these various techniques.   
Surgical management 
The literature relating to the management of surgical fistula is extensive, but of 
limited quality.  Chassar Moir and Lawson reviewed the position with regard to 
urogenital fistulas in Britain in the 1970’s (Moir, 1973; Lawson, 1978), and Lee et al., in 
the USA in the 1980’s (Lee et al., 1988).  However, little has been published on the 
subject since that time, apart from small case series, and descriptions of surgical 
techniques; the largest recent UK series was of 41 cases managed in tertiary practice 
by Ockrim et al., in 2009 (Ockrim et al., 2009). 
Only 107/124 (86%) of the identified studies in the Bodner-Adler et al., review 
documented a success rate (Bodner-Adler et al., 2017).  Interpretation of their meta-
analysis of outcome is difficult; they report ‘success’ rates of 92.9% for ‘conservative’ 
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(minor surgical) treatments and 98.0% for surgical treatments; 97.0% (abdominal), 
93.8% (vaginal), 98.9% (laparoscopic/robotic) and 100% (others).  However, only 
87/1359 (6.4%) of women were apparently completely symptom-free, and 754/1359 
(55.5%) completely dry.  Only 406 (30.0%) were reported to be healed or cured; it is 
not stated, but one assumes this means that these fistulas were anatomically closed, 
but the women experienced some residual symptoms.   
No studies have randomised cases by route of surgery, and clearly few surgeons 
would consider themselves to have equipoise on this point.  The candidate’s 
preference has always been for the vaginal approach where possible, accepting that 
the abdominal route has a place where access vaginally is limited (by virtue of the 
patient’s nulliparity, or previous surgery or other pelvic pathology) or where there is 
concurrent ureteric involvement requiring re-implantation.  Hence, it is not surprising 
that there are no studies randomising patients between route of surgery.  Neither 
Bodner-Adler et al., (Bodner-Adler et al., 2017), nor the International Consultation on 
Incontinence (ICI) review (candidate’s own analysis) (de Ridder et al., 2013) found any 
difference between abdominal and vaginal approaches, nor between transvesical and 
transperitoneal approaches. 
Given the wide variation in case mix, definitions of cure, and duration of follow-up, 
and the overall poor quality of research on fistulas in LMICs alluded to earlier in this 
chapter, the interpretation of reports on the outcome of treatment of fistula is even 
more problematic.  ‘Success rates’ between 45% and 100% are reported. 
Long-term outcomes 
The majority of studies involving fistula patients in LMICs have defined the success of 
a procedure at the time of catheter removal or discharge from hospital; only one 
study has reported later outcomes, albeit that at only six months postoperatively 
(Browning and Menber, 2008).  Reports from HICs have usually reserved the 
definition of success until clinic follow-up.  In the review by Bodner-Adler et al., only 
79/124 (64%) studies provided information on length of follow-up; in this sub-set 
follow-up averaged 20 months (Bodner-Adler et al., 2017).   
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Chapter 2: Group I publications1 
(Works upon which a candidate primarily bases his claim to have satisfied the standards 
for the award of the degree) 
 
This submission for ‘degree by publication’ includes eight papers, comprising: 
• One systematic review, examining: 
o aetiology and treatment comparing HICs and LMICs (paper 1) 
• Two retrospective, individual surgeon, cohort studies describing the 
epidemiology and treatment outcome in: 
o fistula patients managed in south-east Nigeria over a 25-year period 
(paper 2) 
o fistula patients managed in north-east England over a 25-year period 
(paper 3) 
• Two prospective cohort studies examining: 
o urodynamic findings in women with lower urinary tract fistulae, and 
their association with treatment outcome (paper 4) 
o long-term treatment outcome following fistula repair, based on 
symptoms and quality of life (paper 5) 
                                               
1 The candidate’s publications are categorised as group I, IIa and IIb, as follows: 
Group I - Works upon which a candidate primarily bases his claim to have satisfied the 
standards for the award of the degree (Chapter 2); 
Group II - Other works put forward as evidence of the scope of the candidate's 
contribution: 
IIa - to the specific field of study in which the primary submissions lie - i.e. 
urogenital fistula (see Appendix A); 
IIb - to the broader field of study - i.e. urogynaecology (see Appendix B). 
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• Three retrospective national cohort studies based on HES data, examining: 
o the risk of lower urinary tract fistula following hysterectomy (paper 6) 
o the risk of ureteric injury and fistula following hysterectomy (paper 7) 
o patterns of care and outcomes of treatment of lower urinary tract 
fistula in the NHS in England (paper 8) 
 
These publications are listed below, including details of the candidate’s contribution 
to the work in each case; the contribution of other authors is recognised in the 
acknowledgements section on page xi; photocopies of individual publications follow. 
 
1. Hillary C, Osman N, Chapple CR, Hilton P. The aetiology, treatment and 
outcome of urogenital fistulae managed in well- and low-resourced countries: 
a systematic review. Eur Urol 2016; 70(3): 478-492. 
Personal contribution 25%: specific systematic reviews on the epidemiology, and 
management of urogenital and intestine-genital fistula following surgery and 
radiotherapy were carried out by the candidate, as well as drafting of these aspects of 
the manuscript; other searches and writing were carried out by co-authors; all authors 
approved the final version of the manuscript for publication. 
 
2. Hilton P, Ward A. Epidemiological and surgical aspects of urogenital fistulae: a 
review of 25 years’ experience in southeast Nigeria. Int Urogynecol J & Pelvic 
Floor Dysfunct 1998; 9: 189-194. 
Personal contribution 95%: protocol development, data collection, analysis and writing of 
the manuscript were carried out wholly by the candidate; the majority of surgery was 
carried out by my co-author, Sr Dr Anne Ward, who approved the final version of the 
manuscript for publication. 
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3. Hilton P. Urogenital fistula in the UK – a personal case series managed over 25 
years. BJU Int 2012; 110(1): 102-110. 
Personal contribution 100%: protocol development, urodynamic studies, surgery, data 
collection, analysis and writing of the manuscript were carried out wholly by the 
candidate. 
 
4. Hilton P. Urodynamic findings in patients with urogenital fistulae. BJU Int 1998; 
81: 539-542. 
Personal contribution 100%: protocol development, urodynamic studies, surgery, data 
collection, analysis and writing of the manuscript were carried out wholly by the 
candidate. 
 
5. Dolan LM, Dixon WE, Hilton P. Urinary symptoms and quality of life in women 
following urogenital fistula repair: a long-term follow-up study. BJOG 2008; 
115(12): 1570-1574. 
Personal contribution 50%: protocol development, urodynamic investigation, data 
collection, analysis and all surgery were carried out by the candidate.  Some urodynamic 
investigations were carried out by one of my co-authors and drafting of the manuscript 
by the other.  All contributors approved the final version of the manuscript for 
publication. 
 
6. Hilton P, Cromwell D. The risk of vesicovaginal and urethrovaginal fistula after 
hysterectomy performed in the English National Health Service – a 
retrospective cohort study examining patterns of care between 2000 and 
2008. BJOG 2012; 119(12): 1447-1454. 
Personal contribution 50%: protocol development and writing of the clinical aspects of 
the manuscript were carried out by the candidate; coding and analysis of the database 
analysis and writing the epidemiological aspects of the manuscript were carried out by 
my co-author, Dr David Cromwell; both authors approved the final version of the 
manuscript for publication. 
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7. Kiran A, Hilton P, Cromwell DA. The risk of ureteric injury associated with 
hysterectomy: a 10-year retrospective cohort study. BJOG 2016; 123(7): 1184-
1191. 
Personal contribution 50%: protocol development and writing of the clinical aspects of 
the manuscript were carried out by the candidate; coding and analysis of the database 
analysis, and writing the epidemiological aspects of the manuscript were carried out by 
my co-authors, Drs Amit Kiran and David Cromwell; all authors approved the final version 
of the manuscript for publication. 
 
8. Cromwell D, Hilton P. Retrospective cohort study on patterns of care and 
outcomes of surgical treatment for lower urinary-genital tract fistula among 
English National Health Service hospitals between 2000 and 2009. BJU Int 
2013; 111(4b): E257-E262. 
Personal contribution 50%: protocol development and writing of the clinical aspects of 
the manuscript were carried out by the candidate; coding and analysis of the database 
analysis and writing the epidemiological aspects of the manuscript were carried out by 
my co-author, Dr David Cromwell; both authors approved the final version of the 
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Abstract
Context: Urogenital fistula is a global healthcare problem, predominantly associated
with obstetric complications in low-resourced countries and iatrogenic injury in well-
resourced countries. Currently, the published evidence is of relatively low quality,
mainly consisting retrospective case series.
Objective: We evaluated the available evidence for aetiology, intervention, and out-
comes of urogenital fistulae worldwide.
Evidence acquisition: We performed a systematic review of the PubMed and Scopus
databases, classifying the evidence for fistula aetiology, repair techniques, and outcomes
of surgery. Comparisons were made between fistulae treated in well-resourced coun-
tries and those in low-resourced countries.
Evidence synthesis: Over a 35-yr period, 49 articles were identified using our search
criteria, which were included in the qualitative analysis. In well-resourced countries,
1710/2055 (83.2%) of fistulae occurred following surgery, whereas in low-resourced
countries, 9902/10 398 (95.2%) were associated with childbirth. Spontaneous closure
can occur in up to 15% of cases using catheter drainage and conservative approaches are
more likely to be successful for nonradiotherapy fistulae. Of patients undergoing repairs
in well-resourced countries, the median overall closure rate was 94.6%, while in low-
resourced countries, this was 87.0%. Closure was significantlymore likely to be achieved
using a transvaginal approach then a transabdominal technique (90.8% success vs 83.9%,
Fisher’s exact test; p = 0.0176).
Conclusions: It is difficult to conclude whether any specific route of surgery has
advantage over any other, given the selection of patients to a particular procedure is
based upon individual fistula characteristics. However, surgical repair should be carried
out by experienced fistula surgeons, well versed in all techniques as the primary attempt
at repair is likely to be the most successful.
Patient summary: Urogenital fistulae are a common problem worldwide; however, the
available evidence on fistula management is poor in quality. We searched the current
literature and identified that 95% of fistulae occur following childbirth in low-resourced
countries, whereas 80% of fistulae are associated with surgery in well-resourced
countries, where successful repair is also more likely to be achieved. The first attempt
at repair is often the most successful and therefore fistula surgery should be centralised
to hospitals with the most experience.
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1. Introduction
Urogenital fistula represents a major global health problem,
responsible for significant physical, social, and psychological
morbidity. In low-resourced countries (LRC), it is estimated
that at least 3 million women worldwide have an untreated
fistula, while between 30 000 and 130 000 new fistulae
develop annually in Africa alone [1]. Vesico-vaginal fistula is
the most common type and in LRC most often results from
neglected prolonged obstructed labour, which is associated
with tissue ischaemia resulting from compression of the
bladder and vagina by the foetal presenting part against the
bony pelvis. In contrast, urogenital fistulae are relatively
uncommon inwell-resourced countries (WRC) and in the UK
it is estimated that approximately 120 repairs are carried out
on an annual basis [2]. Hence, the literature on fistula repairs
in WRC relates to case series or retrospective cohorts from
relatively fewcentres. In comparison to fistulae in LRC,which
are largely of obstetric aetiology, those that occur inWRC are
associated with iatrogenic factors (surgery or radiotherapy)
in almost three quarters of cases [2].
In response to the growing public health issues
surrounding obstetric vesico-vaginal fistulae, various char-
itable and nongovernmental bodies are involved in the
development ofmanagement programmes and in establish-
ing specific treatment centres [3]. As a result, most fistula
repairs are performed by relatively few fistula surgeons in
areas of high fistula prevalence, each with their own
favoured methods for repair. Therefore, much of our
knowledge results from the opinions of comparatively
few, borne out of large case series rather than a trial setting.
Consequently, there is wide variation in the definitions of
fistula location and complexitywith little standardisation of
treatment protocols and outcome measures.
We aimed to systematically review the current literature
on urogenital fistulae in economically less-resourced and
WRC, with emphasis on the aetiology, approach to
treatment, and the outcomes of fistula management, in
order to allow conclusions to be made about the most
appropriate management of fistulae worldwide.
2. Evidence acquisition
In accordance with the Preferred Reporting Items for
Systematic Reviews and Meta-analysis statement, a pro-
spective search protocol was developed and registered with
the PROSPERO database (ID number: CRD42015019021).
Published evidence was identified through a search of the
PubMed and Scopus databases using the following search
terms: ‘‘obstetric fistula’’, ‘‘vaginal fistula’’, ‘‘bladder fistu-
la’’, ‘‘urethral fistula’’, ‘‘urinary fistula’’, ‘‘vesicovaginal
fistula’’, ‘‘genital fistula’’, and ‘‘fistula’’, which yielded
12 626 articles. The search was limited to women and
the English language and further refined by excluding the
following MeSH headings ‘‘infant’’, ‘‘child’’, ‘‘neonate’’,
‘‘male’’, ‘‘penile’’, ‘‘Crohn’s disease’’, ‘‘hypospadias’’, ‘‘anal’’,
‘‘rectal’’, ‘‘arterial’’, and ‘‘venous’’. The search was limited to
the period between January 1980 and March 2015 and
further excluded case reports, which yielded 680 articles
(Fig. 1). Forty-seven additional records were identified
through searching the references of included articles and
other review texts. Abstract screening followed by full text
screening was performed.
The primary outcome was to report fistula aetiology;
secondary outcomes included surgical technique and surgi-
cal outcomes. Each article was rated following the Oxford
Centre for Evidence-Based Medicine levels of evidence scale
(Fig. 2) [4].
3. Evidence synthesis
After screening these abstracts and excluding articles with
fewer than 20 patients (for quality purposes), 98 full texts
were identified, which includes four articles found through
reviewing the references of other included articles. Of these,
49 were excluded for not reporting fistula aetiology, not
clearly reporting outcomes, or excluding those that describe
a significant proportion of recto-vaginal fistulae or ureter-
ovaginal fistulae. Table 1 demonstrates that from49 studies,
15 studies reported on fistula repair in WRC [2,5–18],
while 34 studies reported on fistula management in LRC
[19–52]. In all, two studies were randomised controlled
trials (RCTs) and two were feasibility cohort studies that
compared new treatments. RCTs compared outcomes for
patients randomised to use fibrin glue compared with
Martius flap interpositioning [42] and to trimming versus
no trimming of the fistula tract [43]. The two cohort studies
included in this review investigated the use of Floseal
haemostatic matrix (Baxter Healthcare Corp., IL, USA) [19]
and porcine small intestinal submucosa (Surgisis Biodesign,
Cook Medical, Bloomington, IN, USA) [25] as interposition
materials. Eleven studies included prospective data, while
34 were retrospective series.
3.1. Fistula aetiology
3.1.1. Surgery/radiotherapy
The 15 included articles reporting data from WRC included
2055 fistulae, of which 1710 (83.2%) were of a surgical
aetiology; in contrast, the 34 included articles reporting
data from LRC included 10 398 fistulae, of which only
459 (4.4%) were of a surgical aetiology (Table 2). Of
the 2055 fistulae in WRC, 46.2% were associated with
simple abdominal hysterectomy and hysterectomy by any
route was an aetiological factor in 62.7% of all fistulae and
75.4% of the 1710 cases of fistulae resulting from surgery.
Some cases were associated with other types of pelvic
surgery (12.7%), including benign and malignant colorectal,
urological, and gynaecological procedures that were other-
wise unspecified in the included articles.
Of the 2055 fistulae reported from WRCs, 268 (13.0%)
followed radiotherapy (with or without previous radical
surgery); in comparison, only 17/10 015 (0.2%) of fistulae
seen in LRCs followed radiotherapy.
3.1.2. Childbirth
Of fistulae reported from LRCs, 9902/10 398 (95.2%) cases
were of an obstetric aetiology. Prolonged neglected
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[(Fig._2)TD$FIG]
Fig. 2 – Evidence-based medicine levels of evidence scale [4].
[(Fig._1)TD$FIG]
Fig. 1 – Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow-diagram to demonstrate progress of articles through the review.
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obstructed labour was a causative mechanism in the
majority of these, and where specified, caesarean section
and instrumental delivery were associated in 9% and 2%
respectively. A further 35.2% of fistulae resulted from
delivery without any further specific details. Emergency
peripartum injury (bladder/uterine rupture, caesarean
hysterectomy for bleeding, or foetal destructive proce-
dures) were associated with fistula formation in 1.8%, 1.9%,
and 0.5% of cases respectively.
Of so-called ‘obstetric fistulae’ in LRCs, 940/9902 (9.5%)
were associated with caesarean section and 1341/9902
(13.5%) were associated with some surgical intervention.
Seventy one out of 2055 (3.5%) fistulae in WRCs were
classified as obstetric in origin; however, those fistulae that
occur following caesarean section in WRCs were classified
as ‘‘surgical fistulae.’’
Miscellaneous causes, such as trauma, foreign bodies, and
infection are not included in these data, as they represented
onlyavery smallproportionof fistula cases; oneof the largest
studies [2] could not be included as the exact aetiology of
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Table 2 – Fistula by aetiology
Cause Well-
resourced
countriesN (%)
Low-resourced
countries N (%)
Surgical causes
Abdominal hysterectomy 949 (46.2) 123 (1.2)
Radical hysterectomy 87 (4.2) 3 (0.0)
Vaginal hysterectomy 39 (1.9) 42 (0.4)
Urethral diverticulectomy 19 (0.9) 0 (0.0)
Anterior colporrhaphy 33 (1.6) 7 (0.1)
Laparoscopic hysterectomy 29 (1.4) 1 (0.0)
Midurethral tape 15 (0.7) 3 (0.0)
Colposuspension 2 (0.1) 0 (0.0)
Autologous fascia sling 12 (0.6) 0 (0.0)
Urethropexy 2 (0.1) 0 (0.0)
Vaginoplasty 0 (0.0) 2 (0.0)
Periurethral bulking agent 8 (0.4) 0 (0.0)
Periurethral cyst excision 16 (0.8) 0 (0.0)
Hysterectomy NOS 185 (9.0) 100 (1.0)
Pelvic surgery NOS 262 (12.7) 162 (1.6)
D&C 1 (0.0) 8 (0.1)
Cystoplasty 2 (0.1) 0 (0.0)
Pessary 11 (0.5) 2 (0.0)
Cystolitholapaxy 0 (0.0) 6 (0.1)
Caesarean section (WRC only) 38 (1.8) – –
Subtotal 1710 (83.2) 459 (4.4)
Obstetric causes
Caesarean section (LRC only) – – 940 (9.0)
Uterine/bladder rupture 9 (0.4) 184 (1.8)
Instrumental delivery 5 (0.2) 208 (2.0)
Caesarean hysterectomy 4 (0.2) 193 (1.9)
Prolonged obstructed labour 3 (0.1) 4665 (44.9)
Foetal destructive procedures 0 (0.0) 57 (0.5)
Obstetric NOS 50 (2.4) 3655 (35.2)
Subtotal 71 (3.5) 9902 (95.2)
Radiotherapy 268 (13.0) 17 (0.2)
Malignancy 0 (0.0) 14 (0.1)
Congenital 6 (0.3) 6 (0.1)
Total 2055 10 398
D&C = dilatation of cervix and curettage of endometrium; LRC = low-
resourced country; NOS = not otherwise specified; WRC = well-resourced
country.
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fistula formation was not apparent and one study included
solely radiotherapy induced fistulae [17].
3.2. Fistula management
Six studies directly commented on the conservative treat-
ment of fistulae (two in LRCs and four in WRCs)
[5,10,37,45,49,52]. In WRCs, the usual current practice is to
perform a delayed repair of the fistula following a period of
catheter drainage to allow necrotic tissue to slough and local
inflammatory responses to subside. Successful closure rates
from this conservative management approach, however, are
likely tobeunderestimatedgiven that successfuloutcomes in
this context are not referred for surgical intervention, and
therefore oftenunreported. A similar ‘‘delayed’’ approachhas
usually been undertaken in LRCs, although both Waaldijk
[52] and Tayler-Smith et al [49] selected patients for
conservative management if the time-to-fistula develop-
ment was short, the fistula itself was small (<3 cm), and
the prospects for spontaneous healing were good. In the
Waaldijk series [52], catheter drainage was continued in
265/1716 (15.4%) of patients, achieving fistula closure in
264 patients, while Tayler-Smith et al [49] demonstrated
spontaneous closure rates in four out of 35 (11%) patients.
Patients with a longer history or those in whom the fistula
edgeswere cleanwere selected for immediate surgery,while
those with no evidence of healing following catheterisation
underwent repair. In total, 1451/1716 cases in the Waaldijk
[52] series were treated with surgery, with anatomical
closure in 1369/1451 (94.3%).
Given the heterogeneity in fistula characteristics and
locations, it is difficult to comment on the surgical approach.
Of studies which specify a particular approach in WRCs,
924/1307 (70.7%) of procedures were performed transvagin-
ally. In comparison, 5376/6369 (84.4%) of patients reported
from LRCs, where a specific approach was documented,
underwent a transvaginal approach; with 14.6% undergoing
a transabdominal procedure and 1% having a combined
abdominal/vaginal approach.
A variety of interposition grafts have been used. These
include omentum or perivesical peritoneum during abdomi-
nal repairs, and the Martius bulbocavernosus muscle/fat
graft, or labial skin flap at transvaginal repairs. Peritoneum
can be used for high fistulae and gracillis myocutaneous
flaps were used in two studies in large or postradiotherapy
fistulae [24,47]. No high quality evidence exists to support
the use of graft interposition in any context, and anecdotally
the use of grafting by obstetric fistula surgeons has declined
in LRCs.
The largest series of radiotherapy-induced fistulae, from
Pushkar et al [17], describes the transvaginal approach in all
patients using either a Martius flap or a Latzko colpocleisis
in patients with small, defined fistulae. Many patients with
radiation-induced fistula will ultimately undergo urinary
diversion either due to the complexity of the fistula itself,
poor tissue viability, anaesthetic issues, or surgeon prefer-
ence [2]. Reporting of patients undergoing diversion are
not included in this review; however, urinary diversion is
seen as a treatment of choice in many patients with
radiotherapy-induced fistulae, owing to the wide field
abnormality in this context. Others argue that in carefully
selected patients with malignant- or radiotherapy-induced
fistulae, repair should be attempted. In Hilton’s series [10]
reported in 2012, of the 19/36 (53%) patients with
malignant- or radiotherapy-induced fistulae who under-
went a primary repair operation, 95% were successfully
closed after the first surgery.
Two feasibility cohort studies [19,25] investigated the
benefit of Floseal haemostatic matrix (Baxter Healthcare
Corp.) and porcine small intestinal submucosa (Surgisis
Biodesign, Cook Medical) grafts respectively. One RCT
investigated theuseof autologous fibrin glueversus standard
Martius flap interposition grafting [42], while the other
assessed the outcomes of patients undergoing trimming
versus no trimming of the bladder edge of the fistula [43].
3.3. Definition of success
The definition of surgical success varies between studies. In
general, these range from ‘‘anatomical closure of fistula’’,
‘‘anatomical closure of fistula but residual leakage’’, or ‘‘failed
repair’’, while others use the ‘‘need for a repeat procedure’’ as
the definition of failure. A common practice in studies in
WRCs is to perform a cystogram prior to catheter removal
following surgery, while those in LRCs opt to perform
catheter removal 14 d postoperatively, with catheter
reinsertion in the presence of continued urinary leakage.
There may therefore be some discrepancy in the reporting of
urinary leakage that is due to the closure of the fistula from
that caused by stress or urgency urinary incontinence.
The timing of the outcome definition is clearly impor-
tant. While the majority of studies involving patients in
LRCs will define the success of a procedure at the time of
catheter removal, those in WRCs will reserve the definition
of success until discharge or at clinic follow-up.
3.4. Management outcomes
Of patients managed conservatively, Hilton [10] demon-
strated 24 patients in his UK series (6.9% of total) showing
spontaneous successful closure following 6–8 wk of
catheter drainage; spontaneous closure was not seen in
any of the radiotherapy-induced fistulae in this series.
While in LRCs, successful conservative management was
achieved in 264/1716 patients, constituting 15.6% of
patients and 16.2% of fistula closures in the Waaldijk series
[52], and in four out of 35 (11%) patients with small necrotic
fistulae reported by Tayler-Smith et al [49].
Of patients undergoing surgical closure in WRCs, the
median overall closure rate was 94.6% (range, 75.8–98.6%).
Studies included with the lowest overall success had a high
proportion of radiation-induced fistulae [8,12,17]. In this
context a higher success rate was claimed in one small
series when interposition grafts were used [two out of two
(100%) success rate vs four out of six (67%) when no grafts
were used], although these differences are not statistically
significantly different [8]. The highest anatomical closure
rate of included studies was reported by Pushkar et al [18]
E U RO P E AN URO LOGY 7 0 ( 2 0 1 6 ) 4 7 8 – 4 9 2488
 38 
 
  
for patients undergoing a transvaginal repair of urethrova-
ginal fistulae. Of studies that reported postfistula repair
stress urinary incontinence (SUI) in WRCs [5,6,10,13,18],
the median rate was 6.5% (range, 1.1–51.9%), with the
highest rates seen following a transvaginal repair of
urethrovaginal fistulae.
Of patients undergoing surgical repair in LRCs, the
median overall closure rate was 87.0% (range, 58.0–100%).
The median SUI rate for patients with a closed fistula was
10.0% (range, 3.8–30.0%), across all surgical approaches and
fistula characteristics.
Abou-Elela et al [19] used Floseal matrix to promote
healing and haemostasis and demonstrated 100% success
rates following initial attempts at repair in a series of
20 cases. Farahat et al [25] used porcine small intestinal
submucosa interposition grafting by either transvaginal or
transabdominal approaches in patients with large, compli-
cated vesico-vaginal fistulae. The group demonstrated a
91.3% overall success, with seven out of seven transvaginal
procedures and 14/16 transabdominal procedures achieving
closureover a follow-upperiodof 6mo,withno reported SUI.
In one randomised trial by Safan et al [42], 13/19 (68%) of
patients were dry at the 3-mo postoperative follow-up visit
following a transvaginal repair using fibrin glue versus
11/19 (58%) of patients (not statistically significant)
undergoing a transvaginal repair using a Martius flap.
Shaker et al [43] demonstrated that 24/32 (75%) of patients
had a closed fistula at the 3-mo postoperative follow-up
visit following trimming of the bladder edge of the fistula by
5 mm using a transvaginal approach compared with 21/31
(67.6%) of patients when trimming is not performed. Again,
these findings did not reach statistical significance.
There are no randomised studies available that directly
compare the outcomes of transabdominal versus transvagi-
nal approaches, given that each surgeon has a particular
preference for a certain indication and clearly there would
be ethical issues with the conduct of such a study. Of the
included studies, three [9,10,16] reported the outcomes of
transvaginal versus transabdominal approaches for fistula
repair. Amongst these, the overall success rates were 90.8%
of 286 vaginal repairs and 83.9% of 250 abdominal repairs
(Fisher’s exact test; p = 0.0176). It must be emphasised that
these reports were reviewing nonrandomised cohorts; it is
likely that the particular approach used in individual cases
was selected based on the preoperative evaluation and
dependant on individual surgical bias and it is not therefore
valid to carry out a direct comparison of outcomes.
3.5. Discussion
To the best of our knowledge, this is the first review article
of its type to compare the aetiologies and management of
lower urinary tract fistula in WRCs and LRCs. Most studies
included were retrospective case series, while 11 included
prospective data, two were nonrandomised cohort studies,
and two were RCTs.
We demonstrate that while 83.2% of fistulae in WRCs
result from surgical intervention, 95.2% of fistulae in LRCs
result from obstetric causes. The large majority of obstetric
fistulae seen in LRCs occur as a consequence of prolonged
neglected obstructed labour, where sustained pressure
necrosis arises due to compression of the bladder base and
anterior vaginal wall between the foetal head and
symphysis pubis. Furthermore, iatrogenic injury, especially
of these devitalised areas during a caesarean delivery may
lead to fistula formation subsequently. As the necrotic
tissue sloughs off postoperatively, the fistula may become
manifest. It is important to note that the fistulae that occur
following caesarean section in WRCs are more akin to
surgical fistulae, as prolonged obstructed labour is unlikely
to be involved in this context.
It must be emphasised that the fistulae that occur after
pelvic surgery, are not necessarily a consequence of
inadvertent organ injury or surgical misadventure. Tissues
may become devitalised as a consequence of extensive
dissection or haematoma formation with fistulae forming
weeks later. Fistulae that result following ionising radiation
may present many months to years later and are thought to
occur due to chronic small vessel inflammatory changes
leading to tissue ischaemia.
It is apparent that any surgical procedure in the pelvis
can lead to fistulae formation. In the current study, 75.4% of
postsurgical fistulae resulted following a hysterectomy.
Hilton and Cromwell [53] examined Hospital Episode
Statistics for English National Health Service hospitals
and found that the overall rate of fistula formation following
a hysterectomy was one in 788. Furthermore, the study
demonstrated a 46% rise in the rate of fistula formation
following a hysterectomy from 2000 to 2008, which the
authors concluded could reflect the reduced exposure of
trainees to these cases associated with a fall in the number
of hysterectomies performed.
Spontaneous closure of fistulae is feasible and the rate
with which this occurs is likely to be underestimated due to
the fact these cases are seldomreferred for further treatment.
A 6–8-wk period of continuous catheter drainage allows the
diversion of urine away from the visceral communication,
which canallowspontaneous closurebefore epithelialisation
of the fistula track can occur and this is certainly worth
attempting in patientswith vesico-vaginal or urethrovaginal
fistulae [54]. In patients with a significant degree of necrotic
material and slough, catheterisation can allowmaturation of
the fistulous tract to a sufficient degree that closure can be
performed. Rates of spontaneous closure, even for obstetric
fistulae, are reported in up to 28% of patients when early
catheter drainage is instituted [55]. Radiotherapy-induced
fistulae, however, are seldom if ever associated with
spontaneous closure and operative management should be
performed as appropriate.
There is debate surrounding the optimum timing of
repair; immediate or delayed. While the exact definition of
what constitutes an ‘‘immediate’’ repair varies between
studies, most would consider less than 6 wk. Intuitively,
repair should be performed following a period of catheter-
isation to allow inflammation to settle and necrotic material
to slough off whilst providing the opportunity for spontane-
ous closure and allowing the patient to recover from
the initial surgery. Waaldijk [52] using a definition of
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‘‘immediate’’ as within 3 mo of creation, reported 95.2%
successful initial closure rates. The rationale behind imme-
diate surgical treatment is to prevent distress to the patient,
contain skin irritation, and in LRCs, to minimise stigmatisa-
tion.
There is currently an absence of adequate trial data,
however, to support immediate repair over a delayed
approach. In the experience of the authors, it is certainly
more challenging to perform a repair between the 3rd wk
and the 3rd mo following fistula formation.
A further area of contention in contemporary fistula
surgery surrounds the route of surgery. Clearly, where there
is synchronous ureteric involvement, vesico-uterine fistulae,
or when access to the vagina is limited, then a transabdom-
inal approach is more likely to be indicated. In the current
review, 71% of lower urinary tract fistulae were repaired
transvaginally in WRCs compared with 84% in LRCs. The
success rates for transvaginal versus transabdominal repairs
were 90.8% and 83.9% respectively.While this is a significant
finding, clearly these results should be interpreted with
caution, given that these approaches are not chosen at
random, but based upon specific patient characteristics.
Both laparoscopic- and robot-assisted repair of vesico-
vaginal fistula repairs have been performed. Nezhat et al [56]
performed the first laparoscopic vesico-vaginal fistula repair
in 1994,whileMelamud et al [57] reported on the first robot-
assisted repair of a vesico-vaginal fistula in 2005. The recent
systematic review of the literature performed byMiklos et al
[58] including 44 studies and a total of 256 patients,
demonstrated that there is an absence of appropriate high
level evidence in the contemporary literature and it can
therefore be surmised that a significant selection bias exists
in these articles. Furthermore, only two of the articles
included in this review contained a sample size of> 15 cases.
With minimally invasive approaches, the same surgical
principles as used with open surgery apply: namely
separation of the vagina from the bladder and the interposi-
tion of well-vascularised tissue between both organs.
Vascularised tissue flaps are used to reinforce a repair, fill
deadspace, and to improvevasculogenesis followinga repair.
While this can be useful in complex, radiotherapy-induced,
recurrent, or obstetric fistulae, there is no high level evidence
to confirm benefit of tissue interposition, particularly as the
decision to use tissue transfer techniques is based on specific
fistula characteristics. Despite this, a Martius interposition
flap is readily available during a transvaginal approach and is
therefore commonly performed in this context. During an
abdominal procedure, the greater omentum is commonly
used as an interposition flap, while a variety of other tissues
and materials have been used, including peritoneum
[9,22,24,45], gracillismuscle [24,47], porcine small intestinal
submucosa [25], Floseal haemostatic matrix [19], and
bladder mucosa advancement flaps [6].
4. Conclusions
We have reviewed the English language literature since
1980 relating to lower urinary tract fistula, with a view to
highlighting differences in aetiology and management
between LRCs and WRCs. Only 49 relevant studies were
identified, and most were of low quality.
Over 80% of all fistulae reported in the included studies
were of obstetric aetiology, and of those reported from LRCs,
childbirth was the causative factor in over 95%. In contrast,
of the fistulae reported in the included studies from WRCS,
over 80% occurred following pelvic surgery, with hysterec-
tomy being the antecedent operation in over three quarters
of these cases.
Closure of a fistula can be achieved in up to one third of
cases by conservative management. Whilst the heteroge-
neity of cases and management pathways makes compari-
son of reported series difficult, spontaneous closure seems
most likely to occur where there has been minimal tissue
damage, and is seen more often with obstetric and surgical
fistulae than postradiation fistulae.
For similar reasons, comparison between different surgi-
cal approaches is also difficult, and is more often based on
individual surgeon preference than on evidence-based
criteria. There is no proven benefit to delayed repair and
surgery can be undertaken once it is clear that conservative
measures are not going to be successful, and as soon as any
oedema, inflammation, tissue necrosis, and infection are
resolved.
There is no high level evidence that any specific route of
surgery has an advantage over any other; similar success
rates are reported for vaginal and abdominal, and for
transvesical and transperitoneal approaches, and for repairs
with and without interposition grafting. It has, however, to
be borne in mind that series tend to be reported from high-
volume centres and as a consequence clinical judgment has
been exercised, rendering cohorts highly selected. Clearly
an abdominal approach may be appropriate in the context
of a complex procedure where the fistula is high in the
bladder, close to the ureter(s), associatedwith radiotherapy,
and involving the uterus. There is limited experience with
laparoscopic approaches and inevitably this will require the
appropriate technical knowledge and definitive statements
can only be made when larger series are reported in the
literature.
Intuitively, optimum results are more likely if fistula
surgery is carried out by surgeons well versed in all
available techniques. Limited surgical experience would
seem to make failure of a repair more likely and an
association between workload and outcome has been
shown [2]. Outcomes from first repairs are consistently
shown to be better than from repeat procedures. These
factors all argue in favour of centralisation of management
in areas of high prevalence/workload by an experienced
multidisciplinary team. This pragmatic approach to man-
agement would seem to be equally applicable to both well
and low-resourced settings.
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Abstract: The aim of the study was to determine the 
epidemiological background, clinical details and surgical 
outcome of patients presenting with urogenital fistulae to 
St Luke's Hospital, Uyo, and the associated VVF Unit at 
Mbribit Itam, Akwa Ibom State, Nigeria, between 
January 1970 and December 1994. A retrospective 
review of hospital operating theater records and case 
notes was carried out. Clinical details and outcome were 
assessed for the total cohort of 2484 patients. 
Epidemiological data were extracted from the case 
notes of 715 patients presenting between January 1990 
and December 1994. Of these 92.2% were of obstetric 
etiology, 80.3% following neglected obstructed labor, 
6.9% following cesarean section, and 5.0% followed 
ruptured uterus; 4.4% followed pelvic surgery and the 
remaining 3.4% of miscellaneous causes included 
malignancy, coital injury, infection and trauma; 8% 
had a coexisting rectovaginal fistula or third-degree 
perineal tear. Only 37.3% of patients were aware of their 
age; the median age of this group was 28 years. Literacy 
was difficult to judge reliably, although 29% were able 
to sign their name. Parity ranged from 0 to 17, and only 
31.4% of fistulae related to first pregnancies. Although 
73.1% were delivered in hospital, in 97.1% labor was 
initially managed at home, with a traditional birth 
attendant, in a maternity home, or in church; 34.1% were 
delivered by cesarean section, although the live-birth 
rate was only 10.3% in the causative pregnancy. For a 
variety of reasons 124 women were not operated upon: 
1954 underwent only one operation, giving a presump- 
tive cure rate at first operation of 81.2%; 247 underwent 
two, 116 three, 32 four, and 11 five operations during the 
Correspondence and offprint requests to: Mr P. Hilton, Consultant 
Gynaecologist, Royal Victoria Infirmary, Newcastle upon Tyne, NEI 
4LP, UK. 
study period. The ultimate closure rate was 97.7%, with 
only 0.6% undergoing urinary diversion. The type and 
distribution of fistulae recorded in this series is 
consistent with previous series of largely obstetric 
fistulae from the developing world. Surgical cure rates 
are also comparable. The epidemiological background is 
at variance with previous reports in several respects; this 
may reflect biosocial differences in the population 
studied. 
Keywords: Epidemiology; Obstetric trauma; Surgery; 
Urogenital fistula 
Introduction 
The prevalence of urogenital fistula is largely unknown, 
although high levels have been reported especially in 
areas of sub-Saharan Africa, particularly in Sudan [1], 
Chad [21, Nigeria [3], Ethiopia [4] and Ghana [5]. An 
incidence of 1-2 per 1000 deliveries has been estimated, 
with a worldwide annual incidence of 50000-100000 
[6] and a prevalence of untreated fistulae of 500 000- 
2 000 000 [6]. The incidence clearly relates to the level 
of maternity care provision, those areas with high 
maternal mortality tending also to have high fistula 
rates. Danso and colleagues [5] have suggested that a 
more realistic estimate of the incidence of fistula in any 
community might be that it approaches the maternal 
mortality rate. This might indicate an annual incidence 
worldwide of up to 500000. Harrison [7,8] reported an 
overall maternal and perinatal mortality rate of 10 and 90 
per 1000, respectively, and 34 and 125 per 1000 in 
primipara under 16 years of age in northern Nigeria. The 
majority of fistula patients in developing countries have 
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been said to be teenage primigravidae [3,6,9-11]. 
Although obstructed labor is undoubtedly the most 
significant single etiologic factor, the problems are 
compounded by many social and cultural factors which 
may delay referral to specialist care once arrest of labor 
occurs [12-14]. This study was undertaken to compare 
the influence of these and other etiologic and 
epidemiologic factors with earlier reports, and to 
determine the fistula types and surgical success within 
the unit. 
total) resulted from neglected obstructed labor and the 
remainder from cesarean section or ruptured uterus; 
assisted vaginal delivery did not seem to be a significant 
etiologic factor. Previous gynecologic surgery was a 
factor in 4.4% of cases, and 3.4% arose from 
miscellaneous causes, including malignancy (1.7%), 
coital injury (0.9%), other trauma (0.5%), and infection 
(0.3%); the latter cases related to lymphogranuloma. 
Patients and Methods 
The study was undertaken during the course of two visits 
made by the first author to St Luke's Hospital, Uyo, and 
the associated VVF Unit at Mbribit Ram, Akwa Ibom 
State, Nigeria, in 1989 and 1995. Cases were identified 
from operating theater record books, and notes were 
subsequently retrieved from the hospital records depart- 
ment; 2979 operative procedures were initially identified 
undertaken in 2484 patients between January 1970 and 
December 1994; 2389 case notes were subsequently 
retrieved (96%). Details of the causative processes, 
fistula site and surgical procedure(s) undertaken were 
well recorded in notes throughout the study period. 
Epidemiological data were less well recorded in the 
early part of the study, and it was decided to limit 
analysis of these aspects to the period between the two 
visits, i.e. between January 1990 and December 1994: 
715 patients were identified during this period, from 
whom 656 case records (92%) were available for review. 
Results 
Etiology 
The etiologic factors, as far as could be established from 
case notes, are shown in Table 1: 92.2% of cases were of 
obstetric etiology. The majority of these (80.3% of the 
Table 1. Etiology in the 2389 cases out of 2484 identified, for whom 
notes could be retrieved from the hospital records department 
Major aefiology No. Percentage No. Percentage 
Sub-group 
Obstetric 2202 92.2 
Obstructed labour 1918 80.3 
Cesarean section 165 6.9 
Ruptured uterus 119 5.0 
Surgery 105 4.4 105 4.4 
Miscellaneous 82 3.4 
Malignancy 42 1.7 
Coital injury 22 0.9 
Trauma 11 0.5 
Infection 7 0.3 
Radiotherapy 0 0.0 0 0.0 
Total 2389 100.0 2389 100.0 
Patient Source 
Fifty percent of patients lived in the local state (Akwa 
Ibom); the remaining 50% were largely from neigh- 
boring states, although a proportion travelled distances 
up to 1000 miles for treatment. 
Age, Educational and Marital Status 
Only 245 of the 656 patients for whom notes were 
retrieved in the epidemiologic part of the study (37.3%) 
were aware of their age at the time of presentation. This 
reflects their literacy, the relative under emphasis on age 
and birth date in this society, and also the impact of the 
civil war of 1967-1970, those unaware of their age 
stating simply that they were born before the war. Those 
who were aware of their age ranged between 7 and 68 
years, with a median of 28 years. 
The many languages used among the patient group 
made literacy difficult to judge, and it was rarely 
specifically recorded in notes; 29.0% were able to sign 
their name on the operation consent forms, suggesting 
that they had received at least a rudimentary education; 
the remainder indicated consent to surgery by their right 
thumbprint. 
At the time of presentation 410 patients (62.5%) were 
married, 72 (11.0%) were single and 106 (16.2%) 
widowed; only 68 (10.4%) had been deserted by their 
husbands since the development of their fistula, 2.9% 
being separated and 7.5% divorced. 
Past Obstetric History 
Of the obstetric fistulae 31.4% followed first pregnancies 
(Fig, 1); parity ranged from 0 to 17, with a median of 
three pregnancies; 7.6% of the patients' previous 
pregnancies had ended in spontaneous miscarriage, 
individual patients reporting 0-6 miscarriages, with a 
median of 0, and mean of 0.27 miscarriages; 44.4% of 
previous pregnancies had ended in stillbirth, individual 
patients reporting 0-8 (median 0, mean 1.0) stillbirths. 
Although 48.1% of the previous pregnancies had 
resulted in a live birth, only 27.5% of patients had had 
one or more previous live births (range 0-10, median 1, 
mean 1.7). 
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Fig. 1. Parity distribution of the 605 obstetric cases, out of 715 
managed between January 1990 and December 1994, for whom notes 
could be retrieved. 
Antecedent Labor and Delivery 
The site in which the patients spent the majority of their 
labor and the place of delivery are shown in Table 2. 
Only 2.9% of women had spent the majority of their 
labor in hospital: most had labored at home, with a 
traditional birth attendant, in a peripheral maternity 
home or health center, or in church. By the time of 
Table 2. Place of labor and delivery in the 605 obstetric cases out of 
the 656 managed between January 1990 and December 1994, for 
whom notes could be retrieved 
Labor Delivery 
No. Percentage No. Percentage 
Home 330 54.6 90 14.9 
Traditional birth attendant 167 27.7 57 9.5 
Health center 35 5.8 5 0.8 
Maternity home 30 5.0 5 0.8 
Church 25 4.0 6 0.9 
Hospital 18 2.9 442 73.1 
Total 605 100.0 605 100.0 
Table 3. Mode of delivery and live-birth rate for the 605 obstetric 
cases out of the 656 managed between January 1990 and December 
1994, for whom notes could be retrieved 
Mode of delivery No. Percentage Live births Live birth rate (%) 
Spontaneous 320 52.9 11 3.4 
Cesarean section 206 34.0 47 22.8 
Ventouse 24 4.0 3 12.5 
Forceps 12 2.0 1 8.3 
Symphysiotomy 18 3.0 0 0 
or craniotomy 
Laparotomy 18 3.0 0 0 
Vaginal breech 7 1.2 0 0 
Total 605 100.0 62 10.3 
191 
delivery 73.1% had been transferred to hospital, the 
duration of labor prior to transfer averaging 2.5 days. 
The mode of delivery in the associated pregnancies is 
shown in Table 3. The neonatal outcome appeared to 
relate to mode of delivery. The live-birth rate was only 
3.4% following spontaneous vaginal deliveries, 11.1% 
following assisted vaginal deliveries, and 22.8% follow- 
ing cesarean section. The overall live-birth rate from 
antecedent pregnancies was only 10.3%. 
Duration of History 
The length of history at presentation was extremely 
variable, ranging from a few days to 38 years; the 
average delay was 61.5 months. 
Menstrual Status 
The menstrual status of patients at the time of 
presentation showed an interesting pattern: 44% of 
patients were amenorrheic at the time of referral, and the 
average delay between the associated pregnancy and 
presentation was 23.4 months; 39% had resumed 
menstruation and their average delay to presentation 
was 51.0 months. The remaining 17% of patients were 
presumed postmenopausal, and had a mean delay to 
presentation of 183.4 months. 
Fistula Types 
Fistulae may be classified on the basis of site or 
complexity, complex cases being those with poor 
access for repair, significant tissue loss, ureteric 
involvement, or where there is a coexistent rectovaginal 
fistula. In this series 4.5% had ureteric involvement and 
8.0% were associated with coexistent rectovaginal 
fistula. The site of fistulae is shown in Table 4. Over 
70% were mid-vaginal, juxtacervical or large (i.e. 
involving the whole of the bladder base between mid- 
vaginal and cervical levels). 
Table 4, Site of the initial fistula in the total group of 2484 patients for 
whom an operative record was identified 
Fistula site No. Percentage 
Urethral 70 2.8 
Subsymphyseal 75 3.0 
Bladder neck 132 5.3 
Mid-vaginal 579 23.3 
Large 432 17.4 
Juxtacervical 773 31.1 
Vault 5 0.2 
Uterus or cervix 77 3.1 
Multiple 89 3.6 
Unspecified 252 10.2 
Total 2484 100.0 
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Primary Surgical Procedures Discussion 
Of primary operations 83% were carried out vaginally 
and 17% abdominally. Of the vaginal procedures 3% 
were repaired in a 'reverse lithotomy' position, with the 
patient prone on the operating table; these were largely 
bladder-neck or subsymphyseal fistulae; 4% of proce- 
dures were combined with a rectovaginal fistula repair; 
0.6% of patients underwent urinary diversion. 
Surgical Outcome 
The assessment of surgical cure in this environment is 
difficult, as patients, especially those traveling long 
distances, rarely return for follow-up. Equally, however, 
they are rarely happy to leave the unit until they are dry. 
For the purposes of this retrospective study, therefore, 
cure has been defined as the point at which patients were 
subjectively dry at their last assessment, and subse- 
quently underwent no further surgery within the study 
period. 
During the study period 124 patients were not 
operated upon; 1954 underwent a single operation and, 
as far as could be established from the notes, were cured 
at this first operation (82.8%); 247 patients underwent a 
second operation, 116 a third, 32 a fourth and 11 a fifth 
operation during the study. In total, therefore, 2979 
urogenital fistula procedures were carried out in the 2484 
patients. There were in addition 32 patients who were 
known still to be wet after a first operation, yet 
underwent no further surgery; 10 still wet after a 
second operation, 1 after a fourth opration, and 2 after 
a fifth operation. These were therefore added to calculate 
'corrected' cure rates (Fig. 2). Although the cumulative 
corrected cure rate rises progressively with succeeding 
operations, the cure rate by operation falls from 81.2% 
for first procedures to 65.0% for those requiring two or 
more procedures. 
1 (10% 
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70~ 
60% 
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40% 
30% 
20% 
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Fig. 2. Corrected cumulative cure rate and cure rate by operation 
number. 
The majority of patients in the study area are delivered at 
home, and in the absence of any effective process for the 
registration of births it is impossible to estimate the 
incidence of urogenital fistula with respect to delivery 
rate. Of those women attending hospital for delivery, 
however, the rate equates to 1.69 fistulae per 100 
deliveries (based on 50% of the cases being from the 
local state area). The maternal mortality rate in the 
hospital within the period of the study varied between 
0.6% and 1.6% (Itina S, personal communication). The 
overall fistula prevalence would therefore seem to be in 
keeping with previous reports [5,6,10], and in particular 
with the suggestion of Danso and colleagues, that the 
incidence of fistulae in any community might approach 
the maternal mortality rate [5]. It is, however, important 
to realize that whereas all maternal deaths, and probably 
most fistulae, eventually find their way tO hospital, the 
majority of deliveries take place in the community. 
Although the incidence of fistulae and of maternal deaths 
may be related, neither figure should be taken to 
represent the overall incidence of the conditions in the 
population served. 
The etiology of these cases, with 92.2% of obstetric 
etiology and 80.3% apparently related to neglected 
obstructed labor, is also very much in keeping with those 
of other series. The distribution of fistula types is also 
compatible with their largely obstetric etiology. Over 
70% were mid-vaginal, juxtacervical or large in type. 
This distribution indicates the area of the vagina at 
greatest risk during obstructed labor, and therefore 
reflects the predominance of this factor in etiologic 
terms. 
The association between obstetric fistulae and tradi- 
tional surgical practices, e.g. circumcision and gishiri, 
has previously been emphasized [3,14] as an important 
etiologic factor in fistula, especially when they occur in 
relation to a first pregnancy. Such practices were not 
commonly recorded in the notes of patients in this series, 
and although probably not consistently specifically asked 
about, are not thought to be a significant factor in the 
etiology of fistulae in this population. 
The importance of early marriage and childbearing in 
the development of obstetric fistulae has also to be 
emphasized (Table 5). Tahzib [3], from northern 
Nigeria, found 32.9% of patients to be under 16 years 
of age and 54.8% under 20 at the time of the 
development of their fistula. In the series reported from 
Ethiopia by Kelly and Kwast [15], 7% were under 16 
and 42% under 20 at presentation. Murphy, also from 
northern Nigeria, reported that 88% of new referrals 
were under 16 at the time of their marriage, and 64% 
were under 18 at the time of their first pregnancy [14]. 
They also demonstrated, however, that the age distribu- 
tion at marriage and first childbirth was not, in fact 
different from that of a control population of patients 
(with postpartum cardiac failure), early marriage and 
early childbearing being the norm, particularly in the 
Muslim culture of Hausaland. Within our present series 
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Table 5. Epidemiologic details from several series of fistula patients from different cultures within sub-Saharan Africa 
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Northern Nigeria [14]  Northern Nigeria [3] Ethiopia [15] Ghana [5] Southeast Nigeria 
- present study 
Mean age (yrs) 20 
% <16 45 
% <20 69 
Mean parity ? 
% in first pregnancy 65 
% divorced/deserted 54 
% literacy 8 
% home delivery ? 
21 22 26.6 28 
33 7 4 13 
55 42 21 32 
1.6 2.1 2.6 3.5 
52 63 42.7 31 
'~ 52 ? 10 
0.2 '~ ? 29 
64 58 ? 27 
many patients were unaware of their age, although the 
mean age of those who did know was 28 years, and only 
13.1% were under 16 years of presentation. It is likely 
that most of those who were unaware of their age were 
born prior to the civil war in Nigeria. 
Murphy also found that 65% of new fistula patients 
had developed their fistula in relation to a first 
pregnancy, and 90% of their long-term patients had no 
living children [14]. In the current series only 31.4% 
arose in relation to first pregnancies; 48% of previous 
pregnancies to fistula patients had resulted in live births, 
and 27.5% of the patients had one or more living 
children. In respect of their previous obstetric experience 
our population seems more closely related to that 
reported from Ghana by Danso and colleagues, where 
the mean age of patients was 26.6, with only 21.3% 
being under 20 years, and the mean parity was 2.6 [5]. 
Others have also drawn attention to the educational 
background of fistula patients and their families. Murphy 
[14] found that the husbands of only 15% of their new 
patients and 8% of their long-term patients had received 
any form of modern education, compared to 31% of their 
control population [14]. Tahzib [3] found that only 0.2% 
of patients themselves had even the most rudimentary 
education, compared to 7% of all women delivering in 
that population [8]. Although the educational status of 
our patients was difficult to establish, 29% were literate 
to the extent of being able to sign their name at least, 
indicating that they had probably completed primary 
education. 
Most previous reports have emphasized the impor- 
tance of home delivery to the etiology of fistulae. Tahzib 
found that only 6.4% of their patients had delivered in 
hospital, and 64.4% at home [3]. Kelly and Kwast 
reported that 59.4% of women were either unattended, or 
attended only by family members or unqualified 
practitioners in labor [15]. In the present series 73% 
delivered in hospital, although 97% had spent the greater 
part of their labor away from hospital, with a substantial 
delay - averaging 2.5 days - before transferring to 
hospital. In some parts of the world this delay reflects 
geographic factors and problems of access. In Ethiopia 
Kelly and Kwast reported that 75% of the population 
live 2.5 days' walk from the nearest all-weather road 
[15]. In the present series 50% were from the local state 
area, and although the riverine nature of the Niger delta 
and Cross River area makes transportation difficult for 
some, for the majority this would not be the case. Of 
greater significance in determining delay in transfer to 
hospital is the local culture of mistrust or fear of hospital 
practices, the sense of failure in not achieving normal 
delivery, and the need to obtain consent from husband or 
elders for hospital attendance. The development of many 
independent neo-Christian churches in the area also 
appears to be of some significance in contributing to 
delay in some cases a number of women laboring in 
church for several days before ultimate transfer to 
hospital in extremis. 
The high incidence of operative delivery is also in 
contrast to previous series: 34% were delivered by 
cesarean section, compared to 7.3% reported by Kelly 
and Kwast [15] and 6.7% reported by Tahzib [3]. 
Despite this, the perinatal outcome was not greatly 
improved: although those delivered by cesarean section 
had a live-birth rate of 22.8%, the overall live-birth rate 
was only 10.3% (compared to 7.3% reported by Kelly 
and Kwast) [15]. 
The length of time between development of the fistula 
and presentation to hospital was also considerable in 
many cases, averaging over 5 years. The occurrence of 
amenorrhea following the development of a fistula is 
well known, although whether this reflects the gross 
tissue loss within the pelvis or a hypothalamic influence 
as a result of the physical and emotional effects of a 
traumatic labor, stillbirth and fistula development, is not 
clear. As the live-birth rate is so low, clearly lactation is 
unlikely to be a significant factor. Whether the high 
number of postmenopausal women in this series reflects 
the effects of obstructed labor on the ovary, with the 
development of primary ovarian failure, is difficult to 
judge. In those deemed postmenopausal the average time 
from the development of the fistula to presentation was 
over 15 years; it was not possible to judge from the 
hospital records how many had been amenorrheic since 
their causative pregnancy. The average time to presenta- 
tion in those who had resumed menstruation was 51.0 
months, compared to 23.4 months in those who remained 
amenorrheic. This might be taken to imply that the 
natural history of the hypothalamic suppressive effect of 
the development of a fistula tends towards spontaneous 
ressolution after 2 years, even if the fistula remains 
untreated. Alternatively, however, these findings may 
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simply reflect the fact that the more dramatically 
affected patients, who are more likely to develop 
amenorrhea, are also more likely to present earlier for 
treatment than their less traumatized sisters who may 
have resumed menstruation at any stage. 
As alluded to above, the assessment of  surgical cure in 
this environment is difficult, as patients, especially those 
traveling long distances, rarely returned for follow-up. 
For the purposes of  this study, cure has been defined as 
the point at which patients were subjectively dry at their 
last assessment, and subsequently underwent no further 
surgery within the study period. One has to accept that 
there may be some patients who had persistent fistulae 
but who did not return to the unit. Given the nature of  the 
condition, and the relationships developed between 
patients and staff, the fact that patients were rarely 
happy to leave the site unless they were fully continent, 
and the availability of  a postoperative hostel on site, this 
number  is likely to be small. Nevertheless, cure 
calculated on this basis must  inevitably represent an 
over- rather than an underestimate of  the true cure rate. 
The surgical outcome in this series is similar to other 
large series of  obstetric fistulae. Kelly and Kwast 
reported an 88% cure rate, with 6.2% of patients 
having residual stress incontinence [15]. Cure at first 
operation has been looked on as the most  appropriate 
outcome measure by which to judge fistula surgery. It is 
clear f rom the current series that in fistula surgery, as in 
other aspects of  surgical practice, the first attempt at 
treatment gives the optimal result, with 81.2% cured at 
their first operation, but only 65% of  those who required 
two or more procedures being cured by each successive 
attempt. We  feel that this emphasizes the argument for 
specialist management  where this is available, and for 
the establishment of  fistula units for the provision of  both 
service and training of  indigenous doctors in fistula 
surgery [16-18].  
Conclusions 
The type and distribution of  fistulae recorded in this 
series is consistent with previous series of  largely 
obstetric fistulae f rom the developing world. Surgical 
cure rates are also comparable.  The epidemiologic 
background is at variance with previous reports in 
several respects, notably that patients were older, of  
higher parity, higher literacy, and marital support, and 
more  often delivered in hospital than previous series 
f rom other parts of  Nigeria, and elsewhere in the 
developing world. Why  patients in this area should 
have such a high fistula rate despite these factors remains 
uncertain, although this may reflect biosocial differences 
in the population studied. 
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EDITORIAL COMMENT: The authors present their 
experience with urogenital fistula repair for a large series 
of patients in Nigeria. It remains an unfortunate fact that 
the present study reveals no improvement in the incidence 
of urogenital fistula in this area of world compared to 
previous reports. Perhaps even more discouraging is the 
evidence that the patient population seems to be older, to 
have a higher degree of education and a higher incidence of 
operative delivery with no great improvement in the 
overall outcome. Greater efforts are needed to fully correct 
the plight of laboring women in underdeveloped countries, 
if the incidence of postdelivery vesicovaginal fistula is to be 
reduced. 
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Paper 3: Urogenital fistula in the UK:  
a personal case series managed over 25 years. 
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 What ’ s known on the subject? and What does the study add? 
 Whilst several very large series of obstetric fi stulae from the developing world have 
been published, data on fi stulae as seen in the developed world are relatively few. Most 
fi stulae in the UK are known to follow hysterectomy, and several risk factors are 
recognised. 
 We have confi rmed the common association with pelvic surgery, and in particular 
hysterectomy, but also show the broad range of other associated operations, including 
so called  ‘ minimally invasive ’ procedures. High rates of both anatomical fi stula closure 
and continence are shown, when a consistent approach to assessment, selection of 
surgical procedure, and postoperative care are applied. Successful closure is seen more 
often in women who have not undergone previous attempts at repair before referral, 
and as a result a pattern of surpra-regional management is proposed. Whilst overall 
the number of urogenital fi stulae seen in the UK appears to be decreasing, there is a 
suggestion from these data that the rate of fi stula formation following hysterectomy 
may be increasing; we are currently investigating this possibility through detailed 
interrogation of a national dataset. 
 OBJECTIVE 
 •  To review demography, aetiology, surgery 
and outcomes of women with urogenital 
fi stula seen in one unit over the last 25 
years; to provide data for comparison with 
a parallel study based on Hospital Episode 
Statistics. 
 PATIENTS AND METHODS 
 •  This is a prospective case series from a 
tertiary urogynaecology centre providing a 
 de facto supra-regional fi stula service. 
 •  The women included had confi rmed 
urogenital fi stula referred between January 
1986 and December 2010. Index cases were 
identifi ed from a surgical database; data 
were entered prospectively and updated as 
appropriate; statistics are largely 
descriptive. 
 •  The primary outcome is the patient ’ s 
report of absence of urinary leakage. 
 •  Secondary outcomes include operative or 
postoperative complications, anatomical 
closure of the fi stula, other residual or new 
urinary symptoms, and the need for further 
intervention. 
 RESULTS 
 •  In all, 348 women with urogenital fi stula 
were referred; two-thirds were of surgical 
aetiology, with almost half following 
hysterectomy. Although 11% followed 
childbirth, most of these followed operative 
obstetric interventions. 
 •  Spontaneous closure occurred in 6.9% of 
women and 291 underwent surgical 
treatment. 
 •  The anatomical closure rate at fi rst 
operation was 95.7%, although 2.2% 
reported residual urinary incontinence. 
 •  The success rates were similar regardless 
of aetiology, although successful fi stula 
closure was signifi cantly more likely in 
women who had not had attempts at 
closure before referral (98.2 vs 88.2%; 
Fisher ’ s exact test;  P  = 0.003). 
 CONCLUSION 
 •  High rates of fi stula closure are reported 
regardless of aetiology, although previous 
unsuccessful repair militates against 
successful outcome; this emphasises the 
appropriateness of centralisation of the 
management of this increasingly rare 
condition in UK practice. 
 KEYWORDS 
 complication, intraoperative ;  complication, 
postoperative ;  injuries, surgical ;  ionizing 
radiation ;  urinary fi stula ;  vesico-vaginal 
fi stula 
 Urogenital fi stula in the UK: a personal case 
series managed over 25 years 
 Paul  Hilton 
 Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infi rmary, Newcastle upon Tyne, UK 
 INTRODUCTION 
 The prevention and management of 
vesico-vaginal fi stula remains one of the 
greatest global public health challenges. It 
has been estimated that there are currently 
2 – 3 million women with untreated fi stula 
worldwide, and perhaps 30  000 – 130  000 
new cases occur annually of which  > 95% 
are in the developing world. Most are 
obstetric in aetiology, resulting from 
prolonged neglected obstructed labour, and 
around 1 – 2 per 1000 deliveries may be 
affected  [ 1,2 ] . Several very large case series 
have been published  [ 3 – 5 ] , and international 
aid organisations and professional groups 
are becoming increasingly involved in the 
issues of management and prevention  [ 6,7 ] . 
 In the UK, urogenital fi stulae are relatively 
uncommon, and recent Hospital Episode 
Statistics suggest only 105 cases have been 
treated surgically per year over the last 
decade  [ 8 ] . The literature on fi stula in the 
 Accepted for publication 5 August 2011 
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developed world is also relatively sparse; 
ChassarMoir  [ 9 ] reviewed the position in 
Britain in 1973, and Lee  et  al .  [ 10 ] in the 
USA in 1988. Little has been published on 
the subject since that time, apart from small 
case series, and descriptions of surgical 
techniques; the largest recent UK series was 
of 41 cases managed in tertiary practice by 
Ockrim  et  al .  [ 11 ] in 2009. 
 The aims of the present study are to review 
the demographic background, aetiology, 
surgery and outcomes of women with 
urogenital fi stula referred to a single unit 
over the last 25 years, and to provide data 
for comparison with a parallel study based 
on the national Hospital Episode Statistics 
dataset. 
 PATIENTS AND METHODS 
 All women with confi rmed urogenital fi stula 
referred to the author between 1st January 
1986 and 31st December 2010 were 
identifi ed from a personally held password 
protected encrypted surgical database, 
formatted in  HanDBase ® (DDH Software, 
Wellington FL, USA). Only women referred 
for advice or treatment at the Royal Victoria 
Infi rmary, Newcastle upon Tyne are included; 
those treated by the author overseas are 
excluded from this review. Data are entered 
prospectively and updated as appropriate; 
demographic fi elds are entered on referral, 
surgical fi elds are entered immediately on 
completion of operation, postoperative fi elds 
including complications are entered on 
discharge, and outcome is entered at 
outpatient review, and updated at any 
future patient contact (a copy of the 
dataset is included as Fig. S1: HanDBase ® 
surgical database fi elds, please see 
Supporting Information). Anonymised data 
fi elds are regularly uploaded to a desktop 
computer, and converted into a Microsoft ® 
Access TM format. Statistics presented are 
largely descriptive; Fisher ’ s exact test was 
used for comparison of dichotomous 
outcomes. 
 The primary outcome is the patient ’ s report 
of the absence of urinary leakage at 
follow-up 2 – 3 months postoperatively. 
Secondary outcomes include the need for 
surgical treatment, and the procedure(s) 
undertaken, operative or postoperative 
complications, duration of catheterisation 
and hospitalisation, anatomical closure of 
the fi stula, other residual or new urinary 
symptoms, and the need for further 
intervention. 
 RESULTS 
 NUMBER AND SOURCE OF REFERRALS 
 In all, 348 women were referred for the 
assessment or treatment of urogenital 
fi stula during the period of this review, with 
a median (range) age of 44 (7 – 89) years. The 
annual number of referrals has increased 
from about fi ve per year in the 1980s to 25 
per year currently ( Fig.  1A ). About one in six 
of the women was referred from colleagues 
in Newcastle, and half from elsewhere in 
what was previously known as the Northern 
Health Region (currently the North East and 
the northern part of the North West 
Strategic Health Authorities). One in six were 
referred from the rest of England, and a 
similar number from Scotland, Wales, 
Northern Ireland, the Republic of Ireland 
and elsewhere overseas combined ( Table  1 ). 
 In all, 78 women (22.4%) had undergone 111 
previous fi stula repair procedures before 
referral; 55 women had one, 14 women 
two, eight women three, and one woman 
four previous unsuccessful attempts at 
repair. 
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 FIG.  1. 
 A , Annual number (in solid bars) 
and 3-year rolling average (line) 
of referrals to the unit over 
the period of the review 
(1986 – 2010).  B , Hospital Episode 
Statistics during the period 
1990 – 1991 to 2009 – 2010. The 
annual numbers 
of vesico-vaginal and 
urethrovaginal fi stula repairs in 
England are given (in solid bars) 
together with a 3-year rolling 
average (line). 
 TABLE  1  Source of referrals 
Source  N (%)
Newcastle 53 (15)
Northern Region 177 (51)
Rest of England 61 (18)
Scotland, Wales and Northern
Ireland
46 (13)
Republic of Ireland and Overseas 11 (3)
 Total  348 (100) 
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 SITE OF FISTULAE 
 In all, 256 (73.6%) of the fi stulae were 
vesico-vaginal with a further 13 (3.7%) 
having combined vesico-vaginal and 
uretero-vaginal lesions ( Table  3 ). Based on 
Lawson ’ s anatomical fi stula classifi cation 
 [ 12 ] , 70.3% of these (51.7% of the total) 
opened into the vaginal vault, refl ecting the 
preponderance of surgery, and in particular 
hysterectomy, as the causative factor. 
 In all, 38 fi stulae (10.9%) were urethro-
vaginal; 90% of these were of surgical 
aetiology, most commonly following urethral 
diverticulectomy (15, 39.5%), mid-urethral 
tape procedures (seven, 18.4%) and 
colporrhaphy (six, 15.8%). 
 In all, 21 (6.0%) of these fi stulas were 
simple uretero-vaginal; including the 
combined vesico-vaginal and uretero-
vaginal lesions (13), and a few ureteric 
fi stulae involving bowel (four), in total 
10.9% of women had fi stulae involving the 
ureter. 
 MANAGEMENT 
 Immediate management 
 When patients were referred  ≤ 6 weeks of 
the onset of leakage, assessment of the 
upper urinary tracts by IVU or CT was 
advised. If there was evidence of ureteric 
involvement by way of leakage or stricture, 
immediate referral for renography followed 
by stenting or re-implantation was 
 TABLE  2  The aetiology in the present series of 
348 urogenital fi stulae. In addition to the cases 
listed there were two of malignant aetiology 
Aetiology  N 
 Surgical cases 
  Abdominal hysterectomy 132
  Radical hysterectomy 19
  Urethral diverticulectomy 15
  Colporrhaphy 12
  Colectomy 9
  Vaginal hysterectomy 8
  Mid-urethral tape procedures 7
  LAVH 7
  LLETZ 3
  Cystoplasty and colposuspension 2
  Colposuspension 2
  Cervical stumpectomy 2
  Nephroureterectomy 2
  Subtotal hysterectomy 2
  Sling procedures 2
  Partial vaginectomy 2
  Needle suspension 2
  TAH and colporrhaphy 1
  TAH and colposuspension 1
  Laparoscopic oophorectomy 1
  Periurethral bulking agents 1
  Sub-trigonal phenol injection 1
  Lithoclast 1
  Colovaginoplasty 1
  Ileoanal pouch 1
  Sacrospinous fi xation 1
  Unknown surgery in childhood 1
  Subtotal 238
 Obstetric cases 
  Caesarean section 15
  Ruptured uterus 8
  Forceps/ventouse 5
  Caesarean hysterectomy 4
  Symphsiotomy 2
  Obstructed labour 2
  Breech extraction 1
  Placental abruption 1
  Subtotal 38
 Radiotherapy cases 
  Cervical cancer 28
  Endometrial cancer 5
  Multifocal cancer 1
  Subtotal 34
 Miscellaneous cases 
  Vaginal pessary 11
  Foreign body 6
  Infection 5
  Congenital 6
  Catheter induced 3
  Trauma 2
  Unexpalined 2
  Coital injury 1
  Subtotal 36
 LAVH, laparoscopically assisted vaginal 
hysterectomy; LLETZ, large loop excision of the 
transformation zone; TAH, total abdominal 
hysterectomy. 
 AETIOLOGY OF FISTULAE 
 Two thirds of the fi stulae (238 cases, 68.4%) 
were of surgical aetiology, and were 
associated with a large range of different 
operations ( Table  2 ). In 172 cases (72.3% 
of the surgical cases and 49.4% of the 
series as a whole), the fi stula followed 
excision of the uterus and or cervix; in 
132 cases (55.5% of the surgical cases 
and 37.9% of the series as a whole), the 
fi stula developed after simple abdominal 
hysterectomy. In 40 women (16.8% of 
the surgical cases and 11.5% of the 
series) the fi stula followed surgery for 
urinary incontinence or pelvic organ 
prolapse, with a further 15 (4.3%) 
developing after excision of urethral cysts 
or diverticula. 
 In all, 38 women (10.9%) developed the 
fi stula following childbirth ( Table  2 ). 
True  ‘ obstetric fi stula ’ resulting from 
prolonged neglected obstructed labour 
is not seen in current obstetric practice 
in the developed world; two women in 
this series developed fi stulae after 
obstructed labour; one had recently 
immigrated to the UK having developed 
her fi stula 13 years earlier in Bangladesh; 
the other was referred by her medical 
relatives in Uganda. In most of the 
remaining  ‘ obstetric ’ cases the fi stula 
actually followed some form of surgical 
intervention, i.e. caesarean section 
(15, 39.5%) or caesarean hysterectomy 
(four, 10.5%), assisted vaginal delivery 
(fi ve, 13.2%) or trial of vaginal delivery 
after a previous caesarean section (eight, 
21.1%). 
 Two women (0.6%) developed their fi stula 
from direct invasion of malignancy into the 
bladder; one was from ovarian cancer, the 
other from cancer of the rectum. In all, 34 
women (9.8%) had undergone prior pelvic 
radiotherapy for the treatment of cancer 
( Table  2 ). 
 The remaining 36 cases (10.3%) were 
of miscellaneous aetiologies ( Table  2 ). 
About half related to vaginal foreign bodies, 
11 (30.6%) to the use of ring or shelf 
pessaries for the management of pelvic 
organ prolapse, and six (16.7%) to various 
other devices including bottles and 
deodorant can lids, introduced into the 
vagina for sexual gratifi cation or  ‘ by 
accident ’. 
 TABLE  3  Fistula site using modifi cation of 
Lawson ’ s classifi cation  [ 11 ] 
Fistula site  N (%)
Vesico-vaginal (VVF): 256 (73.6)
  Vault 180 (51.7)
  Midvaginal 32 (9.2)
  Bladder neck 17 (4.9)
  Large 13 (3.7)
  Juxtacervical 11 (3.2)
  Subsymphyseal 3 (0.9)
Urethro-vaginal (UVF) 38 (10.9)
Uretero-vaginal 21 (6.0)
Combined VVF  + UVF 13 (3.7)
Vesico-uterine/cervical 11 (3.2)
Vesico-rectal 5 (1.4)
Uretero-rectal/pouch 4 (1.1)
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recommended. Where upper tract 
involvement was excluded, catheter drainage 
was recommended. If spontaneous closure 
of the fi stula had not occurred  ≤ 8 weeks, 
referral for further assessment and probably 
surgical treatment was offered. 
 In 24 (6.9%) women, the fi stula healed 
 ‘ spontaneously ’ , that is either with no 
treatment, or with a period of continuous 
bladder drainage or ureteric stenting (seven). 
A further 33 women did not undergo 
surgery for various other reasons: 14 were 
referred for advice by telephone or by 
correspondence only; 12 declined treatment; 
four with malignant or radiation fi stulae 
died before treatment; and three await 
treatment. Three patients await follow-up at 
the time of analysis. 
 Surgical treatment 
 When surgery was deemed appropriate, 
either because of failure of catheter 
drainage, or late presentation, it is the 
author ’ s usual practice to undertake a 
preliminary examination under anaesthesia 
and cystoscopy; retrograde pyelography is 
also undertaken where the ureters are 
involved in or lie in close proximity to the 
fi stula edge, or where prior IVU or CT 
indicate the possibility of ureterovaginal 
fi stula or stricture. The choice of repair 
procedure is based on the need for 
concurrent ureteric re-implantation, the 
proximity to the bladder neck, the tissue 
mobility and access for repair vaginally. 
Where a vaginal approach was deemed to 
be both feasible and safe, this was always 
the route of choice. Interposition grafting by 
the Martius bulbocavernosus muscle and fat 
graft was used in urethral and bladder neck 
fi stulae, and to fi ll dead space in the vagina 
at colpocleisis for radiotherapy induced 
fi stulae. Omental interposition grafts were 
used at transperitoneal repairs depending on 
the size of the defect, perceived integrity of 
the repair, and availability of omentum. 
 After surgery the bladder is drained 
continuously for 12 days; urine output is 
checked hourly by ward nursing staff 
throughout this period. In the early years of 
the study, a urethral catheter was used; 
latterly both urethral and suprapubic 
16  F Foley catheters have been used 
simultaneously; in this case the urethral 
catheter is removed on day 10, and the 
suprapubic catheter clamped on day 12, 
being fi nally removed when residual urine 
volumes are consistently  < 100  mL, and 
 < 50% of the voided volumes. 
 In all, 291 women (83.6%) underwent one or 
more surgical procedures, with 283 
undergoing repair, and eight having primary 
urinary diversion (2.7%) ( Table  4 ). One 
woman who had undergone surgery for a 
cloacal abnormality in childhood presented 
with a complex urethro-clitoral fi stula with 
bilateral hydronephrosis, and underwent 
ileo-cystoplasty with a Mitrofanoff 
continent diversion. Six women with large 
radiotherapy induced vesico-vaginal fi stulae, 
and one with a vesico-vaginal fi stula 
following a repeat injection of phenol to her 
trigone in the treatment of intractable 
detrusor overactivity, underwent ileal 
conduit diversion. 
 Of the 283 undergoing primary repair, 
69.1% had a vaginal procedure, and 30.9% 
an abdominal procedure. Ureteric 
re-implantation was required in 22 women, 
two of these being bilateral; in seven, 
ureteric re-implantation was combined with 
a transperitoneal repair of a concurrent 
vesico-vaginal fi stula. All of these were of 
surgical aetiology, including 18 (81.8%) 
associated with hysterectomy; 12 related to 
total abdominal hysterectomy, fi ve to radical 
hysterectomy, and one to sub-total 
hysterectomy. 
 Excluding the ureteric re-implantations and 
urinary diversions, 60 women underwent 
abdominal repair operations; 26.6% 
of these were transvesical, and 73.4% 
transperitoneal. In 25% of the 
transperitoneal procedures an omental 
interposition graft was incorporated within 
the repair. Of the 31 cases of obstetric 
aetiology undergoing repair 13 (41.9%) 
required an abdominal repair, compared 
to 43/183 of the surgical cases (23.5%), 
four of 19 of the radiotherapy/malignant 
cases (21.1%), and none of 28 of the 
miscellaneous cases; the distribution of 
abdominal to vaginal repairs in the obstetric 
group is signifi cantly different from the 
surgical and miscellaneous groups (Fisher ’ s 
exact test;  P  = 0.001), although not from 
the radiotherapy group ( P  = 0.218). It 
should be remembered that many of the 
obstetric cases related to caesarean section 
or trial of vaginal delivery after previous 
caesarean section; 100% of those requiring 
surgical repair of fi stulae from other 
obstetric causes ( Table  2 ) underwent vaginal 
repair. 
 Outcome of surgery 
 Anatomical closure vs continence  Of the 
283 women having repair surgery, 279 have 
attended for follow-up; one died from a 
pulmonary embolus 4 weeks after surgery, 
prior to her follow-up appointment, and 
three await follow-up at the time of 
analysis. In all, 261 (93.5%) women reported 
being fully continent, and had no clinical 
evidence of either urethral or extra-urethral 
urinary leakage. Six (2.2%) have anatomical 
closure of their fi stula, but report some 
 TABLE  4  Route and type of primary procedures undertaken 
Primary procedure  N (%)
 Abdominal procedures: 
  Transperitoneal 44 (48.9)  – 11 (25) included omental graft
  Transperitoneal  + ureteric re-implantation 7 (7.8)
  Transvesical 16 (17.8)
  Ureteric re-implantation 15 (16.7)
  Urinary diversion 8 (8.9)
  Subtotal 90 (30.9)
 Vaginal procedures: 
  Layer dissection 169 (84.1)  – 38 (22) included Martius graft
  Urethral reconstruction 15 (7.5)
  Colpocleisis 16 (8.0)
  Urethrocleisis and insertion of suprapubic catheter 1 (0.5)
  Subtotal 201 (69.1)
 Total 291 (100.0)
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residual incontinence (one stress and fi ve 
urgency incontinence). The primary closure 
rate is therefore 95.7%, with a continence 
rate of 93.5%. 
 Primary vs secondary repairs  Successful 
fi stula closure was signifi cantly more likely 
in the women who had not had attempts at 
closure before referral (98.2%) than in those 
who had one or more previous unsuccessful 
procedures (88.2%) (Fisher ’ s exact test; 
 P  = 0.003). 
 In all, 12 women required a second 
operation following unsuccessful closure 
after referral to our unit; one underwent 
secondary diversion, and 11 had second 
attempts at fi stula repair. In nine women, 
the fi stula was anatomically closed by the 
second procedure, although one woman 
reported some residual incontinence that 
was shown to be due to intrinsic sphincter 
defi ciency. The secondary closure rate 
therefore is 81.8%, with a secondary 
continence rate of 72.7%. The differences in 
anatomical closure rate and continence rate 
between fi rst and second procedures 
undertaken in our unit, whilst perhaps 
clinically signifi cant, are not of statistical 
signifi cance (Fisher ’ s exact test,  P  = 0.093 
and  P  = 0.101, respectively). 
 Two women underwent third attempts at 
fi stula repair and both were successful. 
The one woman with residual urethral 
incontinence after a second procedure 
awaits a Mitrofanoff continent diversion 
procedure. 
 Outcome by aetiology  The primary closure 
rate varied between 96% for those fi stulae 
of surgical and miscellaneous aetiologies 
and 90% for those of obstetric aetiology 
( Table  5 ). These closure rates are not 
signifi cantly different (Fisher ’ s exact  P  = 
0.793), although it must be recognised that 
the radiation related cases were less likely to 
undergo a repair operation, with only 52.8% 
undergoing repair compared to 86.1% of the 
surgical cases (Fisher ’ s exact test;  P  < 0.001). 
 Other determinants of outcome  The primary 
closure rate was 83.3% for those women 
undergoing abdominal procedures, and 
96.1% for those having vaginal repairs 
(Fisher ’ s exact test;  P  < 0.001), although 
neither closure rate nor continence rate 
were signifi cantly different between 
vesico-vaginal (95.9%; 91.4%) and urethro-
vaginal (92.1%; 80.0%) fi stulae (Fisher ’ s 
exact test;  P  = 0.662 and  P  = 0.119). 
 The primary closure rate was not 
signifi cantly different between those 
procedures where an interposition graft 
(omental or labial) was (92.0%) or was not 
(96.1%) used in the repair (Fisher ’ s exact 
test;  P  = 0.264). As noted above, the 
decisions about the route of repair and the 
use of interposition grafts are not taken at 
random, but are based on specifi c patient 
characteristics; these fi ndings must 
therefore be interpreted with caution. 
 DISCUSSION 
 The case series described represents one of 
the largest recent series of urogenital 
fi stulae reported from the UK. Although 
there is no current Department of Health 
recognition of fi stula centres, nor specifi c 
funding of fi stula surgery in the UK through 
the NHS specialised services commissioning 
processes, this paper describes the workload 
of a  de facto supra-regional fi stula service. 
Hospital Episode Statistics suggest a 
reduction in the number of urogenital 
fi stula cases operated on in England from 
 ≈ 165 per year in the early 1990s to  ≈ 105 
per year over the last decade ( Fig.  1B )  [ 8 ] . 
Despite this downward trend in fi stula cases 
nationally, the numbers seen in this unit 
continue to increase ( Fig.  1A ). Whilst the 
patterns shown in the present series 
cannot be said necessarily to refl ect the 
whole of UK practice, these fi gures indicate 
that the current caseload of the unit 
represents  > 20% of the national surgical 
activity. 
 The distribution of different aetiologies of 
cases seen in the unit has been consistent 
throughout the period of this review, with 
two thirds being of surgical aetiology, and 
the remainder evenly distributed between 
obstetric, radiation, and miscellaneous or 
traumatic causes. Although fi stulae were 
seen in patients undergoing all types of 
pelvic surgery, overall almost half of this 
series were associated with hysterectomy. 
ChassarMoir  [ 9 ] reported 87% of fi stulae in 
his series of patients treated in the UK to be 
of surgical aetiology in 1973, and Lawson 
 [ 13 ] similarly reported 76% surgical 
aetiology in a small cohort of UK patients in 
1978. Together with the reduction in total 
fi stula cases cited above, these various series 
suggest a signifi cant reduction in the 
proportion of cases associated with pelvic 
surgery between the periods, 1950 – 1970 
and 1980 – 2010 (Fisher ’ s exact;  P  < 0.001). 
Despite this fi nding, the number of 
hysterectomy procedures is also decreasing, 
and it is the author ’ s impression, borne out 
by publicly available data  [ 8 ] , that the rate 
of fi stula formation following hysterectomy 
may be increasing. Online tables suggest a 
 > 40% increase in the rate of fi stula 
 TABLE  5  Results of fi stula repair procedures 
Aetiology Patients,  n 
Healed 
spontaneously,  n (%)
No surgery  – other 
reasons * ,  n (%)
Primary diversion, 
 n (%)
Primary repair 
procedure,  n (%)
Closed at fi rst 
operation † ,  n (%)
Surgical 238 19 (8.0) 13 (5.5) 1 (0.5) 205 (86.1) 195 (96.1)
Obstetric 38 4 (10.5) 3 (7.9) 0 31 (81.6) 28 (90.3)
Radiation/malignant 36 0 11 (30.6) 6 (24.0) 19 (52.8) 18 (94.7)
Miscellaneous 36 1 (2.8) 6 (16.7) 1 (3.4) 28 (77.8) 26 (96.3)
Total 348 24 (6.9) 33 (9.5) 8 (2.7) 283 (81.3) 267 (95.4)
 * ‘ no surgery  – other reasons ’ includes patients referred for telephone advice only, those declining surgery, those dying before treatment or follow-up, and 
those awaiting treatment.  † patients awaiting follow-up are excluded from the calculation of closure rate. 
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following hysterectomy over the last decade, 
from about 1 in 1000 in 2000 – 2001 to 1 in 
600 in 2009 – 2010  [ 8 ] . Assuming that the 
distribution of causes of fi stulae in the 
present series refl ect the national position, 
with 37.9% of fi stulae following total 
abdominal hysterectomy, 5.5% following 
radical hysterectomy, 4.3% following vaginal 
or laparoscopically assisted vaginal 
hysterectomy, and 0.6% following subtotal 
hysterectomy, the same trend is apparent 
for all types of hysterectomy procedure 
( Fig.  2 ). A trend of this nature could be 
explained either by the fact that as the 
number of hysterectomy procedures reduces 
the standards of surgical training and 
practice in gynaecology decline, or that the 
cases that remain are the more complex 
ones, with an increased risk of operative 
complication. We are currently investigating 
these trends further in collaboration with 
the Royal College of Obstetricians and 
Gynaecologists Offi ce of Research and 
Clinical Audit. 
 It is often supposed by patients, their 
lawyers, and even by  ‘ expert ’ witnesses that 
fi stula after hysterectomy results from direct 
injury to the lower urinary tract at the time 
of operation. On occasion this may be the 
case; intuitively, careless, hurried or rough 
surgical technique will make injury to the 
lower urinary tract more likely. However, 
direct operative injury is likely to be 
associated with immediate loss of urinary 
control when the patient leaves theatre or 
has their catheter removed; of 172 fi stulae 
following hysterectomy in this series, only 
seven (4%) presented with leakage of urine 
on the fi rst postoperative day. In other 
cases, compromise to the blood supply by 
suture, diathermy or crushing may result in 
tissue necrosis and subsequent leakage; 
alternatively, a pelvic haematoma at the 
vaginal vault may become infected and then 
discharge into the bladder; in each of these 
latter situations leakage is likely to develop 
later, and in the remaining 96% of women 
with post-hysterectomy fi stulae in the 
present series incontinence developed 
between 3 days and 8 weeks after surgery. 
There is some evidence from animal studies 
that the inadvertent placement of vaginal 
vault sutures into the bladder wall at 
hysterectomy may not carry as great a risk 
of fi stula formation as previously thought 
 [ 14 ] . 
 In 17 women the fi stula developed in 
association with a vaginal foreign body. In 
six of these the device was known or 
presumed to have been introduced into the 
vagina by the woman herself for sexual 
purposes. The device was most commonly a 
deodorant canister, introduced with the cap 
in place; on removing the canister from the 
vagina the cap was retained. Although one 
woman presented within a few hours of 
acute bladder injury from a  ‘ crown-capped ’ 
soft drinks bottle, others presented at 
periods of 1 – 15 months after introduction 
of the foreign body, the delay largely 
refl ecting embarrassment at the nature of 
their condition. In three of these cases large 
vaginal fi bro-epithelial polyps were 
identifi ed; these have not been seen in other 
fi stula types in the present series, and have 
not previously been reported in association 
with urogenital fi stula; they have however 
been considered as a possible development 
from granulation tissue, and their 
identifi cation in association with foreign 
body retention might not therefore be 
unexpected  [ 15 ] . The three examples seen in 
the present series seemed to occur where 
there was rotation of the deodorant cap 
within the vagina such that the concave 
surface was directed laterally or cephalically, 
and either granulation or the vaginal tissues 
themselves had grown into the concavity 
with resultant polypoid tumour formation; 
in one case his had become so large that a 
separate operation was required to excise 
the polyp before an adequate view of the 
fi stula, involving right ureter, bladder base 
and the whole of the urethra, could be 
established. 
 In 11 women the fi stula developed in 
association with the use of vaginal pessaries 
for the treatment of vaginal prolapse; one 
of these was a ring pessary and 10 were 
shelf pessaries. This complication might 
perhaps be anticipated with retained, long 
neglected pessaries, and in one case a shelf 
pessary had been left in place for 6 years 
without review. However, in the remaining 
women, leakage became apparent between 2 
weeks and 6 months after their last pessary 
change. These women had a median age of 
82 years, and whilst perhaps not atypical for 
the group of patients likely to be managed 
by vaginal pessaries, the place of vaginal 
atrophy as a contributory factor in the 
development of the fi stula may be relevant. 
Where there is no absolute contraindication 
to its use, topical oestriol should be 
considered in women with signifi cant 
genital atrophy whose prolapse is managed 
by pessary. 
 Other than in the unusual circumstances 
where injury to the urinary tract is detected 
within the fi rst few days of operation, and 
where extravasation of urine into the tissues 
is not great, it has been the author ’ s 
practice to advocate delayed repair. This 
allows time for necrotic tissues to slough 
and for local infl ammatory change to 
resolve, and spontaneous closure may occur 
in some cases, thereby avoiding the need for 
further surgery. It is worth persisting with 
this line of management in vesico-vaginal or 
urethro-vaginal fi stulae for 6 – 8 weeks, as 
spontaneous closure may occur within this 
period  [ 16 ] . Although only 6.9% of the 
fi stulae in the present series are known to 
have healed with catheter drainage, this is 
certainly an underestimate of the value of 
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 FIG.  2. 
The rate of fi stula formation 
after hysterectomy of different 
types, calculated from Hospital 
Episode Statistics, assuming 
that the distribution of causes 
of fi stula in the present series 
refl ects the national pattern, i.e. 
that 37.9% of all fi stulae in the 
country follow total abdominal 
hysterectomy, 4.3% of all 
fi stulae follow vaginal or 
laparoscopically-assisted 
vaginal hysterectomy  etc . AH, 
abdominal hysterectomy; LAVH, 
laparoscopically-assisted 
vaginal hysterectomy. 
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this approach to management. The outcome 
is not known in most of those women 
referred for telephone advice only, although 
in many of these, catheter drainage was 
recommended; many others would have 
been managed conservatively and not 
referred. It is possible that the actual rate of 
spontaneous healing in surgical fi stulae is as 
high as 20%. 
 Spontaneous closure of radiotherapy-
induced fi stulae was not seen in the present 
series, and seems most unlikely ever to 
occur, in view of the impaired vascularity 
invariably found in association with 
radiation endarteritis. In the present series, 
10% of the obstetric fi stulae healed with 
catheter drainage, although it must be 
recognised that most of these cases were in 
fact not  ‘ true ’ obstetric fi stula resulting from 
ischaemic necrosis from prolonged 
neglected obstructed labour, but resulted 
from obstetric operative interventions. 
However, even in series of obstetric fi stulae 
in the developing world, spontaneous 
healing has been reported in up to 28% of 
cases when bladder drainage is introduced 
early  [ 17 ] . Although some authorities have 
suggested that there is no place for 
non-surgical management of urogenital 
fi stula, (Mourad S, personal communication, 
2010) it is the author ’ s view that 
catheterisation of urethral or bladder 
fi stulae should be considered the preferred 
initial management in all but exceptional 
cases. 
 The route of surgery for the repair of 
urogenital fi stulae has perhaps been the 
greatest area for contention, with many 
urologists advocating an abdominal 
approach, and most gynaecologists, 
especially those with experience of fi stula 
surgery in the developing world, favouring 
the vaginal approach. As indicated above, 
the author ’ s preference has been for the 
vaginal approach where possible, accepting 
that the abdominal route has a place where 
access vaginally is limited (by virtue of the 
patient ’ s nulliparity, or previous surgery or 
other pelvic pathology) or where there is 
concurrent ureteric involvement requiring 
re-implantation. Overall in the present 
series, almost 70% of procedures were 
undertaken vaginally; excluding those 
women requiring primary urinary diversion 
or ureteric re-implantation, 75% were 
repaired vaginally, obviating the need for an 
abdominal incision and the increased 
postoperative discomfort and morbidity 
associated with this, yet with comparable 
cure rate. 
 It is often suggested that vaginal vault 
fi stulae following hysterectomy are not 
amenable to vaginal repair, and based on 
one case series of surgical fi stulae it was 
claimed that the O ’ Connor (transperitoneal 
transabdominal) technique should be 
considered the  ‘ gold standard ’ for 
supratrigonal vesico-vaginal fi stula repair 
 [ 18,19 ] . Most fi stulae seen after abdominal 
hysterectomy are in the midline above the 
inter-ureteric bar, with minimal risk to the 
ureters, and in parous women in particular, 
are usually quite accessible vaginally. Of the 
110 women with vaginal vault fi stulae 
following hysterectomy who underwent a 
primary repair procedure in the present 
series, 74 (67.3%) were treated by the 
vaginal route, with 97% anatomical closure 
and 94% continence rate. Of 47 repair 
procedures on 37 women reported by 
Ockrim  et  al .  [ 11 ] , 49% were undertaken 
vaginally. Surgeons involved in fi stula repair 
should be skilled in both abdominal and 
vaginal approaches, and should have 
experience and versatility to decide the most 
appropriate procedure for each individual 
patient. 
 In most previous reports of fi stula surgery, 
particularly those relating to obstetric 
fi stulae in the developing world, the 
measures of outcomes are either not stated, 
or are based on the patient ’ s report of 
continence at the point of discharge from 
hospital. Longer-term follow-up is often 
diffi cult or impossible, and more objective 
outcome measures impractical in such 
healthcare settings. In the present report, 
cure has been defi ned as the patient ’ s report 
of the absence of urinary leakage, combined 
with the absence of clinical signs of residual 
or recurrent fi stula and the absence of 
clinically demonstrable urinary leakage at 
2 – 3 months postoperatively. Where patients 
reported residual urinary leakage at 
follow-up, or presented later with symptoms 
of incontinence, further assessment by 
cystourethroscopy with or without further 
imaging studies and urodynamic 
investigation were undertaken as 
appropriate, to distinguish anatomical 
failure (with persistent or recurrent 
extra-urethral incontinence) from other 
causes of incontinence (urethral 
incontinence). 
 Primary fi stula closure was apparent in 
95.7% of women, with a continence rate of 
93.5% in the present series. The distinction 
between anatomical and functional outcome 
is important; the persistence of stress 
incontinence after successful anatomical 
closure of obstetric fi stulae has long been 
recognised  [ 12 ] , and may affect 33 – 50% of 
women  [ 20,21 ] . We have previously shown a 
high rate of functional abnormality of the 
lower urinary tract in association with 
fi stula in the UK  [ 22 ] , although long-term 
follow-up of these patients, whilst 
confi rming many to have persistent 
symptoms, suggests that for most these 
have limited impact on health-related 
quality of life  [ 23 ] . It is of interest that 
whilst stress incontinence has always been 
thought to be the greatest persistent 
problem in obstetric fi stula patients, we 
found both stress and urge symptoms to 
persist in similar numbers in UK fi stula 
patients  [ 23 ] , and the disparity between 
anatomical and functional outcome seen in 
the present series was similar for vesico-
vaginal and urethro-vaginal fi stulae. 
 The place of interposition grafting remains 
unclear. Both omental and labial grafts have 
been widely advocated in the past to 
increase local blood supply, reduce scarring 
and enhance the prospect for successful 
repair; however, neither has been subjected 
to randomised trial. Several authors have 
reported improved cure rate where grafts 
have been used in both obstetric  [ 24 ] , and 
surgical fi stulae  [ 11,25 ] . In the present series, 
primary closure rate was not signifi cantly 
different between those procedures where 
an interposition graft was or was not used. 
However, here also it must be noted that 
decisions about route of repair and the use 
of interposition grafts were not taken at 
random, but based on specifi c patient 
characteristics; these fi ndings must 
therefore be interpreted with caution. 
It is noted that there is a recent move 
away from the use of interposition 
grafting amongst obstetric fi stula surgeons 
 [ 6 ] . 
 In women who had undergone previous 
unsuccessful repairs prior to referral, cure at 
fi rst operation after referral was signifi cantly 
less likely. Similarly, in those women whose 
fi rst repair after referral was unsuccessful, 
the secondary closure rate was also slightly 
lower; whilst these latter fi gures were not 
statistically signifi cantly different, the 15% 
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lower rate of closure should perhaps be seen 
as clinically signifi cant. The same 
phenomenon has previously been reported 
in much larger series of obstetric fi stulae  [ 3 ] . 
It cannot be overemphasised that the best 
prospect for cure of a patient with a fi stula 
is at the fi rst operation, and this must be 
undertaken by a surgeon with appropriate 
training and experience. Optimal results are 
only likely to be achieved in specialist 
centres undertaking a  ‘ viable ’ workload of 
cases, although exactly what constitutes 
such a reasonable workload has not been 
defi ned. In 1997 it was reported that an 
average of 84 hospitals in England and 
Wales carry out fi stula repair surgery in 
any one calendar year; the average number 
of procedures undertaken annually in 
those hospitals was less than two  [ 26 ] . 
Clearly this could not be considered as 
a reasonable workload for any aspect 
of surgical practice. It was proposed in 
debate at a joint meeting of the Royal 
College of Obstetricians and Gynaecologists, 
and the British Association of Urological 
Surgeons in 1996 that only two or three 
centres for urogenital fi stula repair were 
required in the UK  [ 26 ] ; despite the 
agreement of both professional groups, such 
a pattern of care has never been formally 
established. The apparently declining number 
of cases since that time, makes such 
centralisation of management even more 
appropriate. 
 In conclusion, this case series describes the 
workload of a  de facto supra-regional fi stula 
service. Whilst the patterns cannot be said 
necessarily to refl ect the whole of UK 
practice, the current caseload of the unit 
represents  > 20% of the national surgical 
activity. High rates of fi stula closure are 
reported regardless of aetiology, although 
the appropriate selection of cases for 
surgery, particularly in those fi stulae after 
ionising radiation, is crucial to this success. 
Previous unsuccessful repair surgery 
militates against successful outcome; this 
emphasises the appropriateness of 
centralisation of the management of 
this increasingly rare condition in UK 
practice. 
 The correlation of these data with publicly 
available national data suggests an increase 
in the rate of fi stula formation associated 
with hysterectomy. If confi rmed, such trends 
could have signifi cant implications for 
training and practice in gynaecology; 
certainly they justify further evaluation 
and explanation and this is presently 
underway. 
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Urodynamic findings in patients with urogenital fistulae
P. HILTON
Royal Victoria Infirmary, Newcastle upon Tyne, UK
Objective To assess the feasibility of carrying out a one showing entirely normal urodynamic findings.
Genuine stress incontinence was found more thanurodynamic investigation in patients with a urogenital
fistula and to establish the incidence of abnormal twice as often associated with urethral or bladder
neck fistulae and detrusor instability was also morelower urinary tract function in such patients.
Patients and methods Of 38 patients referred within the common in this group. Voiding dysfunction of both
hypotonic and obstructive types was found equally inlast 3 years with a diagnosis of lower urinary tract
genital fistula, 30 were investigated by dual-channel the two groups. After surgical treatment, most patients
became continent and free from lower urinary tractsubtracted cystometry before surgical treatment of
their fistula; in addition, urethral pressure profilometry symptoms, although one complained of residual stress
incontinence and nine of urgency or urge inconti-was carried out in 19 patients. Fourteen of the patients
had fistulae into the vaginal vault; the urodynamic nence. Of the latter, six were found to have detrusor
instability, one after repair of vault fistula, three afterfindings in this subgroup were compared with those
of 12 patients with bladder neck and urethrovaginal urethral or bladder neck fistulae and the other two
after mid-vaginal fistulae.fistulae. Twenty-six of the 30 patients underwent
surgical treatment and 24 (92%) were cured anatom- Conclusion There is a high incidence of abnormal lower
urinary tract function in patients with urogenitalically by their first procedure. Ten patients complained
of residual lower urinary tract symptoms and were fistulae. Patients with urethral or bladder neck fistulae
had a higher incidence of both detrusor instability andre-investigated.
Results Of the 38 patients, 47% had genuine stress genuine stress incontinence than those with fistulae
into the vaginal vault. Many of these abnormalitiesincontinence, 40% showed systolic detrusor instability
and 17% impaired bladder compliance. Half had evi- appear to resolve after successful repair of the fistula,
although detrusor instability may persist and requiredence of voiding dysfunction; most appeared to be of
a hypotonic detrusor type, although four cases showed further treatment in some women. These findings are
relevant to the counselling of patients before repairan obstructive pattern. Fifteen patients had more than
one abnormality and only five (17%) had entirely and may be of medico-legal significance.
Keywords Fistula, vesico-vaginal, urethro-vaginal, uro-normal urodynamic findings. The overall incidence of
functional abnormality was highest in the patients dynamics, stress incontinence, detrusor instability
with urethral or bladder neck fistulae, with only
distinct from intra-abdominal pressure. Conventionally,Introduction
the latter is determined by rectal or vaginal pressure.
The feasibility of cystometry in patients with communi-The occurrence of stress incontinence in patients after
the successful repair of obstetric vesicovaginal fistula has cation between the urinary and the genital tract may
therefore be questioned. Schleicher et al. described thelong been recognized, and overall has been estimated to
occur in up to 10–12% of such patients [1–5]. Waaldijk application of cystometry in 18 patients after the repair
of obstetric fistulae [6]; the author is unaware ofdocumented the occurrence of stress incontinence after
repair of fistulae of varying types, describing 1% where previous reports of urodynamic investigation before
fistula repair.there was no sphincter involvement in the fistula, 13%
where there was but with no tissue loss and 16% where Because of concern over the possible incidence of
functional abnormalities of the lower urinary tract afterthere was both sphincter involvement and tissue loss [5].
The recording of detrusor pressure during cystometry fistula repair and the need to counsel patients appropri-
ately before repair, a series of urodynamic investigationsdepends on the ability to record intravesical pressure as
in patients with urogenital fistulae was carried out. The
aims of the study were to assess the feasibility of detrusorAccepted for publication 4 December 1997
539© 1998 British Journal of Urology
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Table 1 The aetiology of fistulae in the present series. Comparativepressure measurement in the presence of a fistula and
values are shown for the total throughput of the unit over the lastto describe the types and incidence of abnormality.
9 years (100 cases) [3]
Associated procedure No (%) of % of totalPatients and methods
Aetiology/pathology present caseload
Over the last 3 years, 38 patients (aged 27–66 years)
with lower urinary tract fistula were referred to the Surgical 23 (77) 75
Abdominal hysterectomy 11Urogynaecology Unit, 30 of whom were investigated
Vaginal hysterectomy 1urodynamically before treatment. Free uroflowmetry was
Laparoscopic hysterectomy 1carried out using an air-displacement technique. Dual-
Radical hysterectomy 2channel subtracted cystometry was then carried out
Urethral diverticulectomy 4
using 4 F fluid-filled lines connected to external trans- Colporrhaphy 1
ducers to measure bladder and vaginal (26 patients) or Colposuspension 1
rectal (four patients) pressure. A rapid-fill (100 mL/s) Sub-urethral sling 1
Augmentation cystoplasty 1method was used, filling by peristaltic pumping through
Obstetric 3 (10) 9a 10 F filling catheter. Urethral pressures were also
Forceps 1measured at rest and during stress in 19 of the patients,
Vaginal delivery after previous 1using a dual-sensor microtransducer catheter (Gaeltec,
Lower segment Caesarean section
Isle of Skye, UK) at 200 mL bladder volume or at Breech delivery (30 years earlier!) 1
the maximum volume tolerated without sensation [7]. Radiation 2 (7) 9
Urodynamic variables between groups were compared Stage 3b CC (RT alone) 1
Stage 2a CC (pre-op RT) 1using nonparametric statistics (Mann–Whitney U-test).
Miscellaneous 2 (7) 7One patient was asymptomatic on anticholinergic
Foreign body 1medication, one healed with prolonged catheter drain-
Fall (no clear penetrating injury) 1age, one died from cachexia related to malignant disease
Total 30
and radiation eCects, and one declined surgical treatment
until the end of the bowling season. Twenty-six of the CC, Carcinoma of the cervix. RT, Radiotherapy.
30 women underwent surgical repair of their fistulae.
Table 2 Variables of filling and voiding cystometry, and restingTen women had residual urinary symptoms after fistula
urethral profiles in the total patient group, in the subgroups withrepair and the urodynamic investigation was repeated
urethral or bladder neck (UBN) fistulae and vault fistulae. There
in these women. The methods, definitions and units were no significant diCerences (Mann–Whitney U-test)
conform to the standards recommended by the ICS
except where specifically noted [8]. Cystometric Total group UBN Vault
variables (n=30) (n=12) (n=14)
Results Free flow rate (mL/s) 13 12 15
Residual urine (mL) 2 3 1Seven of the patients had undergone a total of 11
First sensation (mL) 136 112 153previous unsuccessful repair procedures before referral.
Cystometric capacity (mL) 298 319 293
The aetiology of the fistulae was surgical in 23 (77%), Pressure rise (cmH
2
O)
obstetric in three (10%), related to radiotherapy in two At capacity 14 13 10
(13%), and to a foreign body and trauma in one case On provocation 20 22 17
Max voiding pressure (cmH
2
O) 25 24 27each. The associated surgical procedures are shown in
Max flow rate (mL/s) 11 14 10Table 1. One of the fistulae was vesico-uterine and six
Urethralwere urethrovaginal. Of the 23 vesicovaginal fistulae,
Functional length (mm) 26.5 27.2 25.814 were situated in the vaginal vault, three were mid-
Total length (mm) 32.4 31.9 33.2
vaginal and six at the bladder neck. The distribution of Max closure pressure (cmH
2
O) 38.5 29.2 49.8
aetiologies is consistent with that generally seen in the
UK or elsewhere in the developed world [3].
The variables from filling and voiding cystometry are genuine stress incontinence, 12 (40%) showed systolic
detrusor instability, and five (17%) impaired bladdershown in Table 2. Comparing the urodynamic variables
among the 14 patients with vault fistulae and the 12 compliance. Fifteen patients (50%) showed evidence of
voiding abnormality (flow rate consistently <15 mL/s);with fistulae at the bladder neck or urethra showed
no statistically significant diCerences. The urodynamic most appeared to be of a hypotonic detrusor type,
although four of the patients with voiding dysfunctiondiagnoses are shown in Table 3; 14 patients (47%) had
© 1998 British Journal of Urology 81, 539–542
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Table 3 Functional abnormalities in the total patient group, and presence of large fistulae, whilst it could not be confirmed
in the subgroups with urethral or bladder neck (UBN) and that the pressures recorded were what they would have
vault fistulae. been with an intact urogenital system, the intravesical
pressure diCered from the intra-abdominal pressure.All patients UBN Vault Other sites
The present series of patients had more urethrovaginal(n=30) (n=12) (n=14) (n=6)
and bladder neck fistulae than in our total fistula case-n(%)
load (40% compared with 14%), although there was a
Genuine stress 14 (47) 9 5 0 similar number of vault fistulae (47% compared with
incontinence 52%) [3]. However, the aetiology, patient age and parity
Detrusor instability 12 (40) 6 5 1 distribution, and previous surgical history were compar-
Impaired bladder 5 (17) 0 3 2 able, suggesting that the slightly atypical distribution of
compliance
site probably reflects no more than a clustering eCect.Voiding dysfunction 15 (50) 7 7 1
This allowed a useful functional comparison betweenNo abnormality 5 (17) 1 2 2
urethral and bladder neck fistulae and vault fistulae.
Waaldijk defined sphincter involvement in a fistula to be
when the lower edge of the lesion is within 6 cm of the(13% of the total) showed an obstructive pattern (voiding
pressure >50 cmH
2
O). external urethral meatus [5]. He reported stress inconti-
nence after fistula repair in 13% of patients where thereThe urodynamic findings in the 14 patients with vault
fistulae were compared with the 12 with fistulae at the was sphincter involvement, and in 1% without such
involvement. Within the present series, the incidence ofbladder neck or urethra (Table 3). The overall incidence
of functional abnormality was highest in the latter group, urodynamically proven genuine stress incontinence associ-
ated with fistulae before repair was nine of 12 withwith only one showing entirely normal urodynamic
findings, compared with two in the former group. sphincter involvement and five of 14 without such involve-
ment. In Waaldijk’s series, the assessment was made afterGenuine stress incontinence was found in nine of those
with urethral or bladder neck fistulae, compared with fistula repair and was entirely subjective, whilst in the
present series the functional situation was establishedfive in those with vault fistulae, and detrusor instability
in six and five in the same groups, respectively; voiding before repair, based on the urodynamic investigation. The
definition of sphincter involvement used in these two seriesdysfunction of both hypotonic and obstructive types was
found equally in the two groups. also diCered, although probably not significantly.
It has been our standard practice to use an interpo-After fistula repair, two patients had a persistent or
recurrent fistula (92% cure at first operation). Ten sition graft of labial fat and bulbocavernosus [10]. It is
likely that this limits the incidence of stress incontinencepatients complained of persistent urinary symptoms
despite anatomical closure of their fistulae. One had stress after fistula repair by adding bulk to support the bladder
neck, bringing a new blood supply to the area, andincontinence and nine urgency or urge incontinence; all
had had abnormal cystometry pre-operatively. On repeat limiting rigidity and scar formation between the urethra
and vagina. After surgery, only one of the presenturodynamic investigation, the former was confirmed to
have persistent genuine stress incontinence and six of patients, with a urethral fistula, complained of stress
incontinence; re-investigation confirmed genuine stressthe latter were confirmed to have persistent detrusor
instability. No women with stable bladders before surgery incontinence. This gives an incidence of stress inconti-
nence after repair, in this group of largely surgicalhad persistent symptoms afterward.
fistulae, of only one of 30 or 3%, and a persistence rate
of one in 14 and one of nine of the vault and urethralDiscussion
or bladder neck fistulae, respectively. This latter value
may be directly compared with Waaldijk’s value of 13%Although there are previous reports of urethral pressure
measurement in patients with urethral diverticula and stress incontinence after repair of obstetric fistulae with
sphincter involvement [5].urethrovaginal fistulae [9] this is the first report of cysto-
metry in patients before repair of a urogenital fistula. In Of the nine patients complaining of urgency or urge
incontinence after repair, six were confirmed to havefour cases where fistulae were particularly large, rectal
pressure was used to record intra-abdominal pressure; in persistent detrusor instability, giving an overall incidence
of detrusor instability of six in 30 (20%) and a persistencethe remainder, vaginal pressure was used. In all cases,
the detrusor pressure was recorded satisfactorily, i.e. in rate of one of five for the vault fistulae, but three of six
for the urethral or bladder neck fistulae. No patientsthe presence of small fistulae, intravesical and vaginal
pressure appeared to be diCerent throughout the filling complained of urge incontinence after surgery who had
stable bladders before, i.e. there was no evidence ofand voiding phases of the micturition cycle. In the
© 1998 British Journal of Urology 81, 539–542
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2 Bird G. Obstetric vesicovaginal and allied fistulae. J Obstetso-called de novo detrusor instability after surgery. The
Gynaecol Br Cwlth 1967; 74: 749–52occurrence of detrusor instability in patients with fistula
3 Hilton P. Fistulae. In Shaw RW, Souter WP, Stanton SLis perhaps not surprising. The emotional impact of
eds, Gynaecology, 2nd edn. London: Churchill-Livingstone,developing a fistula is profound, given that most of these
1997: 779–801patients were free from urinary symptoms before the
4 Lawson JB. Injuries to the urinary tract. In Lawson JB,
causative surgery, and had entered hospital for what Stewart DB eds, Obstetrics and Gynaecology in the Tropics
was anticipated to be an uneventful procedure. The and Developing Countries. London: Edward Arnold, 1967:
psychometric background of patients with idiopathic 481–522
detrusor instability has been investigated and they are 5 Waaldijk K. The Surgical Management of Bladder Fistula in
consistently shown to have higher scores on anxiety 775 Women in Northern Nigeria. MD Thesis: Amsterdam,
1989scales than patients with other forms of incontinence or
6 Schleicher DJ, Ojengbede OHA, Elkins TE. Urologic evalu-other chronic illnesses [11,12]. No specific steps are
ation after closure of vesicovaginal fistulas. Int Urogynecoltaken at operation to relieve detrusor instability, and
J 1993; 4: 262–5indeed it is doubtful that they could. The absence of
7 Hilton P, Stanton SL. Urethral pressure measurement bysymptoms of urgency at follow-up in most of the patients,
micro-transducer: the results in symptom-free women andand the reversion to stability in those who were
those with genuine stress incontinence. Br J Obstet Gynaecol
re-investigated, may therefore reflect the resolution of 1983; 90: 919–33
the psychological trauma after successful closure of the 8 Abrams P, Blaivas JG, Stanton SL, Andersen JT. The
fistula, rather than any direct eCect on the detrusor. Standardisation of terminology of lower urinary tract
Why the problems of urgency should persist in some, function; a report produced by the International Continence
despite the anatomical closure of their fistula, and why Society Committee on Standardisation of Terminology. Br
J Obstet Gynaecol 1990; 97 (suppl. 6): 1–16this appears to happen more often in those with urethral
9 Sand PK, Ostergard DL. Urethro-vaginal Fistulae and Urethraland bladder neck than those with vault fistulae is more
Dverticulum. Urodynamics and the Evaluation of FemalediBcult to explain. It is possible that in these patients the
Urinary Incontinence: A Practical Guide. London: Springer,mechanisms are similar to those of detrusor instability
1995: 94–7occurring after bladder-neck elevating procedures in the
10 Martius H. Die operativeWiederherstellung der vollkommentreatment of detrusor instability [13,14].
fehlenden Harnrohre und des Schiessmuskels derselben.
The persistence of these functional problems after Zentralblatt fur Gynakologie 1928; 52: 480
successful repair is clearly of importance in counselling 11 Currie I, Onwude JL, Jarvis GJ. Emotional factors in urinary
patients pre-operatively. Whilst it is undoubtedly import- incontinence. 27th British Congress of Obstetrics and
ant to give confidence to the patient that their fistula Gynaecology. Dublin: RCOG, 1995: abstract 415
can be closed, it is equally important to give a realistic 12 Macaulay AJ, Stern RS, Holmes DM, Stanton SL. Micturition
and the mind: psychological factors in the aetiology andopinion as to what this may mean in symptomatic terms.
treatment of urinary symptoms in women. Br Med J 1987;Injury to the urinary tract accounts for 6–10% of
294: 540–3medico-legal claims in gynaecology [15,16]. Proper
13 Cardozo LD, Stanton SL. Detrusor instability followingevaluation and appropriate counselling before repair
surgery for genuine stress incontinence. Br J Urol 1979;may go some way towards limiting this outcome.
51: 204–7
14 Steel S, Cox C, Stanton SL. Long term follow up of detrusor
instability following colposuspension. Br J Urol 1985;Acknowledgements
58: 138–42
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Using the Bristol Female Lower Urinary Tract Symptom
questionnaire, we have investigated urinary and sexual symptoms
and quality of life in a group of 31 women 50 months (median)
after successful repair of urogenital fistula. All had undergone
urodynamic investigation prior to their repair surgery, and only
36% had normal findings. Almost all women reported one or
more symptoms, and for 65%, these caused at least ‘a bit of
a problem’, although 87% said that their urinary symptoms had
little or no impact on their quality of life. Symptoms were similar
in urethrovaginal and vesicovaginal fistulae and were not
significantly associated with prior functional abnormality.
Keywords Long-term follow up, quality of life, surgery,
urodynamics, urogenital fistula.
Please cite this paper as: Dolan L, Dixon W, Hilton P. Urinary symptoms and quality of life in women following urogenital fistula repair: a long-term follow-up
study. BJOG 2008;115:1570–1574.
Introduction
Urogenital fistulae are most often acquired from obstetric,
surgical, radiation, malignant and miscellaneous causes. In
much of the developing world more than 90% of fistulae
are of obstetric aetiology, whereas in the UK and USA more
than 70% follow pelvic surgery.1 When conservative man-
agement of a urogenital fistula fails and surgical repair is
undertaken, anatomical closure and cure of extraurethral
incontinence are reported between 60 and 98% of women
at their first operation.1 However, some degree of urethral
incontinence may persist in up to half of women after repair
of obstetric fistula, particularly where there is urethral
involvement in the defect.2 A high incidence of associated
functional abnormality of the lower urinary tract has also
been reported prior to repair, in a series of largely surgical
fistulae from the UK, and in this study too the risk of these
abnormalities was greatest in urethral and bladder neck fistu-
lae.3 It seems likely that a high incidence of preoperative
functional abnormality will impact on outcome despite a high
rate of anatomical closure. To investigate this further, we
undertook a single centre study to establish the long-term
incidence of lower urinary tract symptoms (LUTs) after
fistula repair in women who had undergone urodynamic
investigation prior to their repair procedure. We also aimed
to establish the time of onset of these symptoms in relation to
repair surgery, the impact of their urinary symptoms on their
quality of life and any association between preoperative func-
tional abnormality, fistula site and postoperative symptoms.
Methods
A consecutive cohort of women, referred to the senior author
for treatment of urogenital fistula between January 1993 and
December 2002, was identified from our surgical database.
Women with a vesicovaginal or urethrovaginal fistula, who
had undergone preoperative urodynamic investigation and
vaginal or abdominal fistula repair with a minimum of 6
months of follow up, were eligible for inclusion. Women with
fistulae that were managed conservatively and those treated by
primary urinary diversion or colpocleisis were excluded.
All eligible women had undergone dual channel subtracted
filling and voiding cystometry performed using intravesical
and either vaginal or rectal catheters attached to external
pressure transducers. Filling cystometry was performed at
a rate of 50 ml/minutes using normal saline at room
1570 ª 2008 The Authors Journal compilation ª RCOG 2008 BJOG An International Journal of Obstetrics and Gynaecology
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temperature, with the patient supine. Provocation tests were
performed supine and erect on completion of filling. All
methods, definitions and units conform to the standards rec-
ommended by of the International Continence Society, except
where specifically noted. A voiding dysfunction was defined
when two of the following three criteria were present at voiding
cystometry: voiding pressure >50 cm H2O, maximum urine
flow rate of <15 ml/second and residual urine volume >100 ml.
Eligible women were contacted by post and invited to par-
ticipate by completing the Bristol Female Lower Urinary Tract
Symptom (BFLUTS) questionnaire,4 together with a further
self-administered questionnaire that provided information on
parity, body mass index (BMI), interim surgery, current med-
ical problems and regular medication. A stamped addressed
envelope for return was enclosed, and nonresponders were
contacted again 4 weeks later. Additional information was
obtained from case records and those held on the unit surgical
database.
Statistical analysis
All questionnaires were coded for identification. Statistical
analysis was undertaken using Mann–WhitneyU test and Fish-
er’s exact test for continuous and categorical data, respectively.
Results
Questionnaire response rate
A consecutive series of 84 women with urogenital fistulae
were identified. Forty women were not eligible for inclusion
for various reasons: preoperative cystometry not performed
(20); declined surgery or healed without surgery (8); surgical
treatment by urinary diversion (3) or colpocleisis (2); other
fistula types: ureterovaginal (2) colovesical (1), vesicouterine
(1), rectovaginal (1), peritoneovaginal (1); and 1 woman was
known to be deceased. In nine women, case information was
missing or inadequate to allow contact. Therefore, there were
35 contactable women with vesicovaginal or urethrovaginal
fistulae who fulfilled all eligibility criteria for inclusion, and
they were sent postal questionnaires.
Completed questionnaires were returned by 31 women
(89%); 1 was returned unanswered as the woman was deceased.
The median age of respondents was 46 years (range 16–85
years), median parity 2 (range 0–5) and mean BMI
26.9 kg/m2 (SD 4.9). The median length of time between the
surgery and the survey was 50 months (range 7–115 months).
Preoperative findings
Twenty-one of the fistulae were into the vaginal vault (68%)
and 9 were bladder neck or urethral fistulae (29%); 1 was
juxtacervical in position. The aetiology was surgical in 25
women (81%), obstetric in 3 (10%), congenital in 1 (3%),
following pessary use in 1 (3%) and radiation in 1 woman
(3%). The antecedent procedures in the surgical cases were
total abdominal hysterectomy (15), vaginal hysterectomy (2),
laparoscopically assisted vaginal hysterectomy (2), urethral
diverticulectomy (3), colposuspension (2) and colporrhaphy
(1). This distribution of cases is comparable to the total fistula
workload referred to the unit.1
On the basis of preoperative urodynamic investigation,
functional abnormality of the lower urinary tract was present
in 20 women overall (65%) (Table 1); the rate of abnormal-
ity was not significantly different between those with vault
fistulae (62%) and bladder neck or urethral fistulae (78%)
(Fisher’s exact test P = 0.74). Five women (16%) demonstrated
mixed urodynamic diagnoses; the breakdown of the main
diagnoses in pure and mixed forms is shown in Table 2.
Fistula repair was performed vaginally in 27 women
(87%) by a transvesical approach in 2 and a transperitoneal
Table 1. Distribution of urodynamic abnormalities found in association with urogenital fistula and the rate of symptoms and significantly
problematic symptoms at later follow up
n (%) Number with at least one symptom
graded as at least ‘a bit of a
problem’, n (%)
Number with at least one symptom
graded as ‘quite a problem’ or ‘a
serious problem’, n (%)
Preoperative urodynamic diagnosis
No abnormality 11 (35.5) 6 (54.5) 3 (27.3)
Voiding dysfunction 6 (19.4) 4 (66.7) 0
USI 5 (16.1) 4 (80.0) 0
Detrusor overactivity 4 (12.9) 2 (50.0) 1 (25.0)
Mixed urodynamics 5 (16.1) 4 (80.0) 0
Total 31 20 (64.5) 4 (12.9)
Fistula type
Bladder neck or urethral 9 (29.0) 7 (77.8) 1 (11.1)
Vaginal vault 21 (67.7) 13 (61.9) 3 (14.3)
Quality of life after urogenital fistula repair
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approach in 2. Successful anatomical closure of the fistula was
achieved with a single operation in all women. A continence
procedure was combined with fistula repair in three women
with preoperative urodynamic stress incontinence (USI).
Lower urinary tract symptoms
The BFLUTS questionnaire asks respondents to describe
symptoms in terms of their frequency of occurrence as
‘never’, ‘occasionally’, ‘sometimes’, ‘most of the time’ or ‘all
of the time’; in a second stem, they are then asked to grade the
impact of symptoms as ‘not a problem’, ‘a bit of a problem’,
‘quite a problem’ or ‘a serious problem’. Thirty of the 31
women (97%) reported having one or more urinary symp-
toms at a median of 50 months after fistula repair, with
urgency (71%), nocturia (68%), stress incontinence (68%)
and urge incontinence (65%) being the most commonly
reported symptoms.
Table 1 shows the proportion of women in each of the
preoperative cystometric diagnostic groups who reported
bothersome LUTs postoperatively and the frequency of
occurrence of symptoms. Overall, 20 women (65%) had at
least one bothersome symptom (i.e. one that they graded as
being at least ‘a bit of a problem’). Fifty-five percent of
women without functional abnormality preoperatively
reported symptoms that were bothersome after surgery com-
pared with 80% of those with mixed urodynamic findings or
USI; however, these differences were not statistically signifi-
cant. There was no significant difference in the rate of both-
ersome symptoms between those women with urethral or
bladder neck fistulae (78%) and those with fistulae into the
vaginal vault (62%) (Fisher’s exact test P = 0.34).
Urinary incontinence was the most commonly bothersome
symptom (35%), with stress and urge incontinence being
similarly represented. Despite the apparently high incidence
of urinary symptoms, only four women (13%) described
symptoms that were either ‘quite a problem’ or ‘a serious
problem’ to them. One woman with detrusor overactivity
described nocturia in this way; the other three, all in fact with
normal urodynamic findings prior to repair, reported a num-
ber of symptoms in this way: one reported stress incontinence
and nocturnal enuresis; one frequency, bladder pain and
unexplained leakage and one urgency and both stress and
unexplained leakage as significantly problematic.
Of those women with bothersome symptoms, nine (43%)
reported the onset of symptoms as being ‘before the repair’
and nine (43%) felt their symptoms as starting ‘shortly after
the repair’; one described symptoms of recent onset and
others did not specify the onset.
Impact on quality of life
The BFLUTS questionnaire asks respondents to grade how
they would feel if they had to spend the rest of their life with
their current urinary symptoms as ‘perfectly happy’, ‘pleased’,
‘mostly satisfied’, ‘mixed feelings’, ‘mostly dissatisfied’, ‘very
unhappy’ or ‘desperate’. Ten women (32%) had at least
mixed feelings, although only two women described feeling
dissatisfied or unhappy at the prospect. Twenty-seven women
(87%) said that their urinary symptoms caused little (12) or
no (15) interference with their lives.
Sexual function
Twenty-two women were sexually active at the time they
responded to the questionnaires and 15 (68%) described
one or more symptoms in relation to intercourse. Vaginal
dryness (46%), sex life spoilt by urinary symptoms (41%)
and dyspareunia (36%) were the most commonly reported
symptoms. In nine women (41%), the sexual symptoms were
described as being at least ‘a bit of a problem’, and for six
(27%), these were either ‘quite a problem’ or ‘a serious prob-
lem’. Three women described leaking urine during inter-
course, although only one found this ‘a bit of a problem’.
Discussion
We have demonstrated that the majority of women report one
or more urinary or sexual symptoms in the long term follow-
ing successful anatomical closure of urogenital fistula. For
approximately two-thirds of women, these symptoms cause
at least some degree of bother, although only one in eight
found them to be significantly problematic. Nocturia,
urgency and urinary incontinence were the most frequently
reported symptoms, with incontinence the most commonly
bothersome, and stress and urge incontinence occurring with
equal frequency. Recent epidemiological studies undertaken
in Newcastle on a cohort of 3000 women 20 years after their
first delivery (and hence of similar age and parity distribution
to the women reported in this study) also found a high prev-
alence of all symptoms of pelvic floor dysfunction, albeit using
a different questionnaire.5 For example, nocturia, urgency
and stress incontinence were reported by 63, 48 and 30% of
women, with 18, 21 and 14%, respectively, describing the
symptom as causing at least ‘a bit of a problem’.5 For each of
Table 2. Distribution of urodynamic abnormalities in pure and
mixed forms
Preoperative
urodynamic
diagnosis
Pure
diagnoses,
n (%)
Mixed
diagnoses,
n (%)
Pure or
mixed, n (%)
No abnormality 11 (35.5) — —
Voiding dysfunction 6 (19.4) 4 (12.9) 10 (32.3)
USI 5 (16.1) 5 (16.1) 10 (32.3)
Detrusor overactivity 4 (12.9) 1 (3.2) 5 (16.1)
Mixed urodynamics — 5 (16.1) —
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the urinary symptoms examined, however, the prevalence was
1.5 to 2 times higher in our population of women following
fistula repair than it was in the general population.
Hysterectomy has often been looked on as a cause of uri-
nary symptoms, although longitudinal studies suggest that
they are more likely to improve than they are to deteriorate
or to present for the first time following hysterectomy. It
should be noted, however, that 23 (74%) of our women
had undergone prior hysterectomy, and in 19 (61%), it was
an immediate antecedent to their fistula.
Of those women who were able to specify the time of onset
of their symptoms, approximately half felt symptoms had
developed at or around the time of their fistula and or repair,
although half recalled having symptoms before the develop-
ment of their fistula. We cannot exclude the possibility of
recall bias in defining the onset of symptoms, although it
seems likely that only a proportion of the symptomatology
demonstrated in this study can be appropriately ascribed to
the fistula or its repair.
Few studies have reported urodynamic investigation in
women with urogenital fistulae. In a study of women with
obstetric fistulae in Ethiopia where urodynamic investigation
was undertaken after repair, 55% of women were incontinent
despite successful closure of their fistula; USI was most com-
mon abnormality identified.6 We have previously demon-
strated USI in 47% of women prior to repair in a series of
largely surgical fistulae in the UK, although in only 3% did
this persist after repair. Detrusor overactivity was found in
40% at presentation and persisted in half of these at follow
up.3 It is noteworthy, however, that although symptoms were
somewhat more common in the long term after fistula repair
in women with urodynamic abnormalities defined prior to
repair, the majority of the most bothersome symptoms were
actually found in women without such abnormalities. One
might therefore question the value of urodynamics in this
group of women. It should, however, be noted that it has
always been our practice to undertake labial fat/muscle inter-
position grafts (Martius graft) in women with urethral or
bladder neck fistulae. Later, we have also offered concurrent
fascial sling (with urethrovaginal fistulae) or tension-free vag-
inal tape (with vesicovaginal fistulae) in those women with
problematic stress urinary incontinence confirmed urody-
namically. In that sense, the use of bladder function testing
has certainly influenced our practice.
Our previous studies of urodynamic investigation in
women with fistulae suggested that functional abnormalities
were more likely to be found in women with urethrovaginal
or bladder neck fistulae than in those with vault fistulae and
that symptoms were also more likely to persist after repair in
this group.3 In the current series, however, the incidence of
abnormality overall and the distribution of urodynamic diag-
noses were similar in these different fistula types; the overall
prevalence of symptoms and of clinically significant symp-
toms at later follow up was also similar. It is difficult to
explain the difference in findings in our two series, and it
may simply reflect the small sample size and limited power
to draw firm conclusions from either. The findings of the
current series are in keeping with those of the only previous
series of women with obstetric fistulae in which urodynamic
investigation was undertaken.6
Although the causes, types, size and social impact of fistulae
seen in the developing world are very different from those
seen in the UK,1 the follow-up study from Browning and
Menber2 makes an interesting comparison. They found that
the urinary incontinence persisting after anatomically suc-
cessful repair of obstetric fistulae tended to improve over time
(6 months after repair); together with that improvement,
there was evidence of improvement in several aspects of qual-
ity of life, with reintegration into society. Although our
women were assessed over a longer time scale (median 4
years), we did not see a tendency for symptoms to resolve
completely. The patients’ responses to an incontinence-spe-
cific quality-of-life questionnaire, however, show that in the
majority, residual urinary symptoms have limited impact on
their quality of life.
Conclusions
We have demonstrated that LUTs are common after success-
ful anatomical closure of urogenital fistulae of largely surgical
aetiology, and in approximately half of these women, the
symptoms develop at or shortly after the onset of the fistula.
There is no significant difference in urodynamic abnormali-
ties found in association with different fistula types or in the
symptoms found subsequently. Normal cystometry prior to
fistula repair did not appear to be associated with a lower
incidence of bothersome symptoms 4 years postoperatively.
Even where a good prognosis for fistula closure can be given,
women undergoing fistula repair should be counselled about
the possibility of persisting urinary symptoms afterwards;
they can be reassured that in most cases, these will be mild,
with limited impact on their quality of life.
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Objective To estimate rates of vesicovaginal and urethrovaginal
fistula among women undergoing hysterectomy by indication and
type of procedure, and to assess trends in risk over time.
Design Retrospective cohort using data from Hospital Episode
Statistics.
Setting English National Health Service (NHS) hospitals.
Population Women undergoing hysterectomy for selected
common conditions in English NHS hospitals between January
2000 and December 2008.
Methods Unadjusted rates of urogenital fistula were calculated by
type of procedure and indication. Logistic regression was used to
assess whether the risk of fistula was associated with age, or had
changed over time.
Main outcome measure Rate of urogenital fistula (vesicovaginal
and urethrovaginal fistula) within 1 year of hysterectomy.
Results Among 343 771 women undergoing hysterectomy, the
overall rate of fistula was 1 in 788. The rate varied by indication
and procedure, being highest following radical hysterectomy for
cervical cancer (1 in 87; 95% CI 61–128) and lowest following
vaginal hysterectomy for prolapse (1 in 3861; 95% CI 2550–6161).
After total abdominal hysterectomy for endometriosis, menstrual
problems or fibroids, the risk of fistula was lower in women aged
50 years or over than in women under 40 years (adjusted odds
ratio 0.61; 95% CI 0.38–0.98). The overall rate of fistula increased
by 46% during the study period.
Conclusions The risk of urogenital fistula was associated with type
of hysterectomy and indication; the risk increased during the
study period, and was lower after hysterectomy for benign
conditions in women aged 50 years or over.
Keywords Hysterectomy, intraoperative complications, postopera-
tive complications, surgical injuries, urinary fistula, vesicovaginal
fistula.
Please cite this paper as: Hilton P, Cromwell D. The risk of vesicovaginal and urethrovaginal fistula after hysterectomy performed in the English National
Health Service—a retrospective cohort study examining patterns of care between 2000 and 2008. BJOG 2012;119:1447–1454.
Introduction
The prevention and management of vesicovaginal fistula
remains a major global public health challenge.1 It has been
estimated that there are currently 2 000 000–3 000 000
women with untreated fistula worldwide, although over
95% of these are of obstetric aetiology and are in the
developing world.2 In the developed world, urogenital
fistulae are relatively uncommon, and publically available
Hospital Episode Statistics (HES) for England suggest that
approximately 105 cases have been repaired surgically each
year over the last decade.3
Chassar Moir4 reviewed the position of vesicovaginal
fistula in Britain in 1973, and Lee et al.5 did the same in
the USA in 1988. The largest recent UK case series are
those reflecting tertiary-care practices, published by Ockrim
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et al.6 in 2009 (41 cases), and Hilton7 in 2011 (348 cases).
In the latter series, two-thirds of cases were of surgical
aetiology, and the remainder were evenly distributed
between obstetric, radiation and miscellaneous or traumatic
causes. Overall, almost half of this series were associated
with hysterectomy.7
The number of hysterectomy procedures undertaken in
the UK has been falling over the last decade, with the
increasing availability and acceptability of nonsurgical treat-
ments for menorrhagia in particular.8 However, with the
number of surgically treated urogenital fistulae remaining
fairly constant over the same period, this suggests that the
risk of urogenital fistula following hysterectomy may be
increasing.7 In this study, we describe rates of vesicovaginal
fistula and urethrovaginal fistula within 1 year of hysterec-
tomy among women treated in English NHS Trusts
between January 2000 and December 2008, and examine
whether the risk of a urogenital fistula is affected by the
indication, the type of procedure carried out, and the age
at surgery. We also investigate whether the risk of fistula
has changed over time.
Methods
The study used data from the HES database, which con-
tains records of all patient admissions to NHS hospitals in
England. Its records capture patient demographics, hospital
administrative information, diagnostic information using
the International Classification of Diseases (ICD), 10th
revision,9 and operative procedures using the UK Office for
Population Censuses and Surveys classification (OPCS), 4th
revision.10
Patient selection
This study included adult women (18 years and over) who
underwent hysterectomy for selected common indications in
English NHS hospitals between 1 January 2000 and 31
December 2008. The study was restricted to elective proce-
dures and distinguished between four types of hysterectomy:
total abdominal hysterectomy (TAH) (OPCS code: Q07.4),
subtotal abdominal (STH) (Q07.5), vaginal (VH) (Q08.9),
and radical abdominal hysterectomy (RAH) (Q07.1-07.3).
The selected benign conditions were endometriosis (ICD10
code: N80), uterine fibroids (D25), genital prolapse (N81)
and menstrual disorders (N92–N94). Four ‘malignant’ con-
ditions were also selected, namely, cervical carcinoma in situ
(D06), cervical cancer (C53), uterine cancer (C54, C55) and
ovarian cancer (C56). The analysis was restricted to women
under 55 years of age if their primary diagnosis was endo-
metriosis or menstrual irregularities. Further, the analysis
also excluded radical hysterectomies coded to women with
benign diagnoses, and combinations of conditions and pro-
cedures for which there were fewer than 500 cases.
Women were defined as having a postoperative fistula if
the ICD10 codes N82.0 (vesicovaginal fistula) or N82.1
(other urinary-genital tract fistula) were found in the diag-
nostic fields of the index procedure episode or any subse-
quent episode that occurred within 1 year of the index
procedure. The majority of fistulae occurred within
6 months of the index procedure. Surgical repair of fistulae
was examined using the most pertinent OPCS codes,
namely, repair of vesicovaginal fistula (OPCS P25.1), repair
of urethrovaginal fistula (P25.2) and construction of an
ileal conduit (M19.1).
Statistical analysis
The unadjusted incidence rate of urogenital fistula was
expressed as the percentage of fistulae within 1 year of hys-
terectomy; rates were stratified by type of procedure and
indication. We estimated the 95% confidence intervals (CI)
assuming that the number of events followed a Poisson dis-
tribution. Fisher’s exact test was used to judge the statistical
significance of differences between unadjusted rates.
We also examined whether the risk of urogenital fistula
had changed over time and was related to patient age at
the time of procedure. The primary analysis was restricted
to TAH procedures for endometriosis, fibroids or men-
strual conditions because of the small number of fistulae
recorded for other procedure–indication combinations.
Two additional analyses were performed. One extended the
first analysis by including both VH and TAH procedures
for these three benign indications. The other examined the
associations among women undergoing TAH for a malig-
nant indication. Logistic regression was used to calculate
adjusted odds ratios (OR) and 95% CI. All P values were
two-sided, and those <0.05 were judged to be statistically
significant. All analyses were performed using STATA ver-
sion 11 (StataCorp LP, College Station, TX, USA). The for-
mulation of this report has followed the STROBE
Statement.11
Results
Between 1 January 2000 and 31 December 2008, there were
351 505 hysterectomies performed in English NHS hospi-
tals for the selected indications (Figure 1). Of the 292 250
operations performed for benign conditions, 3262 (1.1%)
were excluded because the procedure was coded as a radical
hysterectomy (abdominal or vaginal) and 290 (0.1%) were
excluded because of the small number criterion. A further
2645 (2.5%) of the 106 440 women with endometriosis or
menstrual conditions were excluded for being 55 years or
older. Of the 59 255 procedures performed for malignant
conditions, 1537 (2.6%) were excluded because of the small
number criterion. The characteristics of the remaining
343 771 women are summarised in Table 1.
Hilton, Cromwell
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Number of hysterectomy procedures by indication
The number of hysterectomies performed for the different
indications varied over the 9-year period (Figure 2). For
women with menstrual conditions, endometriosis, or fib-
roids, the number of procedures fell by 37%, 30% and
15%, respectively. The number of procedures for cervical
cancer and carcinoma in situ fell by 13% and 39%. In con-
trast, the number of hysterectomies for uterine cancer,
ovarian cancer and prolapse rose by 37%, 18% and 11%,
respectively. Overall, the annual number of hysterectomies
declined by 16% from 43 014 in 2000 to 36 189 in 2005,
before increasing by 5% to 37 923 in 2008. Between 2000
and 2008, the proportion of TAH procedures decreased
from 60% to 53%, whereas VH increased from 34% to
39%. The relative frequency of STH and RAH remained
comparatively static.
Rates of urogenital fistula by procedure and
condition
There were 436 women who had a diagnosis of vesicova-
ginal fistula or urethrovaginal fistula recorded within a year
of their hysterectomy, giving an overall rate of 1 in 788
(95% CI 718–868). However, the risk posed to women dif-
fered across the various combinations of procedure and
indication (Table 2). For women undergoing VH for pro-
lapse, the estimated rate was 1 in 3861 (95% CI 2550–
6161). Among women undergoing a TAH for the other
three benign conditions, the overall rate was 1 in 540 (272/
146 841; 95% CI 479–540), whereas for women who
underwent STH, the rate was 1 in 2279 (9/20 511; 95% CI
1205–5000). For both these abdominal procedures, the dif-
ferences in the fistula rates across the three benign condi-
tions were not statistically significant (Fisher’s Exact;
P = 0.9 for TAH and P = 0.17 for STH). In contrast, the
absolute risk for women undergoing VH differed slightly
across the three conditions (Fisher’s Exact, P = 0.04), the
rate ranging from 1 in 486 for endometriosis to 1 in 1922
for fibroids.
The risk of vesicovaginal fistula or urethrovaginal fistula
was greatest among those women who had cervical cancer,
with TAH and RAH both having estimated rates of around
1 in 100 (Table 2). Among women undergoing TAH, the
rate was roughly five times greater than the rates for
351 505 elective hysterectomies 
performed in English NHS 
hospitals between 2000 & 2008
292 250 performed for 
benign conditions
59 255 performed for 
Excluded 
3262 radical hysterectomy
290 with infrequent procedure-
indication combinations
2645 women aged 55 years or 
more with indication endometriosis 
or menstrual problems
Excluded 
1537 with infrequent procedure-
indication combinations
286 053 benign
hysterectomies analysed hysterectomies analysed
339 fistulae identified 97 fistulae identified
Figure 1. Flow chart of included and excluded patients and
procedures.
Table 1. Patient characteristics of women undergoing hysterectomy
in NHS hospitals for selected conditions between 2000 and 2008
(after exclusions as described in text)
Prolapse
N81
Endometriosis
N80
Menstrual
N92 to
N94
Fibroids
D25
Benign conditions
All patients 87 329 24 947 78 848 94 929
Average age
Mean 61.1 41.1 41.0 47.4
SD 11.9 5.7 5.8 7.5
Age group
Under 40 5% 45% 45% 14%
40–50 14% 50% 50% 60%
50–60 28% 5% 5% 20%
60–70 30% – – 4%
70 and over 23% – – 2%
Type of hysterectomy
Abdominal subtotal – 2331 6634 11 546
Abdominal total 2386 19 216 53 851 73 774
Vaginal 84 943 3400 18 363 9609
Cervical
cancer
in situ
D06
Cervical
cancer
C53
Uterine
cancer
C54, C55
Ovarian
cancer
C56
Malignant conditions
All patients 3886 5327 34 261 14 244
Average age
Mean 46.0 45.1 65.7 60.6
SD 11.4 13.1 10.9 12.5
Age group
Under 40 38% 44% 1% 6%
40–50 31% 27% 6% 16%
50–60 18% 16% 26% 27%
60–70 10% 8% 33% 27%
70 and over 3% 6% 34% 24%
Type of hysterectomy
Abdominal subtotal – – – 1080
Abdominal total 2890 2627 31 032 13 164
Abdominal radical – 2700 538 –
Vaginal 996 – 2691 –
Risk of vesicoinal fistula after hysterectomy
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women with cervical carcinoma in situ (relative risk 4.6;
95% CI 1.7–12.2; P < 0.001). Among the other uterine can-
cers, RAH also posed an increased risk of urogenital fistula,
but overall the rates of fistula were of the same order of
magnitude as the rates for the benign conditions.
Effect of age and year of surgery
For the benign conditions of endometriosis, fibroids and
menstrual disorders, there were noticeable changes in the
number of fistulae after TAH across the age categories and
by year of surgery (Table 3). In terms of age, the rate of
fistula was stable until women passed 50 years of age, after
which it fell by around 40%. The rate of fistula increased
from 0.15% in 2000–02 to 0.22% in 2006–08, a rise of
46%. Adjustment for possible confounding by indication
and time period did not alter these patterns. Extending the
model to include both VH and TAH for these benign con-
ditions produced comparable results for the estimated rela-
tionship between rate of fistula and age categories and year
of surgery. For patients with malignant conditions, there
was no association between the adjusted OR for fistula by
year of surgery (P = 0.97) nor by age category (P = 0.86).
Surgical repair
The majority of women with fistula underwent one of the
repair operations. Urogenital fistula repair procedures
(P25.1, P25.2) were found for 71% of fistulae among
women with benign conditions (241/339). None of these
women had a urinary diversion. For women with malig-
nant conditions, fistula repair was identified for 41% (41/
97) of women. Another three women (all of whom had
RAH for cervical cancer) had a urinary diversion.
Discussion
This study of elective hysterectomies in English NHS hospi-
tals has established the overall rate of lower urinary–genital
tract fistulae within 1 year of surgery, of 0.13% or 1 in 788.
The rate was highest among women who had either an
RAH or TAH for cervical cancer, with approximately 1 in
100 experiencing a fistula. The most common type of hys-
terectomy undertaken for fibroids, endometriosis and men-
strual disorders was TAH, and resulted in an estimated
fistula rate of 1 in 540. For the same diagnostic groups, the
rate was 1 in 2279 for STH. The lowest rate of fistula
following hysterectomy was observed for VH for prolapse
(1 in 3861).
The Cochrane review of approaches to hysterectomy for
benign disease found no difference in the rate of fistula
following abdominal, vaginal and laparoscopic routes;12
and the VALUE study, a non-randomised cohort study of
hysterectomy from the UK, although not reporting on the
development of fistula, found no difference in the rate of
operative bladder injury between abdominal, vaginal and
laparoscopic routes.13 The national cohort study from Fin-
land on the other hand reported a higher rate of both blad-
der injury (relative risk 11.4) and subsequent fistula
formation (relative risk 2.2) following laparoscopic proce-
dures.14 Unfortunately, the OPCS-4 coding used in HES
does not allow easy separation between open and laparo-
scopic hysterectomies. There is an option to use an addi-
tional code for ‘laparoscopic approach’ alongside the codes
for hysterectomy, although an evaluation of OPCS coding
completeness in other situations has shown that laparo-
scopic procedures are under-reported.15 Given the range of
surgical techniques and coding systems used during our
study period, we do not feel that much of use can be stated
about the risks of fistulae associated with laparoscopic
hysterectomy procedures.
It is often stated that distorted anatomy (e.g. from fib-
roids or malignancy), abnormal tissue adhesion (e.g. from
previous caesarean section or endometriosis) or previous
radiation therapy increase the risk of urinary tract injury
and fistula formation following hysterectomy.16 The HES
database does not include radiotherapy treatments, and
given the average age of these women (51 years) does not
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Figure 2. Number of hysterectomy procedures in English NHS hospitals
for selected conditions between 2000 and 2008.
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have sufficient historical information to capture obstetric
history. We did not find the rate of fistula to be increased
in women undergoing abdominal hysterectomies for
fibroids or endometriosis compared with women with
menstrual problems (although there was variation in risk
for women having vaginal procedures for these benign
Table 2. Rates of fistula within 1-year of undergoing hysterectomy, by condition and type of procedure
Conditions Type of hysterectomy No. of procedures No. of Fistulae Fistula rate (%) 95%
confidence
interval (%)
Benign conditions
Prolapse Abdominal total 2386 1 0.04 0.00 0.23
Vaginal 84 943 22 0.03 0.02 0.04
Endometriosis Abdominal subtotal 2331 0 0.00 0.00 0.16*
Abdominal total 19 216 36 0.19 0.13 0.26
Vaginal 3400 7 0.21 0.08 0.42
Menstrual Abdominal subtotal 6634 1 0.02 0.00 0.08
Abdominal total 53 851 103 0.19 0.16 0.24
Vaginal 18 363 23 0.13 0.08 0.19
Fibroids Abdominal subtotal 11 546 8 0.07 0.03 0.14
Abdominal total 73 774 133 0.18 0.15 0.21
Vaginal 9609 5 0.05 0.02 0.12
‘Malignant’ condition
Cervical carcinoma in situ Abdominal total 2890 5 0.17 0.06 0.40
Vaginal 996 1 0.10 0.00 0.56
Cervical cancer Abdominal total 2627 21 0.80 0.49 1.22
Abdominal radical 2700 31 1.15 0.78 1.63
Uterine cancer Abdominal total 31 032 28 0.09 0.06 0.13
Abdominal radical 538 3 0.56 0.11 1.63
Vaginal 2691 0 0.00 0.00 0.14*
Ovarian cancer Abdominal subtotal 1080 1 0.09 0.00 0.52
Abdominal total 13 164 7 0.05 0.02 0.11
*One-sided confidence interval.
Table 3. Estimated association between rates of fistula and various risk factors for women undergoing total abdominal hysterectomy for fibroids,
endometriosis and menstrual disorders
No. of procedures No. of fistulae Rate (%) Adjusted
odds ratio
95%
confidence
interval
P value
Condition
Fibroids 73 774 133 0.18 1 0.99
Endometriosis 19 216 36 0.19 0.98 0.67 1.43
Menstrual disorders 53 851 103 0.19 1.01 0.76 1.32
Age group (years)
Under 40 42 873 77 0.18 1 0.037
40–44 43 957 92 0.21 1.14 0.83 1.55
45–49 37 312 78 0.21 1.14 0.82 1.58
50 plus 22 699 25 0.11 0.61 0.38 0.98
Year of surgery
2000–02 56 561 83 0.15 1 0.033
2003–05 47 535 97 0.20 1.38 1.03 1.85
2006–08 42 745 92 0.22 1.44 1.07 1.94
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indications). The HES database gives no information on
the stage of endometriosis or the size of fibroids, making it
difficult to comment on their significance as risk factors.
Calculating precise rates of post-hysterectomy fistula
requires a large sample size and a complete data set. Both of
these criteria were met in this study, with the data extracted
from the HES database containing 343 771 procedures in
total, and over 10 000 patients for many of the indication–
procedure combinations analysed. However, in any study
using routine data, there are potential limitations arising
from coding omissions and inaccuracy. The quality of the
clinical coding in HES has been shown to vary between
NHS trusts,17 although the overall quality is considered to
be high in relation to operations and procedures.18
Coding accuracy could have influenced the identification
of hysterectomy procedures, and the classification by type.
However, studies that have compared medical notes to
routine data for hysterectomy have found very good agree-
ment.19 In addition, to remove records affected by coding
errors, we restricted our analysis to patient records with (a)
expected combinations of diagnosis and procedure, and (b)
age ranges consistent with the diagnosis.
Coding accuracy and completeness could have also
affected our estimated incidence of fistula. In series of fistu-
lae from the developed world, between 50% and 90% fol-
low hysterectomy,7,20 and postoperative fistula rates
between 0.1% and 4.0% are reported.16,21 The overall rate
described in our study (1 in 788) lies within this range of
estimates, and is consistent with other large-scale national
studies.14,21 There is no reason to suspect that the coding
of fistula would be more complete for some procedures
than for others, so the estimated relative rates among the
different patient groups are likely to be robust.
Comparison with other studies
Our study is the first to report a significantly lower risk of
urogenital fistula for women over 50 years of age. This is at
odds with a study by Forsgren et al.,21 who reported the
rate of ‘fistula disease’ to be higher in women over 50 years
of age. However, their study did not separate intestinal
from urinary fistulae, and almost 60% did not involve the
urinary tract. The same group recently examined the extent
of association between ‘fistula disease’ in women with
diverticulitis undergoing hysterectomy and reported the
main associations being with intestino-genital and uro-
intestinal fistulae.22 It is conceivable therefore that the
increase in fistulae reported in older women in these stud-
ies relates more to bowel than urinary fistulae, and to the
prevalence of inflammatory bowel disease than to hysterec-
tomy. The VALUE study found a reduction in overall seri-
ous morbidity with increasing age at operation, although
this was limited to women with fibroids and to women
undergoing vaginal hysterectomy.13
Our analysis provides no insight into the reasons for
lower risk of urogenital fistula for women over 50 years of
age. We can speculate that the reduced vascularity and
uterine size in the estrogen-deficient postmenopausal pelvis
might reduce the risk of operative injury or postoperative
haematoma formation. The finding is unlikely to reflect
confounding because of the exclusion of women over
55 years old coded as having hysterectomy for endometri-
osis and menstrual problems from the analysis because
indication was an explanatory factor in the multiple logistic
regression. Moreover, a lower risk of urogenital fistula for
women over 50 years of age was still apparent if the analy-
sis was restricted to women with uterine fibroids whose age
range was not restricted. A quarter of the women were
aged over 50 years.
The national cohort studies from Sweden,21 and Fin-
land,14 both showed lower overall rates of fistula following
hysterectomy for benign indications, most notably for
TAH (1 in 1019 and 1 in 959, respectively, compared with
one in 540 in this series). One possible explanation for the
difference is that the Swedish study covered the period
1973–2003 and the Finnish study 1990–95 whereas our
study covered a later period (2000–08). We also observed a
46% increase in risk of fistula following hysterectomy for
benign conditions over the study period. One explanation
for this could be an increase in the proportion of more
difficult procedures among all hysterectomies. Between
2000 and 2008, the total number of hysterectomy proce-
dures fell by 12% and those for the main benign indi-
cations (excluding prolapse) fell by 27%. This was mainly
a result of the fall in the number of hysterectomies for
menorrhagia, a trend that has been ongoing since the mid-
1990s.23
Another potential contributory factor is the changes in
surgical training and practice in gynaecology. A conse-
quence of the reduced number of hysterectomy proce-
dures is that trainees, in the UK at least, obtain less
surgical experience during their training. It was calculated
in 2001 that even if every hysterectomy carried out in
the NHS were carried out by a trainee (and the majority
are not), each would undertake only 27 procedures per
year during their training.24 The reduction of the length
of the working week resulting from the ‘New Deal’ and
the European Working Time Directive,25,26 and reduced
years in training implemented following the Report of
the Working Group on Specialist Medical Training and
‘Modernising Medical Careers’,27,28 both add to this
problem. Trainees themselves perceive this to be an issue.
Although the quality of supervision of surgical training is
reported to be of a good standard, trainees’ satisfaction
with operative teaching declined consistently between
1995 and 2008, and operating volume was seen as a
significant factor in this.29
Hilton, Cromwell
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Conclusions
This is the largest reported cohort study on the risk of urogen-
ital fistula following hysterectomy. Overall, 1 in 788 hysterec-
tomies in the NHS in England is followed by vesicovaginal
fistula or urethrovaginal fistula. The rate is highest following
RAH for cervical cancer (1 in 87), and lowest following VH
for prolapse (1 in 3861). The most common procedure–
indication combination is TAH for benign indications, which
carries a risk of fistula formation of 1 in 540. Whereas urogen-
ital fistula remains an uncommon complication of hysterec-
tomy,30 our study also identified a trend of increasing surgical
morbidity within the NHS, of which all concerned in the
provision of service and training should be aware.
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following hysterectomy and their clinical presentation in practice.
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to investigate outcomes of surgery in the NHS. Compare HES with central and local clinical databases, with particular
reference to provision of demographic data, case ascertainment, completeness of data, availability of clinical detail
(endometriosis stage, clinical history). 2,3
Discuss coding issues including provision or not of codes for recent and novel procedures (e.g. laparoscopic hysterec-
tomy).
(Optional advanced task): Regression analysis was conducted at patient-level data and not hospital-level aggregated
data. Compare the two approaches. Which one would account for variation in rates per individual surgeon? Can the
two approaches be combined?
3. Results and implications: The authors describe an increase in the overall rate of fistula of 46% during the study per-
iod. A possible contributory factor to this increase proposed by the authors is the change in surgical training and
practice in gynaecology and the reduced number of hysterectomies performed by trainees—discuss.
Would the findings of this paper affect your counselling of women for hysterectomy depending on their indication for
surgery? (Data S1)j
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Objective To evaluate the rates of ureteric injury among women
undergoing hysterectomy.
Design Retrospective cohort.
Setting English National Health Service hospitals.
Population Women undergoing hysterectomy in 2001–2010.
Methods Unadjusted rates of ureteric injury, within 1 year of
hysterectomy, calculated by indication and type of procedure.
Multivariable logistic regression used to assess the risk of ureteric
injury with year of surgery.
Main outcome measures Ureteric injury within a year of the
hysterectomy.
Results In 2001–2010, 377 073 women underwent hysterectomy,
of whom 1792 (0.5%) experienced a ureteric injury. In both
benign and malignant groups the rate of injury was higher in
2006–2010 than 2001–2005. After 2006, ureteric injuries were
most common for abdominal radical hysterectomy for uterine
cancer (10.7%; 95% CI 7.3–15.1%). The proportion of women
having a ureteric injury was similar for ovarian and cervical
cancer (1.9–4.0% depending on type of procedure). For benign
conditions, the rate of injury tended to be lower, typically <1%.
Women with endometriosis had the highest risk among this group
(1.7% following total abdominal hysterectomy; 95% CI 1.4–2.0%).
Conclusion The risk of ureteric injury within 1 year of
hysterectomy varied by type of hysterectomy for benign and
malignant conditions. The rates of injury have increased between
2001 and 2010.
Tweetable abstract Ten-year study shows ureteric injury rates
have increased.
Please cite this paper as: Kiran A, Hilton P, Cromwell DA. The risk of ureteric injury associated with hysterectomy: a 10-year retrospective cohort study.
BJOG 2016;123:1184–1191.
Introduction
Ureteric injury is an uncommon but serious complication
of gynaecological surgery.1 Iatrogenic trauma is the com-
monest cause of ureteric injury. Recent systematic reviews
have reported that gynaecological and colorectal surgery
may be associated with ureteric injury in up to 6% of
cases.1–3
It is often stated that the majority of iatrogenic ureteric
injuries follow what was thought at the time to have been
straightforward operations.1 Presumed risk factors include
those contributing to abnormal anatomy, abnormal tissue
adhesion or major intraoperative haemorrhage.1,3 Risks are
higher in surgery for pelvic malignancies, and this may
reflect one or more of these factors.
Injury to the ureter at hysterectomy most typically
occurs in the lower third, the most common mechanisms
being, in descending order of frequency, ligation, kinking
by suture, transection/avulsion, partial transection, crush,
and devascularization.1 It is perhaps because of these mech-
anisms that the diagnosis of iatrogenic ureteric injury may
be delayed, identified after the index procedure, in 65–80%
of cases. The delay in diagnosis results in more common
and serious complications including renal unit loss.1
The objectives of this study were to: (1) evaluate the risk
of ureteric injury, including the later consequences of
1184 ª 2015 Royal College of Obstetricians and Gynaecologists
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injury, ureterovaginal fistula or ureteric stricture, associated
with hysterectomy; (2) determine whether the risk of ure-
teric injury was affected by the type of hysterectomy or the
indication for surgery; and (3) establish whether the rates
of ureteric injury have changed over time.
Methods
We used data extracted from the Hospital Episode Statistics
(HES) database.4 HES holds records for patients admitted
to English NHS hospitals, with each record containing data
on patient demographics, hospital administrative informa-
tion, diagnostic information using the International Classi-
fication of Diseases (ICD), 10th revision,5 and operative
procedures using the UK Office for Population Censuses
and Surveys classification (OPCS), 4th revision.6 Records
relating to the same individual are linked using a unique
patient identifier (HESID).
Patient selection
The study cohort contained adult women with selected
benign and malignant indications who had an elective hys-
terectomy in the 10-year period between 1 January 2001 and
31 December 2010. The study was separated into women
with benign conditions and women with malignant condi-
tions. The group of benign conditions included endometrio-
sis (ICD10 code: N80), uterine fibroids (D25), genital
prolapse (N81), and menstrual disorders (N92–N94). The
group of malignant conditions were limited to cervical car-
cinoma-in-situ (D06), cervical cancer (C53), uterine cancer
(C54, C55) and ovarian cancer (C56). Women who had a
primary diagnosis of endometriosis or menstrual disorders
were restricted to age below 55 years, assuming that older
women were likely to be postmenopausal, and therefore
probable coding errors; no age restriction was applied to
women in other diagnostic groups.
The study distinguished between four types of open pro-
cedures: total abdominal hysterectomy (TAH; OPCS code:
Q07.4), subtotal abdominal (STH; Q07.5), vaginal (VH;
Q08.9), and radical abdominal hysterectomy (RAH; Q07.1–
07.3). We excluded radical hysterectomies coded to women
with benign diagnoses, and combinations of conditions and
procedures for which there were fewer than 500 cases. We
also identified laparoscopic procedures as follows: total
laparoscopic hysterectomy (TLH; Q56.8), laparoscopically-
assisted vaginal hysterectomy (LAVH; Q08.9), laparoscopi-
cally assisted subtotal hysterectomy [LASH; code as for
subtotal hysterectomy (Q07.5) with additional laparoscopic
approach qualifier (Y50.8)].
Ureteric injuries within a year of hysterectomy were iden-
tified using codes for relevant diagnoses and related surgical
treatment. A woman was identified as having an injury if
the diagnostic fields of the index procedure episode, or a
subsequent episode within 1 year of the index procedure
contained: ureteric injury (S37.1), hydronephrosis with
ureteric stricture (N13.1) or other urinary-genital tract fis-
tula (N82.1). Ureteric injury was also identified if surgical
treatments for ureteric fistula or obstruction were identified
within the same timeframe. These included: insertion of
stent; insertion of nephrostomy tube; ureteroscopic
dilatation; removal of suture from ureter; ureteric repair;
closure of ureteric fistula; and re-implantation of ureter
(see Supporting Information Appendix S1 for OPCS codes).
Statistical analysis
Rates of ureteric injury were estimated for women by the
indication and type of hysterectomy, and were expressed as
the percentage of injuries within 1 year of hysterectomy.
We also investigated whether the rate of injury varied over
time by indication. Inspection of the time-series did not
reveal linear/incremental changes but, for several condi-
tions, the series were stable before increases after 2006. We
therefore grouped events into 2001–2005 and 2006–2010
time periods. Finally, we derived overall injury rates associ-
ated with laparoscopic procedures. We calculated 95% con-
fidence intervals (CI) for the estimated rates assuming that
the number of events followed a Poisson distribution. The
statistical significance of differences in injury rates between
patient groups were tested using the chi-square test (tabu-
lation of injury/non-injury and patient group).
Multivariable logistic regression was used to assess
whether the risk of injury was associated with age, indica-
tion, and time. This analysis was restricted to women who
underwent total abdominal hysterectomy and vaginal hys-
terectomy, due to the limited number of events for other
procedures. All statistical tests were two-sided, and P-values
lower than 0.05 were judged to be statistically significant.
All analyses were performed using STATA SE version 11 (Sta-
taCorp LP, College Station, TX, USA). The formulation of
this report has followed the STROBE Statement.7
Results
There were 380 351 hysterectomies for the selected condi-
tions in English NHS hospitals between 1 January 2001 and
31 December 2010. Removing records that did not meet the
inclusion criteria left 377 073 hysterectomies in the analysis
(Supporting Information Figure S1). The number of
procedures for benign and malignant conditions was 310
105 and 66 968, respectively. The characteristics of these
women are shown in Supporting Information Table S1.
Number of hysterectomy procedures by indication
In the benign group, the number of hysterectomies per
year demonstrated a decrease from 33 713 in 2001 to
30 480 in 2010 (test for trend, P = 0.058). The number of
1185ª 2015 Royal College of Obstetricians and Gynaecologists
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hysterectomies varied by year across the various conditions
(Supporting Information Figure S2). In women with pro-
lapse, the number of hysterectomies increased from 8781
in 2001 to 10 687 in 2010 (test for trend, P < 0.001) and
those with menstrual conditions showed a decrease from
10 300 in 2001 to 6710 in 2010 (test for trend,
P < 0.001).
In the malignant group, the number of hysterectomies
per year increased from 5963 in 2001 to 7778 in 2010 (test
for trend, P < 0.001). The most notable differences were
for uterine cancer, which increased from 3270 in 2001 to
4999 in 2010 (test for trend, P < 0.001) and for carci-
noma-in-situ, which decreased from 525 in 2001 to 361 in
2010 (test for trend, P = 0.004) (Supporting Information
Figure S2).
Rates of ureteric injuries by indication and
procedure
Among the 377 073 women in the study, 1792 (0.5%) had
a ureteric injury recorded within a year of their hysterec-
tomy. The annual number of injuries increased from 90 in
2001 to 259 in 2010 (test for trend, P < 0.001).
Of the 1792 women identified as having ureteric injury,
66% (1184) were identified by surgical treatment codes
only (i.e. they had no related diagnostic code in any
treatment episode), 25% (447) were identified by diagnos-
tic code only (i.e. they had no related surgical code in
any treatment episode) and 9% (161) were identified by
both. All ureteric injuries were recorded within 2 months
of the index procedure; 42% of those identified by a
diagnostic code and 38% of those identified by a surgical
code were found within the same admission as the index
procedure.
The rate of ureteric injury was higher from 2006
onwards for six of the eight conditions (Figure 1). The
change was greatest for women with ovarian cancer,
increasing from 1.06 to 3.86%. In the majority of sub-
groups, the change in the injury rate corresponded to an
increase in the number of surgical treatments for injury.
Tables 1 and 2 give the rates of ureteric injury for the
benign and malignant conditions for the various types of
hysterectomy. For benign conditions, the 2006–2010 injury
rates did not vary greatly by type of procedure in absolute
terms, except for women with endometriosis, where the
rate was as high as 1 in 100. The risk of injury associated
with vaginal hysterectomy tended to be less than with other
types of hysterectomy, being four times less than abdomi-
nal total procedures for prolapse (chi-square, P < 0.001)
and about half the rate of abdominal hysterectomy for
fibroids (chi-square, P < 0.001). For malignant conditions,
the pattern was more varied (Table 2). The 2006–2010
injury rate was not associated with type of hysterectomy
among women with cervical cancer. In contrast, there was
a two-fold difference between subtotal and total abdominal
hysterectomy for women with ovarian cancer (chi-square,
P = 0.028). The greatest variation by type of procedure
exists for women with uterine cancer, ranging from 0.17 to
10.67%. All 2006–2010 injury rates had increased compared
with those from 2001–2005, but the increase in the injury
rate for abdominal radical hysterectomy stands out, chang-
ing from around 1 in 300 women to 1 in 10.
Effect of age and period of surgery
A feature of the patient populations analysed in this paper
is the different age structures of women across the condi-
tions. It was therefore possible that some of the variation
in the rates across the conditions and procedures was due
to the different age structures. Consequently, we performed
a multivariable logistic regression to examine the patterns
of ureteric injury rate in more detail.
The only groups with sufficient events for this analysis
were total abdominal hysterectomies (benign and malignant
conditions) and vaginal (benign only). For total abdominal
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Figure 1. Rate of ureteric injury (95% CI) following hysterectomy for
benign (above) and malignant conditions (below), for 2001–2005 and
2006 –2010.
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hysterectomies in the benign group, the regression model
did not find an association between risk of injury and age,
and confirmed the different relative risks by condition and
over time (see Table 3). We further examined whether the
relative risks across the benign conditions had changed
between 2001–2005 and 2006–2010 by introducing an
interaction term for condition and year, but we found no
evidence that the relative risks had changed. For the malig-
nant conditions, there was a weak relation between age and
risk, being highest among women under 40 years. As
before, we explored whether the relative risks across the
conditions changed over time, and again found no signifi-
cant interaction between condition and time.
For vaginal hysterectomies in the benign group, the
regression model revealed a potential association between
risk of injury and age, but this had a minimal effect on the
adjusted odd ratios describing the risk of injury by condi-
tion and time (Table 3). As before, we found no evidence
that the relative risks across the conditions changed over
time (interaction term was non-significant).
Laparoscopic hysterectomies
Of 310 105 hysterectomies in the benign group, 4.7%
(14 692) were laparoscopic. Women undergoing laparo-
scopic hysterectomies had a rate of ureteric injury of
0.6% (94/14 692), which was higher than for other types
Table 1. Rate of ureteric injury by benign conditions and type of procedure, for 2001–2005 and 2006–2010
Conditions Type of
hysterectomy
2001–2005 2006 –2010
No. of
procedures
No. of
ureteric
injuries
Rate of ureteric
injuries % (95% CI)
No. of
procedures
No. of
ureteric
injuries
Rate of ureteric
injuries % (95% CI)
Prolapse Abdominal total 1374 3 0.22 (0.05, 0.64) 1142 4 0.35 (0.10, 0.90)
Vaginal 44 315 39 0.09 (0.06, 0.12) 52 432 46 0.09 (0.06, 0.12)
Endometriosis Abdominal subtotal 1 265 14 1.11 (0.61, 1.86) 1325 21 1.58 (0.98, 2.42)
Abdominal total 11 187 81 0.72 (0.58, 0.90) 8899 150 1.69 (1.43, 1.98)
Vaginal 1823 11 0.60 (0.30, 1.08) 1918 18 0.94 (0.56, 1.48)
Menstrual Abdominal subtotal 3294 4 0.12 (0.03, 0.31) 4186 4 0.10 (0.03, 0.24)
Abdominal total 31 325 41 0.13 (0.09, 0.18) 22 861 49 0.21 (0.16, 0.28)
Vaginal 9987 7 0.07 (0.03, 0.14) 8963 20 0.22 (0.14, 0.34)
Fibroids Abdominal subtotal 6020 24 0.40 (0.26, 0.59) 7573 41 0.54 (0.39, 0.73)
Abdominal total 41 741 149 0.36 (0.30, 0.42) 37 734 242 0.64 (0.56, 0.73)
Vaginal 5057 2 0.04 (0.00, 0.14) 5684 16 0.28 (0.16, 0.46)
Table 2. Rate of ureteric injury by malignant conditions and type of procedure, for 2001–2005 and 2006–2010
Conditions Type of
hysterectomy
2001–2005 2006 –2010
No. of
procedures
No. of
ureteric
injuries
Rate of ureteric
injuries % (95% CI)
No. of
procedures
No. of
ureteric
injuries
Rate of ureteric
injuries % (95% CI)
Cervical
cancer-in-situ
Abdominal total 1689 7 0.41 (0.17, 0.85) 1282 3 0.23 (0.05, 0.68)
Vaginal 531 1 0.19 (0.00, 1.05) 550 0 0.00 (0.00, 0.67)
Cervical cancer Abdominal total 1458 20 1.37 (0.84, 2.11) 1480 36 2.43 (1.70, 3.37)
Abdominal radical 1495 22 1.47 (0.92, 2.23) 1412 35 2.48 (1.73, 3.45)
Uterine cancer Abdominal total 16 355 38 0.23 (0.16, 0.32) 19 548 183 0.94 (0.81, 1.08)
Abdominal radical 309 1 0.32 (0.01, 1.80) 300 32 10.67 (7.30, 15.06)
Vaginal 1092 1 0.09 (0.00, 0.51) 3013 5 0.17 (0.05, 0.39)
Ovarian cancer Abdominal subtotal 656 8 1.22 (0.53, 2.40) 463 9 1.94 (0.89, 3.69)
Abdominal total 6967 73 1.05 (0.82, 1.32) 8368 332 3.97 (3.55, 4.42)
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of hysterectomy [0.3% (889/295 413), laparascopic versus
open procedures, chi-square P < 0.001]. Among the vari-
ous indications, the highest rate was observed among
women who had endometriosis, 2.2% (50/2363) for
laparoscopic procedures and 1.0% (245/24 054) for open
procedures.
Of the 66 968 hysterectomies in the malignant group,
8.0% (5321) were laparoscopic. Women who had laparo-
scopic hysterectomies had a rate of ureteric injury of 0.2%
(8/5321), which was lower than the rate for open proce-
dures [1.3% (798/61 647), laparascopic versus open proce-
dures, chi-square P < 0.001). There were insufficient events
for further stratification by condition.
Discussion
Main findings
This 10-year study of elective hysterectomies in English
NHS hospitals examined the rates of ureteric injury within
1 year of the procedure among women with selected condi-
tions. The overall rate of injury is low but has more than
doubled over time, from 0.29% in 2001–2005 to 0.66% in
2006–2010. An increase in the rates of injury was observed
in six of the eight selected conditions, and was associated
with a greater number of women having a surgical treat-
ment for ureteric injury. Only two-fifths of ureteric injuries
identified in this study were recorded during the admission
of the index procedure.
In the group of benign conditions, the injury rate was
highest in women with endometriosis who had abdominal
hysterectomy (total or subtotal), affecting 1 in 60 during
2006–2010. The rate was lowest in women with prolapse
who had a vaginal hysterectomy, affecting 1 in 1140 in
2006–2010. The risk of ureteric injury was typically greater
among women with a malignant condition, being greatest
among those with ovarian or uterine cancer. The most
unexpected finding was an increase in the injury rate for
abdominal radical hysterectomy in women with uterine
cancer, changing from around 1 in 300 women during
2001–2005 to 1 in 10 during 2006–2010.
Table 3. Association between ureteric injury and condition, age and period of surgery, for total abdominal and vaginal procedures
n Abdominal total n Vaginal
Ureteric injury
OR (95% CI)
P-value Ureteric injury
OR (95% CI)
P-value
Benign condition
Prolapse 99 263 1.48 (0.67 3.26) 96 747 0.75 (0.43, 1.31)
Endometriosis 26 417 6.89 (5.40 8.80) <0.001 3741 5.46 (3.23, 9.24) <0.001
Menstrual 80 616 1 18 950 1
Fibroids 103 809 2.84 (2.24 3.60) 10 741 1.36 (0.73, 2.51)
Age group (years)
Under 40 53 136 1 14 088 1
40–49 136 413 0.91 (0.75 1.10) 0.534 30 650 0.83 (0.53, 1.30) 0.004
50–59 57 249 1.01 (0.79 1.30) 28 054 0.35 (0.17, 0.71)
60–69 35 562 1.16 (0.72 1.87) 31 481 0.58 (0.30, 1.12)
70 and above 27 745 1.24 (0.64 2.40) 25 906 1.06 (0.57, 1.96)
Year of surgery
2001–2005 157 388 1 61 182 1
2006–2010 152 717 1.95 (1.67 2.26) <0.001 68 997 1.56 (1.13, 2.16) 0.007
Malignant condition
Cervical cancer-in-situ 4052 1
Cervical cancer 5845 5.11 (2.60, 10.05) <0.001
Uterine cancer 40 617 1.72 (0.89, 3.29)
Ovarian cancer 16 454 7.60 (4.01, 14.41)
Age group (years)
Under 40 4975 1 Insufficient events
40–49 7577 0.59 (0.42, 0.84) 0.027
50–59 15 316 0.66 (0.47, 0.91)
60–69 19 352 0.67 (0.48, 0.92)
70 and above 19 748 0.75 (0.54, 1.03)
Year of surgery
2001–2005 30 552 1
2006–2010 36 416 3.49 (2.90, 4.22) <0.001
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Strengths and limitations
This study is the first from England to report rates of
ureteric injury using a large national database. Ureteric
injury is an uncommon condition, for which a large sam-
ple is required to capture the events; one of the main
strengths of this study is therefore its sample size. By
using the HES database, we were able to identify a suffi-
cient number of ureteric injuries and extend the analysis
to provide rates of ureteric injury by condition and type
of hysterectomy.
A limitation of using routinely collected patient infor-
mation like HES is the potential for coding omissions
and inaccuracies. Although the quality of HES coding has
been widely accepted,8 it has been shown to vary by NHS
trusts.9 In our study, for example, the coding recorded by
hospitals in the North West region indicated a notable
increase in the number of ureteric injuries for uterine
cancer and ovarian cancer in the second half of the study
(2006–2010) (regional results not shown). In a sensitivity
analysis, we excluded the North West region to assess
how this altered our results. The rate (95% CI) for uter-
ine cancer fell to 0.46 (0.37–0.56) from 0.96 (0.84–1.10)
and the rate for ovarian cancer fell to 2.46 (2.14–2.82)
from 3.86 (3.46–4.29). Other results did not change sub-
stantially. The study did not have the ability to explore
the reasons for the change in the North West region, but
it is important to note that the number of cases remained
small.
We had expected ureteric injuries to be identified
with both diagnostic and treatment codes. However,
only 9% of records had both codes present. Surgical
codes were identified in 75% of women, the proportion
increasing by approximately 10% in the latter years of
the study.
There is a possibility that our results are affected by ‘sus-
ceptibility bias’. Endometriosis or gynaecological cancers
give an increased risk of ureteric obstruction; surgery
undertaken for these conditions, which results in ureteric
injury, might therefore be erroneously assigned causality.
However, the risk of bias is likely to be small because the
majority (60%) of ureteric injuries were not recorded con-
currently with the hysterectomy.
Finally, while we presented ureteric injury rates for
laparoscopic hysterectomies, we caution against comparing
these with the rates for open procedures. It is possible for
coders to distinguish between open and laparoscopic hys-
terectomies in HES by entering allowing an additional
OPCS code for ‘laparoscopic approach’ alongside the codes
for hysterectomy. However, these codes have been shown
to be under-reported,10 and we suspect that a minority of
patients in the open procedure groups will have had
laparoscopic procedures.
Interpretation
The reduction in the use of hysterectomy for the treatment
of heavy menstrual bleeding (HMB) has previously been
reported,11,12 and our data show a continuance of this
trend. In contrast, an increasing trend in surgery for pelvic
organ prolapse (POP) has also been highlighted,13 and we
have shown that this is associated with an increase in the
use of hysterectomy for POP. Although there appears to
have been an increase in demand for uterine-preserving
surgery for prolapse in some areas, the lack of data on
long-term outcomes and need for subsequent hysterec-
tomy14,15 may have limited its application to date. Khan
et al.16 have recently reported a reduced use of hysterec-
tomy at prolapse surgery among Medicare beneficiaries in
the USA, although on-going research may better define the
place of these procedures in future.17 The risk of ureteric
injury associated with vaginal hysterectomy for POP, how-
ever, seems to be low, and was unchanging over time dur-
ing our study period. The risks associated with
hysterectomy for other benign indications, most notably
endometriosis, are significantly higher than for HMB and
POP; despite, or perhaps because of, decreasing application,
the risk of ureteric injury in this group has doubled over
our study period. This is in contrast to our earlier findings
in relation to lower urinary tract fistula following abdomi-
nal hysterectomy, where we found no difference in risk for
different benign indications.18
The trend seen in relation to hysterectomy for
endometriosis during the study period (23% reduction in
procedures; doubling in risk of ureteric injury) is similar to
that seen in cervical cancer (16% reduction in procedures,
near doubling in risk). This perhaps reflects the surgical
complexity of these cases and argues in favour of cen-
tralised surgical management of advanced endometriosis by
a multidisciplinary team.
The finding of an increasing rate of ureteric injury at
hysterectomy in malignant conditions again contrasts with
earlier findings in relation to vesicovaginal fistula, where
we found no change in risk over time.18 The prevalence of
uterine cancer has been increasing over the last four dec-
ades, most notably since the 1990s;19 our data confirm a
continuing upward trend in the number of hysterectomies
undertaken in England for this diagnosis. While the preva-
lence of ovarian cancer may be decreasing in some age
groups, as a result of oral contraceptive use,20 hysterectomy
for the treatment of the condition also continues to
increase in England. For both uterine and ovarian cancers,
the increase in use of hysterectomy during our study per-
iod has happened alongside an increase in the risk of ure-
teric injury. There are, of course, issues of disease staging
that ICD-10 diagnosis codes do not include, and the extent
of surgery may not be fully captured by the OPCS codes.
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Changes in management, e.g. the use of pelvic or para-aor-
tic lymph node sampling/dissection in uterine cancer or
stripping of peritoneal disease in ovarian cancer, which
may carry an increased risk of complications, may therefore
easily be overlooked within HES data. Nevertheless, the
increasingly high rates of ureteric injury seen within a year
of hysterectomy for uterine and ovarian cancers (four-fold
increase between 2001–2005 and 2006–2010) do demand
re-appraisal by those providing or commissioning cancer
services.
As in our study, an analysis of severe complications
following hysterectomy in the VALUE study (n = 37 512)
found ureteric damage to be associated with the presence
of endometriosis.21 The Cochrane review of surgical
approaches to hysterectomy for benign indications found
no difference in the rate of fistula following hysterectomy
by abdominal, vaginal, and laparoscopic routes from 34
included studies with 4495 women. When bladder and
ureter injuries were pooled under a single category ‘uri-
nary tract injury’ (n = 2090), a significant increase in
urinary tract injury was detected for laparoscopic com-
pared with both abdominal (OR 2.4, 95% CI 1.2–4.8)
and vaginal routes (OR 3.7, 95% CI 1.1–12.2).22
Although our data are consistent with these findings, the
limitations of coding for laparoscopic procedures in HES
referred to earlier, means that we cannot confidently
confirm this trend.
Although all ureteric injuries identified in the study were
recorded within 2 months of the index procedure,
approximately 60% of injuries were not recorded during
the admission of the index procedure but at a later admis-
sion, i.e. they might be looked on as having a delayed diag-
nosis. This is in keeping with recent reviews of iatrogenic
injury to the urinary tract and urogenital fistula,1–3 and
indicates a need for awareness of risk factors prior to oper-
ation, meticulous surgical technique, alertness to symptoms
and signs postoperatively, and early recourse to further
imaging investigation where there is any suspicion of ure-
teric injury.
Conclusion
Using a large national database, this study has identified
the number of ureteric injuries found within 1 year of
elective hysterectomy, and showed these to vary by con-
dition, indication, and procedure. The overall rate of
ureteric injury was 0.66% in recent years (2006–2010),
an increase from 0.29% in the 5 years previously. This
could be attributable in part to improvements in coding
of injuries in later years, and, as the events are rare,
small increases in the number of ureteric injuries can
significantly increase the observed rate. Further research
is also needed to look at the patient populations now
being considered for surgery in order to understand
more definitively the causal pathways linking surgery and
outcomes.
Nevertheless, although ureteric injury remains an
uncommon complication of hysterectomy, its potential sig-
nificance is such that any adverse trend must be taken seri-
ously. The demonstration of increasing surgical morbidity
within the NHS, and the particular changes seen in associa-
tion with hysterectomy in advanced endometriosis, as well
as uterine and ovarian cancers, are issues of which all
involved in the procurement and provision of service and
training should be aware.
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Table S1. Characteristics of women undergoing hysterectomy for benign and malignant 
conditions between 2001 and 2010 
  
Benign conditions  
(n=310,105 ) 
  
Prolapse 
N81 
(n=99,263) 
Endometriosis 
N80 
(n=26,417) 
Menstrual 
N92 to N94 
(n=80,616 ) 
Fibroids 
D25 
(n=103,809) 
Age (years), mean (sd) 61.2 (11.8) 41.3 (5.8) 41.3 (5.7) 47.4 (7.5) 
     
Age group, % (n)     
   under 40 4.1 (4,095) 36.5 (9,654) 36.3 (29,247) 9.8 (10,140) 
   40 to 49 13.2 (13,072) 56.3 (14,876) 57.0 (45,968) 60.2 (62,497) 
   50 to 59 25.5 (25,313) 7.1 (1,887) 6.7 (5,401) 23.7 (24,648) 
   60 to 69 31.3 (31,073) - - 4.3 (4,489) 
   70 and above 25.9 (25,710) - - 2.0 (2,035) 
     
Type of hysterectomy, % (n)     
   Abdominal subtotal - 9.8 (2,590) 9.3 (7,480) 13.1 (13,593) 
   Abdominal total 2.5 (2,516 ) 76.0 (20,086) 67.2 (54,186) 76.6 (79,475) 
   Vaginal 97.5 (96,747) 14.2 (3,741) 23.5 (18,950) 10.4 (10,741) 
  
Malignant conditions 
(n=66,968) 
  
Cervical 
cancer in situ  
D06 
(n=4,052) 
Cervical 
cancer  
C53 
(n=5,845) 
Uterine  
cancer 
C54, C55 
(n=40,617) 
Ovarian 
cancer 
C56 
(16,454) 
Age (years), mean (sd) 46.2 (11.4) 44.8 (13.1) 65.7 (10.9) 60.7 (12.5) 
     
Age group (years), % (n)     
   under 40 32.7 (1,326) 41.1 (2,402) 1.2 (468) 4.7 (779) 
   40 to 49 33.9 (1,372) 29.0 (1,695) 5.0 (2,029) 15.1 (2,481) 
   50 to 59 18.6 (753) 15.1 (884) 23.1 (9,379) 26.1 (4,300) 
   60 to 69 11.6 (468) 8.9 (519) 33.8 (13,714) 28.3 (4,651) 
   70 and above 3.3 (133) 5.9 (345) 37.0 (15,027) 25.8 (4,243) 
     
Type of hysterectomy, % (n)     
   Abdominal subtotal - - - 6.8 (1,119) 
   Abdominal total 73.3 (2,971) 50.3 (2,938) 88.4 (35,903) 93.2 (15,335) 
   Abdominal radical - 49.7 (2,907) 1.5 (609) - 
   Vaginal 26.7 (1,081) - 10.1 (4,105) - 
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Figure S2. Number of hysterectomy procedures for benign (above) and malignant conditions (below) 
between 2001 and 2010. 
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Figure S1. Flow chart of patients included in this study and the number of ureteric injuries identified. 
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Appendix S1. Diagnostic (ICD-10) and operative (OPCS-4) codes associated with ureteric 
injury 
 
Ureteric injury ICD-10 codes 
ureteric injury (S37.1) 
hydronephrosis with ureteric stricture (N13.1) 
other urinary-genital tract fistula (N82.1).   
 
Surgical treatment for ureteric fistula or obstruction OPCS codes  
ureteroscopic insertion of stent (M27.4, M27.8 + Y02.2) 
endoscopic insertion of stent (M29.2) 
percutaneous insertion of stent (M13.8 + Y02.2, M33.1, M33.2) 
percutaneous insertion of nephrostomy tube (M13.6) 
ureteroscopic dilatation (M27.8, M29.4) 
removal of suture from ureter (M22.2) 
ureteric repair (M22.1) 
closure of ureteric fistula (M22.3, M22.8, M22.9)  
re-implantation of ureter (M20.1 to M21.9) 
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Paper 8: Retrospective cohort study on patterns of care and outcomes of 
surgical treatment for lower urinary–genital tract fistula among 
English National Health Service hospitals between 2000 and 2009. 
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 What ’ s known on the subject? and What does the study add? 
 Many case series of lower urinary tract fi stula have been reported, usually reporting 
the results from individual surgeons using their preferred techniques. Defi nitions of 
cure and the case-mix or complexity of reported cases vary widely, and a wide range 
of outcome results are reported in the literature, with primary closure rates between 
53% and 95%. 
 Using the Hospital Episode Statistics database we have demonstrated for the fi rst time 
the pattern of care provided nationally. A large number of surgeons (490) are currently 
involved in providing this care in a large number of units (138), with individual 
workloads varying between 1 and 90 procedures in 10 years; only three undertook  > 3 
operations per year. We have demonstrated an overall operative failure rate 
(re-operation rate) of 12%, and a high rate of urinary diversion (24%). Cure rates 
varied between 50 and 100% and were higher in units undertaking  > 3 operations 
per year. 
 OBJECTIVES 
 •  To examine patterns of care among 
women with urogenital fi stula treated in 
the English National Health Service (NHS) 
between 2000 and 2009. 
 •  To assess whether failure of repair was 
associated with hospital or surgeon 
workload. 
 PATIENTS AND METHODS 
 •  We conducted a retrospective cohort 
study using data from Hospital Episode 
Statistics on women undergoing 
vesicovaginal or urethrovaginal fi stula 
repair between January 2000 and 
December 2009 in English NHS hospitals. 
 •  The main outcome measure was the 
number of fi stula repairs and the incidence 
of re-repair; re-repair rates were stratifi ed 
by age, NHS trust and consultant team 
volume. 
 RESULTS 
 •  Between 2000 and 2009, 1194 women 
underwent surgical repair ( n  = 905) or ileal 
conduit ( n  = 289) for urogenital fi stula 
under the care of 490 consultant teams. 
 •  A total of 281 teams performed only a 
single index procedure, and only three 
consultant teams performed a mean of  > 3 
per year. 
 •  The rate of unsuccessful repair was 
11.9% (108/905). 
 •  The rate of re-operation at NHS trusts 
who performed over 30 procedures over 
the 10-year study period was 7.4% 
compared with 13.2% at those undertaking 
fewer ( P  = 0.02). 
 •  A similar difference in re-operations 
between consultant teams performing  > or 
 < 30 procedures did not reach signifi cance 
(8.4% v 12.7%,  P  = 0.13). 
 CONCLUSIONS 
 •  One in nine women required 
re-operation after surgical repair of a 
urogenital fi stula. 
 •  Our results lend weight to the argument 
for a  ‘ minimum workload ’ for fi stula 
management; given the number of fi stulae 
occurring in England currently, this would 
best be provided by a network of supra-
regional centres. 
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 INTRODUCTION 
 Over the last decade there has been 
increasing awareness of the global public 
health issues of obstetric vesicovaginal 
fi stula (VVF), with many professional, 
charitable and non-governmental 
organizations becoming increasingly 
concerned about its management and 
prevention. Training programmes have been 
developed  [ 1 ] , and through the WHO ’ s 
guiding principles for management and 
 Accepted for publication 1 June 2012 
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programme development  [ 2 ] , increasing 
numbers of treatment centres have been 
established  [ 3 ] . Urogenital fi stula in the 
developed world is usually of non-obstetric 
cause, and is numerically a much smaller 
problem. Nonetheless, it can be devastating 
to those women affected and, as it is 
commonly iatrogenic, is a major cause of 
complaint or medico-legal claim  [ 4 ] . It was 
proposed in debate at a joint meeting of 
the Royal College of Obstetricians and 
Gynaecologists (RCOG), and the BAUS in 
1996 that only two or three centres for 
urogenital fi stula repair were required in the 
UK  [ 5 ] . Despite the agreement of both 
professional groups  [ 6 ] , such a pattern of 
care has never been formally established. 
 Evidence of the outcomes of fi stula repair 
surgery in developed countries typically 
describe the results achieved by individual 
surgeons using preferred procedures. They 
tend to be small in sample size, and this 
limits their generalizability and their 
application to service planning, particularly 
in relation to understanding any volume –
 outcome effect. In the present study, we 
aimed to describe patterns of surgical repair 
among women with urogenital fi stula 
treated in English NHS trusts between 2000 
and 2009 using a national dataset. We also 
examined whether the rate of repeat 
surgical repair was associated with volume 
of activity within NHS trusts and with 
consultant team. 
 PATIENTS AND METHODS 
 DATA SOURCE 
 We used data from the Hospital Episode 
Statistics (HES) database, which contains 
records of all patient admissions to NHS 
hospitals in England. Its core fi elds contain 
patient demographics, and hospital 
administrative information. Diagnostic 
information is coded using the International 
Classifi cation of Diseases (ICD), 10th revision 
 [ 7 ] , and operating procedures are described 
using the UK Offi ce for Population Censuses 
and Surveys classifi cation (OPCS), 4th 
revision  [ 8 ] . 
 DESIGN 
 The study included all women aged  ≥ 18 
years who underwent surgery for a 
urogenital fi stula in an English NHS hospital 
between 1 January 2000 and 31 December 
2009. Women were selected if they had an 
ICD-10 code N82.0 (VVF) or N82.1 (other 
urinary-genital tract fi stula) in a diagnostic 
fi eld and an OPCS-4 procedure code 
for repair of VVF (P25.1), repair of 
urethrovaginal fi stula (UVF) (P25.2) or ileal 
conduit/urinary diversion (M19.1). We only 
included procedures that were performed 
during or after the fi rst episode containing a 
diagnosis of urogenital fi stula. For 91% of 
women, surgery was within 6 months of the 
fi rst fi stula diagnosis. Women were allocated 
to the NHS trust that performed the index 
procedure, and to account for mergers 
among NHS acute trusts after January 2000, 
we took the NHS trusts that existed in 
December 2009 as our reference. The 
consultant team was identifi ed from a 
pseudonymized consultant code in the HES 
database. 
 Hospital admissions in the year before the 
index procedure were examined to identify 
historical patterns of care that could be 
possible causative factors. We identifi ed 
previous hysterectomy procedures (OPCS 
codes: Q07 and Q08) and caesarean sections 
(R17, R18 and R25.1). We also identifi ed 
three broad groups of conditions: malignant 
gynaecological (ICD10: C52-C56, D04), 
benign gynaecological (D25, N80, N81, 
N92-N94), and malignant bladder/bowel 
(C18-C20, C67). 
 A woman was defi ned as having a repeat 
repair, and therefore failure of an initial 
repair, if a subsequent episode of care 
contained in any procedure fi eld one of the 
three OPCS codes (P25.1, P25.2 or M19.1) 
after an index procedure of fi stula repair 
(P25.1, P25.2). 
 STATISTICAL METHODS 
 The unadjusted incidence of repeat repair 
was expressed as the percentage of women 
who had further repair surgery after an 
index procedure of fi stula repair. Rates were 
stratifi ed by age, NHS trust volume and 
consultant team volume. We estimated the 
95% CIs, assuming that the number of 
events followed a binomial distribution. The 
chi-squared test was used to assess the 
statistical signifi cance of differences 
between categorical groups. A trend across 
ordered categories was tested using Cuzick ’ s 
extension of the Wilcoxon rank-sum test  [ 9 ] . 
All  P values were two-sided, and a  P value 
 < 0.05 was considered to indicate statistical 
signifi cance. 
 Funnel plots were used to examine variation 
in the rates of repeat repair between NHS 
trusts and between consultant teams  [ 10 ] . 
The plots contain two funnel limits. The 
inner and outer funnels would be expected 
to contain 95 or 99.8% of providers, 
respectively, if the variation from the rate 
for England was only attributable to random 
fl uctuations. All analyses were performed 
using  STATA version 11 (StataCorp LP, Texas, 
USA). This report was prepared with 
reference to the STROBE Statement  [ 11 ] . 
 RESULTS 
 Between 2000 and 2009, there were 1194 
women who had a surgical repair or an ileal 
conduit constructed for a urogenital fi stula. 
This corresponds to approximately 120 
procedures per year, although there has 
been a slight increase over time ( Fig.  1 ). Of 
the index procedures, 76% (905/1194) were 
fi stula repair operations (P25.1, P25.2), while 
24% (289/1194) were ileal conduit 
formation. 
 The mean ( SD ) age of the women undergoing 
surgical repair was 52.4 (15.6) years. There 
were 177 women (15%) with a malignant 
gynaecological condition, while a further 
328 women (27%) had a benign 
gynaecological condition. There were 171 
women (14%) with a diagnosis of bowel or 
bladder cancer, but there were no frequently 
occurring conditions among the remaining 
518 women (43%). A previous diagnosis of a 
malignant condition was much more 
common among patients undergoing urinary 
diversion than a fi stula repair procedure 
(51.9% v 9.6%; chi-squared test,  P  < 0.001). 
A total of 426 women (36%) had undergone 
hysterectomy in the previous year, and 33 
women (3%) had undergone a caesarean 
section. 
 CONSULTANT AND HOSPITAL VOLUME 
 The index procedures were allocated to 490 
consultant teams, of which 127 (26%) were 
in the main specialty of gynaecology, and 
306 (62%) were in urology. In terms of the 
volume of women treated by individual 
consultant teams, 281 teams performed 
only one index procedure. Only 10 teams 
performed  ≥ 10 index procedures during the 
10-year study period, and only three had 
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carried out a mean of  > 3 procedures per 
year. A similar pattern was observed among 
the repair procedures (P25.1, P25.2; i.e. 
excluding urinary diversions). Among the 
376 consultant teams that performed 
repair surgery, only fi ve teams performed 
 ≥ 10 procedures. The number of index 
procedures performed within each NHS 
trust was also low. Among the 129 NHS 
trusts that performed surgery for urogenital 
fi stula, only 20 trusts undertook  ≥ 10 
index procedures during the 10-year study 
period. 
 REPEAT SURGICAL REPAIRS 
 There were 108 women (11.9%) among the 
905 women undergoing surgical fi stula 
repair who required a repeat operation; their 
progress through re-repair or diversion 
procedures is shown in  Fig.  2 . The  ‘ cure ’ rate 
from one operation was 88.1% (797/905), 
from a re-operation was 81.9% (77/94), and 
from a second re-operation was 68.9% 
(11/16). If the need for secondary urinary 
diversion is considered to indicate failure of 
a previous repair, these fi gures become 88.1, 
71.3 (77/108) and 64.7% (11/17), respectively. 
The relative risk of needing a further 
procedure after a second repair compared 
with after a fi rst operation was 1.52 (95% CI 
0.95 – 2.41;  P  = 0.086). The annual rate of 
re-operation fl uctuated between 4 and 20% 
per year ( Fig.  3 ) but there was no signifi cant 
evidence for the rate of repeat surgery 
having changed over time (test for trend, 
 P  = 0.17). 
 Table  1 describes the strength of association 
between the rate of repeat repair and other 
factors. There was no association between 
rate of repeat repair and age at surgery, and 
there was no linear relationship between the 
rate of repeat repair and volume at NHS 
trusts, nor between the volume of activity 
and outcome among the consultant teams; 
however, there was a noticeable step change 
between NHS trusts who performed  > 30 
procedures over the 10-year study period 
and those that did not (7.4 v 13.2%,  P  = 
0.02). A similar step change was apparent 
among the consultant teams but the 
difference was not signifi cant (8.4 vs 12.7%, 
 P  = 0.13). There were 10 trusts and seven 
consultant teams with re-operation rates 
over twice the national average. However, 
the variation in the rates of repeat repair 
across NHS trusts ( Fig.  4 ) and consultant 
teams ( Fig.  5 ) was consistent with that 
expected from random variation alone. The 
rate of repeat repair was not signifi cantly 
different between main specialities of 
treatment (chi-squared,  P  = 0.24). 
 DISCUSSION 
 We have described the patterns of care and 
outcomes for women undergoing surgical 
treatment of urogenital fi stula in the English 
NHS over the last decade. Approximately 
120 operations per year were undertaken, of 
which a quarter were urinary diversions. A 
large number of surgeons have contributed 
to this surgical workload, although the 
majority performed only one index 
procedure in 10 years. Just three consultants 
performed a mean of  > 2 index procedures 
per year during the study period. The rate of 
unsuccessful repair was lower among NHS 
trusts that had a surgical workload of  ≥ 3 
procedures per year. It was not possible to 
comment on the infl uence of aetiology on 
outcome, since this cannot be defi ned from 
the HES dataset for the majority of cases. In 
other studies, we have examined outcomes 
 FIG.  1.  Number of index surgical repair procedures over time for women diagnosed with a urogenital 
fi stula in English NHS hospitals between 2000 and 2009. 
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 TABLE  1  Rate of repeat repair among index procedures performed between 2000 and 2009 in the 
English NHS, stratifi ed by selected risk factors 
Risk factor
Index
Repeat repairs,  n Rate % (95% CI)  P for trendProcedures,  n (%)
 Age at surgery, years 
  < 40 250 (28) 33 13.2 (9.3, 18.0) 0.24
  40 – 49 300 (33) 36 12.0 (8.5, 16.2)
  50 – 59 149 (16) 19 12.8 (7.9, 20.8)
  60 – 69 97 (11) 11 11.3 (5.8, 19.4)
  ≥ 70 109 (12) 9 8.3 (3.8, 15.1)
 NHS trust volume 
  1 – 5 202 (22) 27 13.4 (9.0, 18.8) 0.10
  6 – 10 318 (35) 40 12.6 (9.1, 16.7)
  11 – 30 183 (20) 26 14.2 (9.5, 18.7)
  Over 30 202 (22) 15 7.4 (4.2, 12.0)
 Consultant volume 
  1 – 3 435 (48) 57 13.1 (10.1, 16.6) 0.15
  4 – 6 182 (20) 22 12.1 (7.7, 17.7)
  7 – 30 133 (15) 16 12.0 (7.0, 17.6)
  > 30 155 (17) 13 8.4 (4.5, 13.9)
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in a single centre by aetiology  [ 12 ] , and 
have examined the risk associated with 
hysterectomy specifi cally on a national basis 
 [ 13 ] . 
 This is the largest cohort study of urogenital 
fi stula of all aetiologies reported using data 
from the developed world  [ 14 ] . But, as with 
any study using routine data, there are 
potential limitations that arise from coding 
inaccuracies and completeness. The quality 
of the clinical coding in HES has been 
shown to vary between NHS trusts  [ 15 ] , 
although the overall quality is considered to 
be high, particularly in relation to surgical 
procedures  [ 16 ] . We restricted our patient 
sample to records with the expected 
combinations of diagnosis and procedure to 
reduce the risk of including poor quality 
records. More detailed quality assurance of 
the data is diffi cult, although the number of 
procedures identifi ed for one of the larger 
units included within this study lies within 
6% of their recently published data  [ 12 ] . 
 The overall cure rate after fi rst operations 
found in the present study (defi ned as 
patients not requiring further surgery or 
diversion during the study period) was 88%. 
Defi nitions of cure and the case-mix or 
complexity of reported cases vary widely 
between studies, and a wide range of 
outcome results are reported in the 
literature, with primary closure rates 
between 53 and 95%  [ 14 ] . 
 The surgical volume required to achieve or 
maintain competence for any particular 
operation is inadequately defi ned. The 
volume – outcome relationship has been 
considered in several clinical areas, including 
cardiology, gastroenterology, orthopaedics, 
ophthalmology and breast cancer surgery 
 [ 17 ] . It is little studied in relation to 
continence surgery, and not at all in relation 
to fi stula surgery. 
 Several studies have examined the learning 
curve for the tension-free vaginal tape (TVT) 
procedure and found that the complication 
rate was relatively higher during the 
surgeon ’ s early cases  [ 18 – 21 ] . A Finnish 
study on TVT reported the incidence of 
complications was 40% in hospitals 
performing  ≤ 15 operations, but reduced to 
14% once this number was exceeded  [ 22 ] . In 
the UK TVT/colposuspension trial  [ 23 ] , 
objective cure rates were found to be higher 
for centres recruiting  > 30 patients 
compared with those recruiting  < 20  [ 24 ] . 
 Surveys on the volume of procedures 
required to maintain good surgical results 
also tend to support the defi nition of a 
 FIG.  2.  Progress of patients through operation and re-operation during the study period. 
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 FIG.  3.  Annual number of surgical fi stula repairs 
(OPCS: P25.1, P25.2) between 2000 and 2009, 
together with the proportion of women who had 
another repair procedure. 
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minimum threshold  [ 25 ] . In a survey of UK 
consultants performing mid-urethral tape 
procedures, the majority view was that 
performing 10 – 20 or 20 – 50 cases of TVT 
under supervision was required to gain 
competence  [ 25 ] . The National Institute for 
Health and Clinical Excellence recommends 
that surgery for urinary incontinence in 
women should be undertaken only by 
surgeons who carry out a suffi cient case 
load to maintain their skills  [ 26 ] . An annual 
workload of at least 20 cases of each 
primary procedure was recommended. 
 It is diffi cult to extrapolate from these 
recommendations to the much more 
heterogeneous and often highly complex 
nature of fi stula surgery. One consideration 
is that success rates appear to be higher for 
fi rst operations than repeat repairs  [ 12,27 ] . 
We found a similar increased risk but did 
not have suffi cient statistical power to 
confi rm this result. 
 The present study found some evidence of a 
volume – outcome relationship at the level of 
a NHS trust, although we did not have 
suffi cient power to detect one at surgeon 
level. Nonetheless, there are strong 
arguments for the centralization of services 
in the case of fi stula management  [ 5 ] . The 
overall numbers are relatively small (120 
cases per year in England), and the number 
of surgeons with specifi c training and 
reasonable workload is in single fi gures. 
In addition to the development of 
urogynaecological and urological surgical 
expertise, support from colo-rectal and 
plastic surgery colleagues is important, and 
the requirement for skilled and experienced 
postoperative nursing, physiotherapy and 
social work input are seen as pivotal to 
optimum care. A small number of supra-
regional centres would allow fi stula repair 
surgery to be undertaken by surgeons with 
appropriate training, a  ‘ minimum viable 
workload ’ , and who work within a 
multidisciplinary team. One argument 
against centralization is that this may limit 
access to care for patients who cannot or 
will not travel greater distances for 
treatment; however, a recent review of a 
single fi stula centre showed that patients 
will travel long distances if they feel they 
can obtain better outcome  [ 12 ] . 
 The pattern of supra-regional management 
for urogenital fi stula was agreed by 
members of the RCOG and BAUS around 
16 years ago  [ 6 ] . Despite subsequent 
application for national specialist funding, 
centres have never been formally 
recognized, nor this pattern of care 
established. The concept of  ‘ any willing 
provider ’ as originally proposed in the 
Health and Social Care Bill was inherently at 
odds with this proposal, and  ‘ any qualifi ed 
provider ’ still leaves local commissioners 
with considerable ambiguity. The Advisory 
Group for National Specialised Services may 
provide an appropriate channel to facilitate 
such arrangements. 
 In conclusion, in the English NHS, around 
120 women per year have surgical 
treatment of urogenital fi stula and around 
12% of women will require another 
procedure after an unsuccessful repair. 
Outcomes appear to be better in NHS trusts 
with fi stula repair workloads  > 3 procedures 
per year over a period of time, but the 
majority of women had their surgery 
performed by surgeons who rarely undertake 
this surgery. The results of the present study 
lend weight to the argument for the greater 
centralization of fi stula management. 
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Chapter 3: Summary of main findings from included papers 
The methodology and main findings of each of the included papers are documented 
below; the findings are then set in the context of existing literature in chapter 4. 
 
Paper 1: Hillary C, Osman N, Chapple CR, Hilton P. The aetiology, treatment and 
outcome of urogenital fistulae managed in well- and low-resourced countries: a 
systematic review. Eur Urol 2016; 70(3): 478-492. 
 
Methods:  
In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-
analysis (PRISMA) statement, a prospective search protocol was developed and 
registered with the PROSPERO database.  Evidence was identified through a search of 
the PubMed and Scopus databases using the following search terms: ‘‘obstetric 
fistula’’, ‘‘vaginal fistula’’, ‘‘bladder fistula’’, ‘‘urethral fistula’’, ‘‘urinary fistula’’, 
‘‘vesicovaginal fistula’’, ‘‘genital fistula’’, and ‘‘fistula’’; this yielded 12,626 articles.  
After limiting to studies involving women published between January 1980 and March 
2015, and excluding various male and child specific terms, and duplicate publications, 
654 articles remained.  Abstract screening followed by full text screening was 
performed.  The primary objective was to report fistula aetiology; secondary 
objectives included reporting surgical techniques applied and outcomes achieved.  
Each article was rated following the Oxford Centre for Evidence-Based Medicine levels 
of evidence scale. 
 
Main findings: 
Of the 654 articles screened, 49 were identified for inclusion in evidence synthesis, 15 
reporting on fistula repair in HICs and 34 on fistula management in LMICs; only two 
randomised controlled trials were identified, the majority of studies (43/49) being 
grade 4 evidence level.  
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The 15 included articles reporting data from HICs included 2,055 fistulas, of which 
83.2% were of a surgical aetiology, and 13.0% followed radiotherapy.  In contrast, the 
34 included articles reporting data from LMICs included 10,398 fistulas, of which only 
4.4% were of a surgical aetiology, and 0.2% followed radiotherapy. 
Of 10,398 fistulas reported from LMICs, 95.2% were of an obstetric aetiology.  Of the 
so-called ‘obstetric fistulas’, 9.5% were associated with caesarean section and 13.5% 
were associated with some surgical intervention.   
There was limited information regarding conservative management, and only a 
proportion of studies reported on specific approaches to surgical management.  
Where a specific approach was described, in HICs 70.7% of procedures were 
performed vaginally, compared to 84.4% of those reported from LMICs.  Although a 
variety of interposition grafts were used in reported studies, we found no high-quality 
evidence to support the use of graft interposition in any context. 
The definition of surgical success varied between studies, generally in the range 
‘anatomical closure’, ‘anatomical closure but residual leakage’, and ‘failed repair’, while 
others use the ‘need for a repeat repair procedure’ as the definition of failure.  The 
timing of determining outcome also varied, most commonly being at the time of 
catheter removal or discharge (typical in LMICs) or at clinic follow-up (more common 
in HICs).  No studies reporting follow-up beyond 3 months were included in this 
review. 
Of patients undergoing surgical closure in HICs, the median overall closure rate was 
94.6% (range, 75.8–98.6%).  Studies included with the lowest overall success had a 
high proportion of radiation-induced fistulas.  Of patients undergoing surgical repair in 
LMICs, the median overall closure rate was 87.0% (range, 58.0–100%).  The median rate 
of postoperative SUI for patients with a closed fistula was 10.0% (range, 3.8–30.0%), 
across all surgical approaches and fistula characteristics. 
There are no randomised studies available that directly compare the outcomes of 
abdominal and vaginal approaches to repair, given that each surgeon has a particular 
preference for a certain indication and clearly there would be ethical issues with the 
conduct of such a study.  Of the included studies, three reported the outcomes of 
non-randomised comparisons; amongst these, the overall success rates were 90.8% of 
286 vaginal repairs and 83.9% of 250 abdominal repairs; whilst statistically significant, 
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it must be emphasised that the particular approach used in individual cases is likely to 
have been selected on the basis of pre-operative evaluation and dependent on 
individual surgical bias and direct comparison of outcomes is not valid. 
 
These findings are set in the context of existing literature on page 127 in chapter 4 - 
paper 1. 
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Paper 2: Hilton P, Ward A.  Epidemiological and surgical aspects of urogenital fistulae: 
a review of 25 years’ experience in southeast Nigeria.  Int Urogynecol J & Pelvic Floor 
Dysfunct 1998; 9: 189-194. 
 
Methods: 
This retrospective, individual surgeon, cohort study was undertaken during the course 
of two visits made by the candidate to St Luke's Hospital, Uyo, and the associated VVF 
Unit at Mbribit Itam, Akwa Ibom State, Nigeria, in 1989 and 1995.  Cases were 
identified from operating theatre record books, and notes were subsequently 
retrieved from the hospital records department; 2979 operative procedures were 
initially identified, undertaken in 2484 patients between January 1970 and December 
1994; 2389 case notes were subsequently retrieved (96%).  Details of the causative 
processes, fistula site, surgical procedure(s) undertaken, and outcome were well 
recorded in notes throughout the study period.   
Epidemiological data were less well recorded in the early part of the study, and the 
protocol was changed to limit analysis of these aspects to the period between the 
two visits, i.e. between January 1990 and December 1994.  A total of 715 patients were 
identified during this period, from whom 656 case records (92%) were available for 
review. 
 
Main findings: 
The length of history at presentation was extremely variable, ranging from a few days 
to 38 years; the average delay in presentation was 5 years.  Overall, 44% of patients 
experienced amenorrhoea at the time of referral, and their average delay between 
the index pregnancy and presentation was 2 years; 39% had resumed menstruation 
and their average delay to presentation was just over 4 years. The remaining 17% were 
presumed postmenopausal and had a mean delay to presentation of around 15 years. 
Amongst the total cohort, 92.2% of fistulas were of obstetric aetiology, with 80.3% 
following obstructed labour, 6.9% following caesarean section, and 5% following 
rupture of the uterus.   
 113 
The impact of civil war in Nigeria (1967-1970) meant that barely a third of patients 
were aware of their age, and a similar proportion literate.  At the time of presentation 
with their fistula, 62.5% were married, 11.0% were single and 16.2% widowed; 10.4% had 
been deserted by their husbands since the development of their fistula.  Of the 
obstetric fistulas 31.4% followed first pregnancies; parity ranged from 0 to 17 (median 
3).  Although 48.1% of the previous pregnancies had resulted in a live birth, only 27.5% 
of patients had had previous live births (range 0-10, median 1). 
In the index pregnancy, 82.3% of women had laboured at home with or without the 
support of a traditional birth attendant.  Despite this, 73% ultimately delivered in 
hospital, with 47.1% undergoing operative delivery.  Only 10.3% had a livebirth resulting 
from the index pregnancy, 22.8% following caesarean section, 12.5% following 
ventouse delivery, 8.3% following forceps, and 3.4% following normal vaginal delivery. 
In this series, 4.5% of fistulas had ureteric involvement and 8.0% were associated with 
coexistent rectovaginal fistula; over 70% were mid-vaginal, juxtacervical or large (i.e. 
involving the whole of the bladder base between mid-vaginal and cervical levels).  Of 
the total, 0.6% of patients underwent urinary diversion, and 99.4% a primary repair 
procedure; of the latter, 83% were carried out vaginally and 17% abdominally.   
For the purposes of this study, ‘cure’ was defined as a patient being subjectively dry at 
their last assessment, and subsequently undergoing no further surgery in the unit 
within the study period.  Overall, 1954 underwent a single operation and, as far as 
could be established from the notes, were cured at this first operation (82.8%); 247 
patients underwent a second operation, 116 a third, 32 a fourth and 11 a fifth operation 
during the study.  In total, therefore, 2979 urogenital fistula procedures were carried 
out in the 2484 patients.  There were in addition 32 patients who were known still to 
be wet after a first operation yet underwent no further surgery; 10 still wet after a 
second operation, one after a fourth operation, and two after a fifth operation.  These 
were added to calculate 'corrected' cure rates - 81.2% for first procedures and 65.0% for 
those requiring two or more procedures. 
 
These findings are set in the context of existing literature on page 129 in Chapter 4 – 
paper 2. 
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Paper 3:  Hilton P.  Urogenital fistula in the UK – a personal case series managed 
over 25 years.  BJU Int 2012; 110(1): 102-110.2 
 
Methods: 
This is a retrospective, individual surgeon, cohort from a tertiary urogynaecology 
centre providing a de facto supra-regional service for urogenital fistula repair in the 
UK.  The women included had confirmed urogenital fistula referred between January 
1986 and December 2010.  Index cases were identified from the unit surgical database; 
data were entered prospectively for all fistula referrals (regardless of whether they 
underwent surgical repair) and updated with operative, postoperative and follow-up 
information as appropriate; statistics are largely descriptive.  The primary outcome 
was the patient’s report of absence of urinary leakage; secondary outcomes included 
operative or postoperative complications, anatomical closure of the fistula, other 
residual or new urinary symptoms, and the need for further surgical intervention. 
 
Main findings: 
During the period of this review 348 women were referred for the assessment or 
treatment of urogenital fistula, aged between 7 years and 89 years (median 44 years).  
The annual number of referrals increased from approximately 5 per year in the 1980’s 
to 25 per year in the 2000’s.  Approximately one in six was referred from colleagues in 
Newcastle, and half from elsewhere in what was previously known as the Northern 
Health Region.  One in six were referred from the rest of England, and a similar 
number from Scotland, Wales, Northern Ireland, the Republic of Ireland and 
elsewhere overseas combined. 
                                               
2 An update of these data, including the total cohort of 498 patients with urogenital 
fistulae referred to and managed by the candidate in the UK, covering the period 
1985-2015, is included as Appendix 3. 
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Seventy-eight women (22.4%) had undergone 111 previous fistula repair procedures 
before referral; 55 women had one, 14 women two, eight women three, and one 
woman four prior unsuccessful attempts at repair. 
Two thirds of the fistulas (238 cases, 68.4%) were of surgical aetiology, and were 
associated with a large range of different operations.  In 172 cases (72.3% of the 
surgical cases and 49.4% of the series as a whole) the fistula followed excision of the 
uterus and or cervix, with 132 cases (55.5% of the surgical cases and 37.9% of the series 
as a whole) occurring after simple abdominal hysterectomy. 
Thirty-eight women (10.9%) developed the fistula following childbirth; in most this 
followed some form of surgical intervention, i.e. caesarean section (15, 39.5%) or 
caesarean hysterectomy (4, 10.5%), assisted vaginal delivery (5, 13.2%) or trial of vaginal 
delivery following a previous caesarean section (8, 21.1%). 
Two women (0.6%) developed their fistula from direct invasion of malignancy into the 
bladder; 34 women (9.8%) had undergone prior pelvic radiotherapy for the treatment 
of cancer.  The remaining 36 cases (10.3%) were of miscellaneous aetiologies, 
approximately half of which related to vaginal foreign bodies, and a third to the use of 
ring or shelf pessaries for the management of POP. 
256 (73.6%) of the fistulas were VVF with a further 13 (3.7%) having combined VVF and 
ureterovaginal fistula; 70.3% of these (51.7% of the total) opened into the vaginal vault, 
reflecting the preponderance of surgery, and in particular hysterectomy, as the 
causative factor. 
In 24 women (6.9%) the fistula healed ‘spontaneously’, that is either with no 
treatment, or with a period of continuous bladder drainage or ureteric stenting.  A 
further 33 women did not undergo surgery for a variety of other reasons. 
In total, 291 women (83.6%) underwent one or more surgical procedures, with 283 
undergoing repair and eight having primary urinary diversion (2.7%).  Of those 
undergoing primary repair, 69.1% had a vaginal procedure, and 30.9% an abdominal 
procedure.  Ureteric re-implantation was required in 22 women, two of these being 
bilateral; in seven, ureteric re-implantation was combined with a transperitoneal 
repair of a concurrent VVF.  
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Excluding the ureteric re-implantations and urinary diversions, 60 women underwent 
abdominal repair operations; 26.6% of these were transvesical, and 73.4% 
transperitoneal.  Of the 31 cases of obstetric aetiology undergoing repair 13 (41.9%) 
required an abdominal repair, compared to 43/183 of the surgical cases (23.5%), 4/19 of 
the radiotherapy/malignant cases (21.1%), and 0/28 of the miscellaneous cases. 
Of the 283 women having repair surgery 279 had attended for follow-up; 261 (93.5%) 
women report being fully continent and had no clinical evidence of either urethral or 
extra-urethral urinary leakage.  A further six (2.2%) had anatomical closure of their 
fistula but reported some residual incontinence (1 SUI and 5 urgency urinary 
incontinence (UUI)).  The primary closure rate was therefore 95.7%, with a continence 
rate of 93.5%. 
Successful fistula closure was significantly more likely in the women who had not had 
attempts at closure prior to referral (98.2%) than in those who had one or more 
previous unsuccessful procedures (88.2%).   
Twelve women required a second operation following unsuccessful closure after 
referral to our unit; one underwent secondary diversion, and 11 had second attempts 
at fistula repair.  The secondary closure rate therefore was 81.8%, with a secondary 
continence rate of 72.7%.   
The primary closure rate varied between 96% for those fistulas of surgical and 
miscellaneous aetiologies and 90% for those of obstetric aetiology.  These closure 
rates were not significantly different although it must be recognised that the radiation 
related cases were less likely to undergo a repair operation. 
The primary closure rate was 83.3% for those women undergoing abdominal 
procedures, and 96.1% for those having vaginal repairs, although neither closure rate 
nor continence rate were significantly different between VVF (95.9%; 91.4%) and UVF 
(92.1%; 80.0%).  The primary closure rate was not significantly different between those 
procedures where an interposition graft was or was not employed in the repair.   
 
These findings are set in the context of existing literature on page 132 in Chapter 4 – 
paper 3. 
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Paper 4:  Hilton P.  The urodynamic findings in patients with urogenital fistulae.  
BJU Int 1998; 81: 539-542. 
 
Methods: 
During the period 1995-1997, 30 of the 38 patients referred to a tertiary 
urogynaecology unit with urogenital fistula underwent urodynamic investigation prior 
to treatment.  Investigation included free uroflowmetry, dual-channel subtracted 
cystometry (in all), and urethral pressure measurement (in 19 patients).   
 
Main findings: 
The distribution of fistula types and aetiologies was consistent with that reported 
elsewhere from this unit (paper 3) and in other HICs (paper 1).  One of the fistulas was 
vesico-uterine, and six were UVF.  Of the 23 VVFs,14 were situated in the vaginal vault, 
three were mid-vaginal, and six at the bladder neck.  
Following investigation 14 patients (47%) were shown to have USI (then described as 
‘genuine stress incontinence’), 12 (40%) showed DOA (then described as ‘detrusor 
instability’), and 5 (17%) impaired bladder compliance.  Fifteen patients (50%) showed 
evidence of voiding dysfunction (flow rate consistently less than 15ml/sec).   
The urodynamic findings in the 14 patients with vault fistulas were compared with the 
12 whose fistulas were at the bladder neck or urethral.  USI was found in 75% of those 
with urethral or bladder neck fistulas, compared to 36% in those with vault fistulas; 
DOA was present in 50% and 35% in the same groups respectively; however, these 
differences were not of statistical significance. 
Following fistula repair two patients had a persistent or recurrent fistula (92.3% cure at 
first operation).  Ten patients complained of persistent urinary symptoms despite 
anatomical closure of their fistulas; one reported SUI, and nine urgency or UUI; all 
these women had abnormal cystometry pre-operatively.  On repeat urodynamic 
investigation the former was confirmed to have persistent USI; this suggests an 
incidence of post-fistula repair USI in this group of largely surgical fistulas, of only 3%, 
and a persistence rate of 11% in women with UVF or bladder neck fistulas.  Of the nine 
women with overactive bladder (OAB) symptoms following repair, six were confirmed 
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to have persistent DOA on repeat urodynamic testing; one followed repair of a vault 
fistula, and 3 followed repair of urethral or bladder neck fistulas.  This indicates an 
overall incidence of post-fistula repair DOA of 20%, and a persistence rate of 20% for 
the vault fistulas, and 50% for the urethral or bladder neck fistulas.  No women with 
stable bladders pre-operatively had persistent symptoms postoperatively, and no 
patients complained of UUI postoperatively who had not had OAB pre-operatively, i.e. 
there was no evidence of so-called ‘de novo’ DOA post-operatively.  
 
These findings are set in the context of existing literature on page 135 in Chapter 4 – 
paper 4. 
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Paper 5:  Dolan LM, Dixon WE, Hilton P.  Urinary symptoms and quality of life in 
women following urogenital fistula repair: a long-term follow-up study.  BJOG 
2008; 115(12): 1570-1574. 
 
Methods: 
A consecutive cohort of women, referred for treatment of urogenital fistula between 
January 1993 and December 2002, was identified from our surgical database.  Women 
with a VVF or UVF, who had undergone preoperative urodynamic investigation and 
vaginal or abdominal fistula repair with a minimum of 6 months of follow up, were 
eligible for inclusion.   
Eligible women were contacted by post and invited to participate by completing the 
Bristol Female Lower Urinary Tract Symptom (BFLUTS) questionnaire, together with a 
further self-administered questionnaire that provided information on parity, body 
mass index, interim surgery, current medical problems and regular medication.  Non-
responders were contacted again 4 weeks later.  Additional information was obtained 
from case records and those held on the unit surgical database. 
 
Main findings: 
A consecutive series of 84 women with urogenital fistulas were identified from the 
unit surgical database within the study period; 40 women were not eligible for 
inclusion for various reasons; in 9 women, case information was missing or 
inadequate to allow contact.  There were 35 contactable women with VVF or UVF who 
fulfilled all eligibility criteria for inclusion, and they were sent postal questionnaires.  
Completed questionnaires were returned by 31 women (89%); 1 was returned 
unanswered as the woman was deceased. 
The median age of respondents was 46 years (range 16–85 years); the median length 
of time between the surgery and the survey was 50 months (range 7–115 months). 
Twenty-one of the fistulas were into the vaginal vault (68%) and 9 were bladder neck 
or UVF (29%).  The aetiology was surgical in 25 women (81%), the antecedent 
procedure being hysterectomy in 19 (76%) of these.  This distribution of fistula types 
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and aetiology was comparable to the total workload referred to the unit (see also 
included papers 3 & 4). 
On the basis of preoperative urodynamic investigation, one or more functional 
abnormalities were present in 20 women (65%); the rate of abnormality was not 
significantly different between those with vault fistulas (62%) and bladder neck or UVF 
(78%).   
Fistula repair was performed vaginally in 27 women (87%) by a transvesical approach 
in two and a transperitoneal approach in two.  Successful anatomical closure of the 
fistula was achieved with a single operation in all women.  A continence procedure 
was combined with fistula repair in three women with preoperative USI. 
Thirty of the 31 women (97%) reported having one or more urinary symptoms at a 
median of 50 months after fistula repair, with urgency (71%), nocturia (68%), SUI (68%) 
and UUI (65%) being the most commonly reported symptoms.  There was no 
significant difference in urodynamic abnormalities found in association with different 
fistula types or in the symptoms found subsequently.  Normal cystometry prior to 
fistula repair did not appear to be associated with a lower incidence of bothersome 
symptoms at a median of 4 years postoperatively. 
The BFLUTS questionnaire asks respondents to grade how they would feel if they had 
to spend the rest of their life with their current urinary symptoms as ‘perfectly happy’, 
‘pleased’, ‘mostly satisfied’, ‘mixed feelings’, ‘mostly dissatisfied’, ‘very unhappy’ or 
‘desperate’.  Ten women (32%) had at least mixed feelings, although only two women 
described feeling dissatisfied or unhappy at the prospect.  Twenty-seven women 
(87%) said that their current urinary symptoms caused little (12) or no (15) interference 
with their lives. 
 
These findings are set in the context of existing literature on page 137 in Chapter 4 – 
paper 5. 
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Paper 6: Hilton P, Cromwell D. The risk of vesicovaginal and urethrovaginal fistula 
after hysterectomy performed in the English National Health Service – a 
retrospective cohort study examining patterns of care between 2000 and 2008. 
BJOG 2012; 119(12): 1447-1454. 
 
Methods: 
The study used data from the HES database, which contains records of all patient 
admissions to National Health Service (NHS) hospitals in England, capturing patient 
demographics, hospital administrative information, diagnostic information using the 
International Classification of Diseases (ICD), 10th revision, and operative procedures 
using the UK Office for Population Censuses and Surveys classification (OPCS), 4th 
revision. 
This study included adult women who underwent elective hysterectomy for selected 
common indications in English NHS hospitals between 1st January 2000 and 31st 
December 2008.   
We distinguished between four types of hysterectomy: total abdominal hysterectomy 
(TAH) (OPCS code: Q07.4), subtotal abdominal (STH) (Q07.5), vaginal (VH) (Q08.9), 
and radical abdominal hysterectomy (RAH) (Q07.1-07.3).  The selected benign 
conditions were endometriosis (ICD10 code: N80), uterine fibroids (D25), POP (N81) 
and menstrual disorders (N92–N94).  Four ‘malignant’ conditions were also selected, 
namely, cervical carcinoma in situ (D06), cervical cancer (C53), uterine cancer (C54, 
C55) and ovarian cancer (C56).   
Women were defined as having a postoperative fistula if the ICD10 codes N82.0 (VVF) 
or N82.1 (other urinary-genital tract fistula) were found in the diagnostic fields of the 
index procedure episode or any subsequent episode that occurred within 1 year of the 
index procedure.  Surgical repair of fistulas was examined using the most pertinent 
OPCS codes, namely, repair of VVF (OPCS P25.1), repair of UVF (P25.2) and 
construction of an ileal conduit (M19.1). 
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Main findings: 
There were 351,505 hysterectomies performed for the selected indications, and after 
exclusions as defined in the paper, there were 286,053 operations performed for 
benign conditions, and 57,718 for ‘malignant’ indications.  In the former group, 339 
fistulas were identified (0.12%), and amongst the latter 97 fistulas were identified 
(0.17%).   
The risk posed to women differed across the various combinations of procedure and 
indication.  For women undergoing VH for POP, the estimated rate was 1 in 3861 (95% 
CI 2550–6161).  Among women undergoing a TAH for the other benign conditions, the 
overall rate was 1 in 540 (272/146 841; 95% CI 479–540), whereas for women who 
underwent STH the rate was 1 in 2279 (9/20 511; 95% CI 1205–5000).   
The risk of VVF or UVF was greatest among those women who had cervical cancer, 
with TAH and RAH both having estimated rates of around 1 in 100.  Among women 
undergoing TAH, the rate was roughly five times greater for women with invasive 
cervical cancer than cervical carcinoma in situ (relative risk 4.6; 95% CI 1.7–12.2; p < 
0.001).   
For the benign conditions of endometriosis, fibroids and menstrual disorders, there 
were noticeable changes in the number of fistulas after TAH across the age categories 
and by year of surgery.  In terms of age, the rate of fistula was stable until women 
passed 50 years of age, after which it fell by around 40%.  The rate of fistula increased 
from 0.15% in 2000–2002 to 0.22% in 2006–2008, a rise of 46%.  Extending the model to 
include both VH and TAH for these benign conditions produced comparable results 
for the estimated relationship between rate of fistula and age categories and year of 
surgery, although the relationship was not seen for malignant conditions. 
 
These findings are set in the context of existing literature on page 139 in chapter 4 – 
paper 6.  
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Paper 7: Kiran A, Hilton P, Cromwell DA. The risk of ureteric injury associated with 
hysterectomy: a 10-year retrospective cohort study. BJOG 2016: 123(7); 1184-1191. 
 
Methods: 
This study employed a similar methodology to that described in the previous included 
paper (paper 6) to investigate the risk of ureteric injury after hysterectomy, between 
1st January 2001 and 31st December 2010. 
The indications explored were defined as in the former study, as were the types of 
hysterectomy, with the exception that we also sought to identify laparoscopic 
procedures as follows: total laparoscopic hysterectomy (TLH; Q56.8), 
laparoscopically-assisted vaginal hysterectomy (LAVH; Q08.9), laparoscopically-
assisted subtotal hysterectomy [LASH; code as for subtotal hysterectomy (Q07.5) 
with the additional laparoscopic approach qualifier (Y50.8)]. 
Ureteric injuries within a year of hysterectomy were identified using codes for 
relevant diagnoses and related surgical treatment.  A woman was identified as having 
an injury if the diagnostic fields of the index procedure episode, or a subsequent 
episode within 1 year of the index procedure contained: ureteric injury (S37.1), 
hydronephrosis with ureteric stricture (N13.1) or other urinary-genital tract fistula 
(N82.1).  Ureteric injury was also identified if surgical treatments for ureterovaginal 
fistula or obstruction, e.g. insertion of stent; insertion of nephrostomy tube; 
ureteroscopic dilatation; removal of suture from ureter; ureteric repair; closure of 
ureterovaginal fistula; or re-implantation of ureter, were identified within the same 
timeframe.  
 
Main findings: 
After exclusions, 377,073 hysterectomies were identified for analysis, 310,105 for 
benign indications and 66,968 for malignant indications.  In total, 1792 ureteric injuries 
were identified (0.5%) within a year of the index procedures.  
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The annual number of injuries showed a significant trend, increasing from 90 in 2001 
to 259 in 2010.  The rate of ureteric injury was higher from 2006 onwards for six of the 
eight conditions, the change being greatest for women with ovarian cancer, 
increasing over three-fold from 1.06% to 3.86%. 
Women undergoing laparoscopic hysterectomies had a rate of ureteric injury of 0.6% 
(94/14,692), which was higher than the overall rate for other types of hysterectomy 
[0.3% (889/295 413).   
Among the various indications, the highest rate was observed among women who 
had endometriosis, 2.2% (50/2363) for laparoscopic procedures and 1.0% (245/24 054) 
for open procedures.  Of the 66,968 hysterectomies in the malignant group, 8.0% 
(5321) were laparoscopic.  Women who had laparoscopic hysterectomies had a rate of 
ureteric injury of 0.2% (8/5321), which was lower than the rate for open procedures 
[1.3% (798/61 647), laparoscopic versus open procedures, chi-square p < 0.001).  
 
These findings are set in the context of existing literature on page 141 in chapter 4 – 
paper 7. 
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Paper 8: Cromwell D, Hilton P. Retrospective cohort study on patterns of care and 
outcomes of surgical treatment for lower urinary – genital tract fistula among 
English National Health Service hospitals between 2000 and 2009. BJU Int 2013; 
111(4b): E257-E262. 
 
Methods: 
This was a retrospective cohort study using data from HES on women undergoing VVF 
or UVF repair between January 2000 and December 2009 in English NHS hospitals.  
Women were selected if they had an ICD-10 code N82.0 (VVF) or N82.1 (other urinary-
genital tract fistula) in a diagnostic field and an OPCS-4 procedure code for repair of 
VVF (P25.1), repair of UVF (P25.2) or ileal conduit/urinary diversion (M19.1).  We only 
included procedures that were performed during or after the first episode containing 
a diagnosis of urogenital fistula.  A woman was defined as having a repeat repair, and 
therefore failure of an initial repair, if a subsequent episode of care contained in any 
procedure field one of the three OPCS codes (P25.1, P25.2 or M19.1) after an index 
procedure of fistula repair (P25.1, P25.2). 
The main outcome measure was the number of fistula repairs and the incidence of re-
repair; re-repair rates were stratified by age, NHS trust and consultant team volume. 
 
Main findings: 
We found a 37% increase in the number of repair or diversion operations carried out 
for lower urinary-genital tract fistulas between 2002 and 2009.  Considering only 
primary fistula repair procedures, we found a 68% increase over the same period 
(from 62 primary repairs in 2002 to 104 in 2009).   
The index procedures were allocated to 490 consultant teams, of which 127 (26%) 
were in the main specialty of gynaecology, and 306 (62%) were in urology.  Overall, 281 
consultant teams performed only one index procedure during the 10-year period 
studied, and only ten teams performed ten or more procedures in the same period.  
Only three consultant teams had carried out over 3 procedures per year consistently 
throughout the 10-year period studied.  114 consultant teams (23%) carried out no 
repair procedures, and only undertook urinary diversion in women with a diagnosis of 
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urinary fistula.  Among the 376 consultant teams that performed repair surgery only 
five teams performed ten or more repairs in the period studied. 
There were 108 women (11.9%) among the 905 women undergoing surgical fistula 
repair who required a repeat operation. The ‘cure’ rate from one operation was 88.1% 
(797/905), from a first re-operation was 81.9% (77/94), and from a second re-operation 
was 68.9% (11/16).  If one assumes that the need for secondary urinary diversion after a 
repair represents failure of the previous repair, these figures become 88.1% (797/905), 
71.3% (77/108) and 64.7% (11/17), respectively.  The relative risk of needing a further 
procedure after a second repair compared with after a first operation was 1.52 (95% CI 
0.95 – 2.41; p = 0.086).  The annual rate of re-operation fluctuated between 4 and 20% 
per year, but there was no significant evidence for the rate of repeat surgery having 
changed over time (test for trend, p = 0.17). 
Whilst there was no association between rate of repeat repair and workload of NHS 
trusts or consultant teams, there was a noticeable step change between NHS trusts 
who performed over 30 procedures over the 10-year study period and those that did 
not (7.4 v 13.2%, p = 0.02).  A similar step change was apparent among the consultant 
teams but this difference was not significant (8.4 vs 12.7%, p = 0.13).  There were ten 
trusts and seven consultant teams with re-operation rates over twice the national 
average, and two Trusts and consultant teams with re-operation rates less than half 
the national average.  However, the variation in the rates of repeat repair across NHS 
trusts and consultant teams was consistent with that expected from random variation 
alone (using the 99.8% limits of certainty).   
 
These findings are set in the context of existing literature on page 143 in chapter 4 – 
paper 8.  
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Chapter 4: Findings from the included studies set in context 
Paper 1: Hillary C, Osman N, Chapple CR, Hilton P. The aetiology, treatment and 
outcome of urogenital fistulae managed in well- and low-resourced countries: a 
systematic review. Eur Urol 2016; 70(3): 478-492. 
 
Although the candidate has undertaken a number of systematic reviews relating to 
aspects of urogenital fistula, covering epidemiology (of oncological fistulas, and those 
involving the gastro-intestinal tract (GIT)), management (of surgical and radiotherapy-
associated fistula and those involving the GIT) (de Ridder et al., 2013), and 
complications of fistula and repair surgery (including urinary tract infection, vaginal 
stenosis, dyspareunia and sexual dysfunction) (Mourad et al., 2012), this particular 
review is included in view the commonality of its themes those of other included 
papers. 
In common with other systematic reviews in the area of urogenital fistula (Mourad et 
al., 2012; Adler et al., 2013; de Ridder et al., 2013; Bodner-Adler et al., 2017; World Health 
Organization, 2018), we found the published evidence to be of poor quality, based 
largely on retrospective case series.  Of 12,626 publications identified in our initial 
search, only 49 were appropriate for inclusion, and only two were RCTs, comparing 
variations in operative technique in obstetric fistulas in LMICs  (Safan et al., 2009; 
Shaker et al., 2011).   
The distribution of aetiologies seen in our review was in keeping with other literature 
(see page 6: Chapter 1: Background literature – Epidemiology of urogenital fistulas – 
Aetiology).  In women reported from HICs, 83% of fistulas were of surgical aetiology, 
and in those reported from LMICs, 95% were of obstetric aetiology.  This is also in 
keeping with our findings in the submitted papers 2 & 3.  
Despite the reported, albeit modest, success rate from conservative management 
(see page 18: Chapter 1: Background literature – Treatment outcomes – Conservative 
management), we found little evidence of the consistent application of this 
management strategy in the included papers.   
Similarly, despite enthusiastic reports of the use of interposition grafting, especially in 
women with large, multiple, recurrent, radiotherapy-associated or urethral fistulas 
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(Rangnekar et al., 2000; Pushkar et al., 2009; Malde et al., 2017), we found no high-
quality evidence to support their use in any of these situations.  It is certainly the case 
that many colleagues working in LMICs describe a decreasing place for interposition 
grafting in their practices. 
The variation in definition of outcome across the included studies was emphasised, 
and again this is in keeping with other reviews (see page 12: Chapter 1: Background 
literature – Outcomes of treatment for lower urinary tract fistula – Definition of cure).  
With that limitation, we did find a statistically significant difference in outcome 
between vaginal procedures (91% cures) and abdominal procedures (84% cures).  We 
do concede however that there is no high-level evidence to support this finding, 
which is based on comparison of cohort studies only, and not randomised controlled 
trials.  It is also discordant with the findings of the ICI review, which found no 
significant differences between ‘early’ and ‘late’ repairs, vaginal and abdominal 
repairs, transvesical and transperitoneal repairs, and repairs with and without the use 
of interposition grafting (candidates own searches and analyses) (de Ridder et al., 
2013). 
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Paper 2: Hilton P, Ward A. Epidemiological and surgical aspects of urogenital 
fistulae: a review of 25 years’ experience in southeast Nigeria.  
Int Urogynecol J & Pelvic Floor Dysfunct 1998; 9: 189-194. 
 
Although larger well-documented case series of obstetric fistula patients managed in 
LMICs have since been published (Muleta et al., 2010a; Waaldijk, 2018), in paper 2 we 
presented what was at the time the largest single surgeon cohort study (Hilton and 
Ward, 1998).  We highlighted the considerable delays from the onset of symptoms to 
presentation, and in keeping with other reports (Muleta et al., 2010a; Bangser et al., 
2011) found an average delay of 5 years.  Additionally, the women in our series often 
travelled distances of up to 1000 miles, to obtain treatment, consistent with the 
concept of Maine’s first and second delays (Thaddeus and Maine, 1991).   
We also reported, for the first time, the association between menstrual status and 
time of presentation.  Although the occurrence of amenorrhea following the 
development of a fistula is well known(Aimakhu, 1974), whether this reflects gross 
tissue destruction within the pelvis or a hypothalamic influence as a result of the 
physical and emotional effects of a traumatic labour, stillbirth and fistula 
development, has not been clear.  As the live-birth rate is so low in obstetric fistula 
patients (10% in our series), lactation is unlikely to be a significant factor in causing 
amenorrhoea.  The average time to presentation in those who had resumed 
menstruation was just over 4 years, compared to 2 years in those who remained 
amenorrhoeic.  We opined that the natural history of the hypothalamic suppressive 
effect of the development of a fistula tends towards spontaneous resolution after 2 
years, even if the fistula remains untreated.  Alternatively, these findings may simply 
reflect the fact that the more dramatically affected patients, who are more likely to 
develop amenorrhea, are also more likely to present earlier for treatment than their 
less traumatized sisters who may have resumed menstruation at an earlier stage.  The 
latter suggestion would however not be in keeping with the findings that that women 
who have difficulties obtaining care in labour also tend to have difficulties securing 
treatment for their fistulas (Tahzib, 1983).   
Amongst the cohort reviewed, 92% of fistulas were of obstetric aetiology, 80% 
following obstructed labour, 7% following caesarean section, and 5% following uterine 
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ruptured; only 4% followed non-obstetric pelvic surgery.  These findings being entirely 
consistent with earlier reports from LMICs (Waaldijk, 1989; Danso et al., 1996; Hilton, 
2003).   
Female genital mutilation (FGM), poor educational attainment, early age at marriage, 
lack of contraception, early pregnancy, and childbearing before growth and 
maturation of the pelvis, have commonly been seen as important factors in 
accentuating the risks of obstruction in labour, and high rates of separation and 
divorce, a common consequence (Murphy, 1981; Tahzib, 1983; Kelly and Kwast, 1993a; 
Ibrahim et al., 2000).  Despite the high proportion of fistulas of obstetric aetiology, 
and the common association with obstructed labour in our cohort, we did not find the 
same distribution of social attributes, and FGM in particular was rarely seen.  The 
mean age was 28 years (compared to 16 - 22 years in the latter cited studies), mean 
parity was 3.5 (compared to 1.2 - 2.1), with less than a third of the fistulas resulting 
from their first pregnancy (compared to 52% - 81%); almost a third had completed at 
least primary education (compared to 0.2% - 8%), and less than a third delivered at 
home (although in many cases they attended hospital after several days at home) 
(compared to 58% - 77%).  Why our patients in south-east Nigeria should have such a 
high fistula rate despite these factors remains uncertain, although this may reflect 
biosocial differences in the population studied.  It is of interest that in the only case-
controlled study exploring this issue, although fistula patients were of shorter stature, 
poorer nutritional status, lower educational level, and lower socioeconomic status, 
the control women actually married at a younger age than index cases, and there was 
no difference in age at first pregnancy or utilization of conventional health and 
maternity care (Onolemhemhen and Ekwempu, 1999).  Abhorrent as it is, how far 
FGM should be seen as a risk factor for fistula, and how far simply an associated 
feature of some populations in which fistula is common, also remains unclear. 
Although ‘cure’ could be determined only from the patient’s report of being dry at the 
time of discharge, and subsequently undergoing no further surgery in the unit during 
the study period, this did allow the calculation of ‘cure rates’ for both primary and 
secondary surgery, in a way that had rarely been reported previously.  We found 81.2% 
‘cure rate’ from first operations, and 65.0% in women undergoing second or 
subsequent procedures.  A closure rate of 88% for primary procedures(Kelly and 
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Kwast, 1993a), and 57.8% from secondary procedures has been reported from the 
Addis Ababa Fistula Hospital (Kelly and Kwast, 1993b) (candidate’s calculation from 
published raw data).  In a more recent personal communication from the same unit, 
Browning reports 92% closure from first operations, 73% from second operations and 
52% from third operations (Mourad et al., 2012).  In the same communication it was 
indicated that 33% of women reported SUI after a first repair procedure, 50% following 
a second repair, and 75% following a third repair.  Although we identified a small 
number of women with residual incontinence who did not undergo further fistula 
repair, these were included as ‘failures’ in our calculation of outcome, which was 
therefore quoted as ‘cure rate’ rather than ‘closure rate’.  It was unfortunately not 
possible to make reliable estimates of post-repair SUI in our cohort.   
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Paper 3:  Hilton P.  Urogenital fistula in the UK – a personal case series managed 
over 25 years.  BJU Int 2012; 110(1): 102-110. 
 
This is one of the largest published cohort studies of urogenital fistula from an HIC - 
the largest with the unpublished re-analysis following the candidate’s retirement, 
when the total number had increased to 498 cases (see Appendix 3).  More 
importantly, it is the first study to show the referral pattern of patients with 
urogenital fistulas.  Although arguments have been made for the general concept of 
‘treatment near to home’ (NHS England, 2014b), it is clear that, given the option, 
patients will travel the length of the country, and indeed cross national boundaries, to 
obtain effective care.  A document describing the commissioning of centralised 
services for urogenital fistulas in the UK has been in draft since 2013 (NHS England, 
2013), but remains to be implemented. 
The distribution of aetiology amongst the included cases was broadly in line with 
earlier reports, with 68% of surgical aetiology.  A further 11% followed childbirth, 
although most of these followed some obstetric surgical intervention, and it would be 
more appropriate to look on 80% of urogenital fistulas being iatrogenic in aetiology in 
current surgical practice in HICs.   
We described ‘spontaneous’ healing (i.e. associated with prolonged catheterisation) 
in only 24 of our referred cases (6.9%).  Recent, largely overlapping, systematic and 
non-systematic reviews found closure with catheter drainage alone in 13% and 31% of 
included surgical fistulas, respectively (Bazi, 2007; de Ridder et al., 2013).  It must be 
noted however, that the number of cases in the included reports varied from 1 to 238, 
with spontaneous closure in 0% to 100%, giving a very large CI around the estimate of 
13% (95% CI 0%, 36%).  Two thirds of the included cases and almost one half of the 
spontaneous closures came from the candidate’s cohort.  It should also be noted that 
many of the referred cases in our cohort attended after epithelialisation had occurred, 
and a consistent approach to conservative management was not appropriate.  Where 
a consistent approach to conservative management has been applied, spontaneous 
healing has been reported in 15-28% of obstetric fistulas (Waaldijk, 1997; Waaldijk, 
2004); one would therefore anticipate that this would be the minimum estimate of 
spontaneous healing in iatrogenic fistulas.  Certainly a case can be made for more 
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widespread use of catheterisation in the early days after fistula recognition, and the 
recommendation of the ICI (the candidate’s own wording) is (de Ridder et al., 2013):  
“Spontaneous closure of surgical fistulae does occur, although it is not possible 
to establish the rate with any certainty; if a vesicovaginal fistula is diagnosed 
within (3 to ) 6 weeks of surgery, indwelling catheterisation can be considered 
for a period of up to (6 to ) 9 weeks (i.e. up to 12 weeks after the causative 
event).”   
As noted previously, the candidate’s preference has always been for the vaginal 
approach to fistula repair surgery where possible, accepting that the abdominal route 
has a place where access vaginally is limited (by virtue of the patient’s nulliparity, or 
previous surgery or other pelvic pathology) or where there is concurrent ureteric 
involvement requiring re-implantation.  Within this cohort the primary closure rate 
was 83.3% for those women undergoing abdominal procedures, and 96.1% for those 
having vaginal repairs (Fisher’s exact test; p < 0.001).  This is consistent with the 
findings in the meta-analysis reported in paper 1, although it must be acknowledged 
that our cohort represented a large proportion (80%) of those in whom this analysis 
was feasible (Hillary et al., 2016).  Given that the decisions about the route of repair 
are not taken at random but are based on specific patient characteristics; these 
findings must be interpreted with caution.  We would simply urge that those involved 
in fistula surgery should have appropriate training, skills and experience to select the 
most appropriate procedure for each patient (de Ridder et al., 2013). 
The fistula closure rate at first operation (that is, the first operation in the referral 
centre) varied by aetiology, 96.3% for miscellaneous fistulas, 96.1% for surgical fistulas, 
94.7% for radiation-associated fistulas, and 90.3% for obstetric (largely obstetric 
surgery) fistulas.  These differences were not significantly different.  It has been 
suggested that urinary diversion may be the procedure of choice in radiotherapy-
associated fistulas (Langkilde et al., 1999).  In keeping with that approach, our review 
of national outcomes from fistula surgery from England (vide infra - paper 8) showed 
that 24% of all patients with a diagnosis of urogenital fistula underwent diversion.  
Nonetheless, in this personal cohort study only 2.7% overall required diversion (albeit 
17.6% for radiotherapy-induced fistulae, compared with 0.6% for other aetiologies).  
These data would suggest that urinary diversion should not be seen as the automatic 
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response to radiotherapy-associated fistulas, and at least some consideration should 
be given to the option of repair. 
Fistula closure was achieved significantly more often in women who had not 
undergone attempts at repair prior to referral (98.2%) than in those with previous 
unsuccessful procedures (88.2%).  Similarly, the primary closure rate after referral 
(95.4%) was higher than the closure rate in those women who needed 2 or more 
repairs after referral (81.8%) – a clinically if not statistically significant difference.  This 
is in keeping with our earlier larger cohort of obstetric fistulas (paper 2) (Hilton and 
Ward, 1998).  These findings indicate that the best time to close a fistula, both from 
the patient’s and surgeon’s perspectives, is at the first operation, and again, this 
strengthens the arguments for centralised management of fistulas. 
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Paper 4:  Hilton P.  The urodynamic findings in patients with urogenital fistulae.   
BJU Int 1998; 81: 539-542. 
 
Although prior to this publication there had been one small series of patients 
undergoing urodynamics after fistula repair (Schleicher et al., 1993), this was the first, 
and indeed remains the only, report of urodynamics carried out prior to repair in 
women known to have urogenital fistula.  Whether it is possible to undertake 
conventional dual-channel cystometry when there is direct communication between 
the bladder and the genital tract has been questioned (Abrams and Hilton, 2002).  We 
were, nevertheless, able to demonstrate that the intra-vesical pressure was different 
from the intra-abdominal pressure (recorded either vaginally or rectally), and that 
detrusor contractions could be identified during both filling and voiding phases of the 
procedure.  It is acknowledged that this was a cohort of women recruited in the UK, 
with aetiologies typical of fistula patients in an HIC; most were surgical fistulas of only 
a few millimetres in diameter, although there were also radiotherapy-associated 
fistulas up to 3cm. diameter.  Intuitively, there must be a maximum fistula size above 
which it is not possible to record detrusor pressures reliably, and this may have 
implication for the value of pre-repair investigation in LMICs.  
We found a high incidence of both USI (47%) and DOA (40%) in this cohort of women 
with largely surgical fistulas, prior to repair.  Whilst there are no directly comparable 
data, these findings can be seen in context with:  
• the reports of post-fistula repair SUI in up to 50% of women (Kelly and Kwast, 
1993b; Waaldijk, 2009; de Ridder et al., 2012);  
• the symptomatic report of bladder spasms in 45% of women immediately after 
obstetric fistula repair (Ekwedigwe et al., 2017); and 
• the urodynamic findings in women with persistent UI after obstetric fistula 
repair, where USI was identified in 31% - 49%, DOA in 3% - 6%, and mixed USI and 
DOA in 20% - 43% ((Schleicher et al., 1993; Murray et al., 2002; Goh et al., 2013).   
This would suggest that whatever mechanisms account for the high incidence of 
functional abnormalities of the urinary tract after repair surgery in fistula patients, be 
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that USI, DOA or both, they are likely to be effective prior to the fistula repair 
procedure.   
By repeating urodynamic investigation after fistula repair (in those women with 
persistent symptoms) we were able to determine both incidence and persistence 
rates (i.e. the number who had the finding prior to repair in whom it was also found 
after repair) for USI and DOA.  This was the first time (and, as far as we are aware, the 
only time) that sequential studies have been carried out in this patient group.  The 
incidence of post-fistula repair SUI was 1/30 or 3%; the persistence rate 1/14 or 7%.  
Post-fistula repair DOA was found in 6/30 or 20% and persisted in 6/12 or 50%.  Perhaps 
most notably, we found no women who had had stable bladders prior to their fistula 
repair who reported symptoms of OAB postoperatively, and no women who 
complained of UUI postoperatively who did not report OAB symptoms pre-
operatively, i.e. there was no evidence of so-called ‘de novo’ DOA postoperatively.  
Clearly these findings are of major significance in terms of counselling women prior to 
fistula repair in HICs; their concordance with the postoperative findings in obstetric 
fistula patients implies relevance also in LMICs. 
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Paper 5:  Dolan LM, Dixon WE, Hilton P.  Urinary symptoms and quality of life in 
women following urogenital fistula repair: a long-term follow-up study.  BJOG 
2008; 115(12): 1570-1574. 
 
The limited availability of long-term follow-up studies in the area of surgery for pelvic 
floor dysfunction is well recognised (Hilton, 2008).  In view of the high incidence of 
symptoms of SUI and OAB, and of functional abnormalities of USI and DOA both 
before and after fistula repair referred to above, we sought to undertake a long-term 
follow-up in women who had undergone anatomically successful fistula repair.  This 
was the first long-term follow-up of fistula patients, and the first use of a validated 
quality of life (QoL) instrument in this patient group (albeit the validation was in HIC 
populations with pelvic floor dysfunctions other than fistula) (Brookes et al., 2004). 
We chose to employ what was then known as the BFLUTS questionnaire (Jackson et 
al., 1996) – now incorporated into the ICI modular set of questionnaires as the ICIQ - 
Female Lower Urinary Tract Symptoms questionnaire (ICIQ-FLUTS) (Bristol Urological 
Institute, 2014).  It must be noted that this looks at the occurrence and impact of 
lower urinary symptoms and does not explore other domains of QoL.  We obtained a 
good response rate of 89% at a median of over 4 years after treatment.  In 
comparison, in a feasibility study to investigate the role of urodynamic investigation in 
women prior to surgical treatment for SUI, we obtained a 75% response rate to the 
ICIQ – FLUTS at 6-months follow-up (Hilton et al., 2015). 
We found very high rates of SUI and OAB symptoms (urgency, nocturia, and UUI) with 
97% of patients reporting one or more of these symptoms.  It must be noted of course 
that these are very common symptoms in parous women; however, the prevalence of 
individual symptoms was 1.5 to 2 times higher in our population of women following 
fistula repair than it was in the general population (Dolan and Hilton, 2010). 
Despite the frequent reporting of lower urinary tract symptoms, for most (87%) these 
caused little or no impact of their QoL.  It was also of interest to note that normal 
cystometry prior to fistula repair did not appear to be associated with a lower 
incidence of bothersome symptoms 4 years postoperatively.  This might be seen to 
bring into question the role of bladder function testing in this patient group.  That 
said, even where a good prognosis for fistula closure can be given, women 
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undergoing fistula repair should be counselled about the possibility of persisting 
urinary symptoms afterwards; they can however be reassured that in most cases, 
these will be mild, with limited impact on their QoL.   
More recently other reports from LMICs including Nigeria (Umoiyoho et al., 2011), 
Ethiopia (Donnelly et al., 2015), Burkina Faso ,(Desalliers et al., 2017) and Bangladesh 
(Imoto et al., 2015), using a range of questionnaire and interview techniques, have not 
only shown the major adverse impact of fistula on QoL, particularly in terms of mental 
and social well-being, but also the beneficial effect of successful treatment.  They 
have however also pointed out the occasional persistence of stigmatisation, physical 
problems, and anxiety over such issues as the sexual functioning, obstetric future and 
financial security.   
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Paper 6: Hilton P, Cromwell D. The risk of vesicovaginal and urethrovaginal fistula 
after hysterectomy performed in the English National Health Service – a 
retrospective cohort study examining patterns of care between 2000 and 2008. 
BJOG 2012; 119(12): 1447-1454. 
 
Although there had been earlier studies of urinary tract injury at hysterectomy 
employing large national datasets (Harkki-Siren et al., 1998; Forsgren et al., 2009), this 
was the largest study to date, and with over 350,000 procedures over 9 years this 
allowed us to investigate, for the first time, the risks fistula developing after 
hysterectomy, both by route of operation, and by indication for the procedure.   
Our ‘headline rates’ of lower urinary-genital tract fistula following hysterectomy were: 
• Overall, for all diagnoses and routes of hysterectomy - 1 in 788  
• VH for POP - 1 in 3861  
• STH for benign indications other than POP - 1 in 2279 
• TAH for benign indications other than POP - 1 in 540 
• TAH or RAH for cervical cancer - 1 in 102 
The national cohort studies from Sweden (Forsgren et al., 2009), and Finland (Harkki-
Siren et al., 1998), both showed lower overall rates of fistula following TAH for benign 
indications, of approximately 1 in 1000.  The Swedish study covered the period 1973–
2003 and the Finnish study 1990–95 whereas our study covered a later period (2000–
08); an increasing risk over time could therefore explain these figures (vide infra).   
The Cochrane review of approaches to hysterectomy for benign disease found no 
difference in the rate of fistula following abdominal, vaginal and laparoscopic routes 
(Nieboer et al., 2009); and the VALUE study, a non-randomised cohort study of 
hysterectomy from the UK, found no difference in the rate of operative bladder injury 
between abdominal, vaginal and laparoscopic routes (McPherson et al., 2004).   The 
national cohort study from Finland on the other hand reported a higher rate of both 
bladder injury (relative risk 11.4) and subsequent fistula formation (relative risk 2.2) 
following laparoscopic procedures (Harkki-Siren et al., 1998).  Unfortunately, the 
OPCS-4 coding used in HES at the time of our study did not allow easy separation 
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between open and laparoscopic hysterectomies and we did not feel that much of use 
could be stated about the risks of fistula associated with laparoscopic hysterectomy. 
As one would expect, the risks for developing postoperative fistula were highest in 
women undergoing hysterectomy for invasive cancer.  Less intuitively, we found the 
risks in women undergoing surgery for benign indications to be lower in women over 
50 years of age.  This has not been reported previously, and indeed the study from 
Sweden found a higher rate of ‘fistula disease’ in women over 50 years (Forsgren et 
al., 2009).  They however included both intestinal and urinary fistulas, and it is 
conceivable that the increase in fistulas reported in older women in these studies 
relates more to bowel than urinary fistulae, and to the prevalence of inflammatory 
bowel disease than to hysterectomy (Altman et al., 2010). 
Perhaps most notably, we found the risk of lower urinary genital tract fistula after 
hysterectomy to have increased by almost 50% between the first and last triennia of 
our study period (i.e. between 2000-2002 and 2006-2008).  This trend has also been 
confirmed more recently in a conference abstract from the USA (Adam et al., 2015).  
Factors that might underlie this trend are discussed after the considerations of papers 
7 & 8, in Chapter 5.  
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Paper 7: Kiran A, Hilton P, Cromwell DA. The risk of ureteric injury associated with 
hysterectomy: a 10-year retrospective cohort study. BJOG 2016: 123(7); 1184-1191. 
By using both diagnostic codes for ureteric injury, stricture, and fistula and operative 
codes for relevant interventions (ICD-10 and OPCS-4 codes are included with the paper 
as supplementary material – see page 102), we identified 1792 ureteric injuries arising 
during, or within 12 months of, 377,073 hysterectomies (0.5%).  The incidence ureteric 
injury at hysterectomy from other large cohort studies and systematic reviews ranges 
between 0.2% and 30% (Harkki-Siren et al., 1998; Brandes et al., 2004; Likic et al., 2008; 
Summerton et al., 2012; de Ridder et al., 2013).  Some of these reviews have suggested 
that the incidence of iatrogenic ureteric injury may have diminished in the last two 
decades (Brandes et al., 2004; Summerton et al., 2012), although the evidence 
supporting this statement is certainly not strong.  In contrast (yet in keeping with our 
earlier data on lower urinary tract fistulas following hysterectomy) the overall number 
of ureteric injuries identified in our study, and the rate of injury (for 6 of the 8 
diagnoses examined) increased between the first (2001-2005) and second (2006-2010) 
quinquennia of this study (see page 145: Chapter 5 for further discussion of this point in 
relation to papers 6, 7 & 8).   
We had not originally intended to report the risks associated with laparoscopic 
hysterectomies, in view of the recognised problems with their coding within OPCS, 
and anticipated under-reporting (National Oesophago-Gastric Cancer Audit, 2010; 
Hilton and Cromwell, 2012); with the encouragement of reviewers and editors 
however we did include these data.  Women undergoing abdominal or vaginal 
hysterectomies had a rate of ureteric injury of 0.3%, whereas those having 
laparoscopic procedures had a rate of 0.6%.  Whilst these figures were statistically 
significantly different, they are in some distinction with the figures reported from 
Finland in 1990s, where the rate of injury after all hysterectomies was 0.1% and that 
after laparoscopic procedures 1.4% (Harkki-Siren et al., 1998).  The earlier timeframe of 
this latter study may mean that it was collected at a period of less advanced 
laparoscopic skills generally.  
The highest rate of ureteric injury was observed among women who had 
endometriosis, 2.2% for laparoscopic procedures and 1.0% for open procedures.  
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Perhaps surprisingly, the rate of ureteric injury in women undergoing surgery for 
malignant diagnoses was lower than for endometriosis and was also lower when 
undertaken by the laparoscopic (0.2%) than open routes (1.3%).  This may reflect the 
greater level of surgical, and in particular laparoscopic, training that gynaecological 
oncologists currently undergo. 
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Paper 8: Cromwell D, Hilton P. Retrospective cohort study on patterns of care and 
outcomes of surgical treatment for lower urinary – genital tract fistula among 
English National Health Service hospitals between 2000 and 2009. BJU Int 2013; 
111(4b): E257-E262. 
 
Using the HES database, we demonstrated for the first time the pattern of care 
provided for urogenital fistula nationally within NHS hospitals in England.  Specifically, 
we explored the fistula workload of individual NHS hospitals and consultant teams 
(pseudonymised) over a 10-year period, and by linking individual patient records 
longitudinally over time, were able to determine treatment outcomes - using the 
‘need for re-operation’ as a marker for failure of the index procedure. 
The difficulty of defining success in fistula treatment has been discussed earlier (see 
page 12: Chapter 1 – Background literature - Outcomes of treatment for lower urinary 
tract fistula - Definition of cure).  Reported cure rates for surgical treatment vary with 
case mix, aetiology and surgical technique, in the range 45% to 100%.  Whilst many 
series do not report outcomes at all, where they are provided, high surgical success 
rates are often described in case series reported from individual surgeons or 
hospitals.  The recent Bodner-Adler et al., review, of VVF following benign 
gynaecological surgery, documented an overall success rate of 98.0% for surgical 
treatments (Bodner-Adler et al., 2017), with 81 of the 107 included studies reporting 
success in 100% of cases.  Despite this, only 6.4% of the 1379 included women were 
described as being completely symptom-free, only 55.5% completely dry, and only 
30.0% reported to be healed or cured.  The definition of failure used in our study – the 
need for a further repair operation or urinary diversion after an index repair 
procedure – whilst clearly not a sensitive measure of outcome, is perhaps the most 
specific available. 
Overall, 24% of women with a diagnosis of lower urinary-genital tract fistula 
underwent urinary diversion; this might be seen as a particularly high rate, given that 
only 2.7% of women in the candidate’s personal cohort underwent diversion (see 
earlier comments in relation to paper 3) (Hilton, 2012).  Equally concerning, 23% of 
consultant teams treating fistulas undertook no repairs at all during the study period, 
and apparently managed all their cases by urinary diversion.  Whilst it is possible that 
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these were all women with radiotherapy-associated fistulas, OPCS coding in HES does 
not include details of prior radiotherapy treatments.  Even if it were possible to 
identify prior radiotherapy as a possible causative factor for fistula by longitudinal 
linkage of records, the fact that fistula may arise anything up to 50 years after 
radiotherapy (Hilton, 2012), would make that approach unlikely to be informative. 
Even amongst those consultant teams that undertook fistula repair procedures, the 
workload could only be described as idiosyncratic, with 75% performing only one 
repair in the 10-year study period, and only 3 teams averaging more than 3 cases per 
year.  The relationship between workload and outcome is discussed earlier (see page 
10: Chapter 1 Background literature – Patterns of care – Non-obstetric fistula in high-
income countries).  We confirmed, for the first time, that such a relationship exists in 
fistula repair surgery, with hospitals undertaking more than 30 cases in 10 years (i.e. 
averaging more than 3 per year) having half the re-operation rate of those doing 
fewer procedures.  Re-operation rates were up to 50%, with 10 hospitals having rates 
more than twice the national average (11%), and one having a rate less than half the 
national average.  We also confirmed the finding of earlier reports (including our 
submitted papers 2 & 3) that the best prospect for success is with the primary 
procedure, with re-operation rates after first, second and third operations being 88%, 
71% and 65% respectively, again, strengthening the arguments for centralised 
management of fistulas; a maximum of 3 units in England would seem to be justified 
(NHS England, 2013). 
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Chapter 5: Further commentary on emerging trends in the 
aetiology of urogenital fistula3 
Recent trends in iatrogenic/surgical fistula 
In papers 6 and 7 we showed the risk of lower urinary-genital tract fistulas and 
ureteric injury after hysterectomy to have increased by 46% and 128%, respectively, 
between the early and later years of our study periods.  This trend has also been 
confirmed more recently in a conference abstract from the USA (Adam et al., 2015).  In 
paper 8, in addition to reporting on patterns of care, we also found a 68% increase in 
primary fistula repair procedures over a similar period. 
 
DRIVERS FOR RECENT TRENDS SEEN IN IATROGENIC FISTULAE IN HIGH-INCOME COUNTRIES 
Between 2000 and 2008, the total number of hysterectomy procedures in England fell 
by 12% and those for the main benign indications (excluding prolapse) fell by 27% 
(Hilton and Cromwell, 2012).  This was mainly a result of the fall in the number of 
hysterectomies for menorrhagia, a trend that has been ongoing since the mid-1990s 
(Reid and Mukri, 2005).  One explanation for the increase in risk of postoperative 
fistulas could therefore be an increase in the proportion of more difficult procedures 
among the remaining hysterectomies – the simpler operations having decreased 
disproportionately in number with increasing use of medical treatment for menstrual 
dysfunction.  The fact that we did not find the rate of fistula to be significantly higher 
in women undergoing an TAH for fibroids or endometriosis than in those with 
menstrual problems, makes this explanation unlikely, however.  Notwithstanding, this 
reduction in gynaecological surgical activity overall, the reduced length of trainees’ 
working week, and reduced years in training, all mean that trainees, in the UK at least, 
obtain less surgical experience now than previously, and may therefore embark on 
independent practice less prepared than a decade ago.   
                                               
3 Much of the material in this chapter comes from a ‘special contribution’ commissioned 
from the candidate by the journal editor.  Hilton, P. (2016) 'Trends in the aetiology of 
urogenital fistula: a case of 'retrogressive evolution'?', Int Urogynecol J, 27(6), pp. 831-7. 
Although peer reviewed, it is not included amongst the submitted papers since it does 
not strictly contain original material. 
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Recent trends in of ‘obstetric’ fistula 
There are no published longitudinal studies on trends in incidence of obstetric fistulae, 
although recent data suggest that there may be a reduction in new cases coming 
forward for treatment in Ethiopia (Wright et al., 2016).  There is however a growing 
perception that an increasing proportion of urogenital fistulae in LMICs are iatrogenic 
in aetiology, rather than being true ‘obstetric’ fistulae from ischaemic mechanisms.  
Although this impression relates primarily to obstetric interventions, especially 
caesarean section, iatrogenic fistulae are also seen increasingly following 
gynaecological procedures in some areas.   
A study of patients managed in the ‘Hamlin Fistula Ethiopia’ (HFE) hospital at 
Barhirdar between 2004 and 2007, found 36% to be type 1 on the Goh classification 
(i.e. more than 3.5cm from the external urinary meatus) (Goh et al., 2008).  In a further 
study of fistulae managed in three other of the six HFE hospitals, Wright and 
colleagues found the proportion classified as being ‘high’ (presumed to be of 
iatrogenic aetiology) increased from 27% to 36% between 2011 and 2015, albeit 
concurrently with a significant reduction in the annual number of referrals seen 
(Wright et al., 2016).  It should be noted however that the Goh classification is more 
appropriate for obstetric than iatrogenic fistulae (Goh, 2004), and neither the 
designation as ‘Goh type 1’ nor ‘high’ can be taken as an absolute indication of 
aetiology, both being likely to overstate the true proportion of iatrogenic cases. 
In a study of women managed in 65 facilities across 11 countries mainly in East Africa 
over an 18-year period, Raassen et al. found 13.2% of fistulas to be iatrogenic in nature 
(Raassen et al., 2014).  Waaldijk, with a personal experience of over 25,000 
conservative and surgical fistula treatments in over 20,000 women treated over three 
decades, reported 139 of his first 1,000 cases to have had a caesarean delivery in their 
index pregnancy, 55 (5.5%) of which were probably iatrogenic in aetiology; this 
compared to 380 of his last 1,000 cases, 163 (16.3%) of which were probably iatrogenic 
(Waaldijk, personal communication).  Hence, although the confirmation of the exact 
aetiology may not be wholly accurate, there is reasonable evidence of a 3-fold 
increase in the rate of iatrogenic fistulae over this period in Nigeria and Niger.  
Similarly, faculty surgeons from other fistula units in Nigeria (Lengmang, S. & Adeoye, 
S., personal communications), Kenya (Raassen, T. & Khisa, W., personal 
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communications), Uganda (Flynn, P., Bishop, M., Breen, M., Putman, J. & Duffy, S., 
personal communications), Ethiopia (Wright, J., & Browning, A., personal 
communication), Tanzania (Browning, A., personal communication), Sierra Leone 
(Maggi, D., personal communication) and Pakistan (Syed, S., personal communication) 
report an increasing number of post-caesarean section fistulae seen in recent years; 
although data are limited, such cases may now represent more than one third of 
fistulae seen in some areas. 
 
DRIVERS FOR RECENT TRENDS SEEN IN ‘OBSTETRIC’ FISTULA IN LOW-INCOME COUNTRIES 
Access to skilled maternity services and obstetric intervention 
The significance of obstructed labour as a contributory factor to maternal and 
perinatal mortality and morbidity is well established; the need to relieve obstruction in 
order to limit these consequences, including fistula formation, is well recognised.  In a 
recent statement, the WHO emphasised that whilst caesarean section can effectively 
prevent maternal and perinatal mortality and morbidity, when medically justified, 
there is no evidence of benefit for women or infants who do not require the 
procedure on medical grounds (World Health Organisation, 2015).  Caesarean section 
is associated with risks that can extend beyond the current delivery and are greater in 
women with limited access to comprehensive obstetric care (World Health 
Organisation, 2015).  The WHO statement also emphasises the imperative to provide 
caesarean sections to women in need, rather than striving to achieve any specific 
intervention rate.  In many resource-poor settings, access to skilled care and crucial 
interventions is limited, and the rate of caesarean delivery is a marker for the 
availability and use of obstetric services in these situations (WHO et al., 2009).  In a 
review of trends in caesarean section rate in Asia and sub-Saharan Africa, Cavallaro et 
al. point out the association between poverty and access to healthcare; although 
rates up to 22% were seen (especially in wealthier urban populations), among the 
poorest quintile of the population, caesarean sections accounted for less than 2% of 
deliveries in 21/26 countries studied (Cavallaro et al., 2013).  Hence, limited access to 
obstetric intervention is likely to remain a significant contributory factor in generating 
fistula, particularly amongst the rural poor.   
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The appropriate workforce 
There is a critical workforce shortage in many areas of the world, particularly in LMICs.  
This inevitably overstretches those staffs that are present and may contribute to 
patient abuse and neglect.  Caesarean section is often delegated to the most junior 
team member, often a doctor with minimal training, supervision or mentorship.  
Decision-making is often poor, and hence caesarean delivery may be undertaken in 
inappropriate cases, with inappropriate timing, and/or using inadequate surgical 
techniques.  Preoperative risk assessment is likely to be inadequate, with failure to 
recognise the increased risk of damage to the urinary tract (at caesarean section or 
hysterectomy) associated with a previous operative delivery (Duong and Patterson, 
2014; Oliphant et al., 2014).  In some areas financial incentives rather than clinical 
priorities may dictate the choice of mode of delivery, and indeed knowledge and 
experience of alternative ways of delivery, especially of a dead baby, are often 
lacking.  In the right circumstances emergency caesarean may be lifesaving, but when 
performed inappropriately it may increase maternal risk whilst being too late to 
improve perinatal outcome (Shah et al., 2009).  
Use of non-medically qualified clinical officers 
The training of non-medically qualified clinical officers (NMQCO) has been introduced 
into a number of LMICs to boost the available cadre of staff able to provide 
emergency obstetric care.  In 19 out of 47 sub-Saharan African countries, NMQCOs are 
authorised to provide obstetric care, and in five countries (Zaire, Burkina Faso, 
Malawi, Mozambique and Tanzania) are they permitted to carry out caesarean 
sections and other emergency obstetric surgery (Mullan and Frehywot, 2007).  The 
use of NMQCOs in providing major obstetric surgery has been found to be cost-saving 
in Mozambique (Kruk et al., 2007), with no significant difference in outcomes 
compared to medical officers in Tanzania (McCord et al., 2009), and Malawi (Chilopora 
et al., 2007).  In a meta-analysis of data from 16,018 women in six non-randomised 
controlled cohort studies, Wilson et al. also reported no difference in mortalities, 
although they did find an increase in postoperative complications (Wilson et al., 2011).  
None of these studies have reported comparative outcomes for more senior doctors, 
nor have they included data on fistulae specifically.  
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The appropriate working environment 
Whilst taken for granted in HICs, a safe and equipped working environment is crucial 
to minimising risk during surgery and is often lacking in LMICs.  Electricity supplies for 
lighting and equipment are often unreliable and running water for scrubbing and 
sterilisation processes may be inconsistent.  Instruments are often unavailable or in 
need of repair, and in keeping with the workforce issue highlighted above, skilled 
assistance for retraction is often unavailable.  Getting access to theatre may be 
especially problematic at night: the difficulties of finding appropriate staff and 
equipment are even greater; this adds to delays in preparing the theatre; in some 
areas patients’ families may be charged with leaving the hospital to purchase drugs 
and materials from off-site pharmacies before an operation can begin.  These are all 
contributors to ‘Maine’s third delay’ (Thaddeus and Maine, 1991), and can mean that 
the ‘decision to delivery interval’ may be measured in days rather than minutes in 
some areas.   
POST-CAESAREAN SECTION FISTULA – TRAUMATIC OR ISCHAEMIC?  
Incontrovertibly, a woman neglected in obstructed labour for several days, ultimately 
delivering a stillborn infant vaginally, then surviving to develop a VVF, should be 
described as having a ‘true obstetric’ or ischaemic fistula.  In contrast, a woman 
identified as being in obstructed labour who is transferred expeditiously to a 
healthcare facility for timely caesarean section, who is delivered of a live infant, and 
then goes on to develop a vesicocervical fistula, would be reasonably described as 
having an iatrogenic injury.  But what of those women who are transferred only after 
considerable delay, or who undergo caesarean section for a dead baby and then 
develop a VVF?  Or those who undergo caesarean section but then develop an 
urethrovaginal fistula or a mid-vaginal VVF or an ureterovaginal fistula?   Should these 
lesions be looked on as ‘obstetric’, iatrogenic, or a combination? 
In Tanzania it is reported that 85% of patients developing fistula now deliver in 
hospital, usually by caesarean section, with an increasing rate of vesicocervical and 
vesico-uterine (probably iatrogenic) fistulae (Browning, A. - personal communication).  
Onsrud et al., also reported a higher rate of uterine or cervical involvement, with less 
surrounding fibrosis, and less apparent treatment delay in post-caesarean section 
fistulae in Democratic Republic of Congo (DRC) (Onsrud et al., 2011).  They considered 
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these to be a distinct clinical (iatrogenic) entity and highlighted the training issues 
discussed above.  Loposso et al. similarly highlighted the risks of fistula in DRC despite 
the availability of caesarean section, but attributed this to the duration of obstructed 
labour prior to hospitalisation, and the delay in achieving caesarean delivery (Loposso 
et al., 2015).  The various colleagues with whom I have discussed this issue (vide supra - 
personal communications from Nigeria, Kenya, Uganda, Ethiopia, Tanzania, Sierra 
Leone and Pakistan), give a range of views on the point.  Hence, it is likely in different 
circumstances fistulae following caesarean section may have varying 
pathophysiology, some being wholly ischaemic, some wholly traumatic, but most a 
combination of mechanisms.   
Similar arguments may be framed around post-caesarean section ureterovaginal 
fistulae.  Although these are commonly looked on as being exclusively iatrogenic in 
aetiology, operating on, or close to, the ureter within an ischaemic field defect 
inevitably puts it at greater risk, and means that ureterovaginal fistula developing 
after caesarean section for obstructed labour is also likely to be at least in part 
ischaemic in nature. 
With the increased use of caesarean section, and consequent increase in ‘repeat’ 
procedures, the rate of placenta praevia and associated abnormal placental 
implantation will continue to rise (Silver et al., 2006; Johnston et al., 2011; Zuarez-
Easton et al., 2015).  Given the technical difficulties of surgery in these circumstances, 
we might also anticipate a progressive increase in the rate of fistula following 
caesarean section.  Although the association has been reported (Mann et al., 2013), a 
trend is not yet evident, and in the author’s own series from the UK, fistula following 
caesarean section or trial of attempted vaginal birth after caesarean (VBAC) have 
consistently represented 6%-8% of cases referred over the last three decades (Hilton, 
2012).  
How might one obtain further information to confirm or refute these impressions?  
Throughout history the establishment of causality in medicine has proved elusive 
(Feezer, 1921; Evans, 1978) and the confirmation of secular trends in causality presents 
even greater challenges.  Difficult as these issues have been to establish in the 
context of infectious diseases (Evans, 1976), they take on a completely different 
magnitude with a problem as complex as obstetric fistula, given its physical, bio-
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social, cultural, economic and geo-political contributors.  Data collection is clearly 
important, but even such powerful tools as the Demographic and Health Surveys 
Program can provide only a small proportion of the information needed to fully 
investigate these issues (Johnson and Peterman, 2008; Demographic and Health 
Surveys, 2018).  Almost all of the United Nations Millennium Development Goals 
potentially impact on the causation and management of fistula (United Nations 
General Assembly, 2000), and yet there remain substantial gaps in our achievement of 
these goals (United Nations, 2015).  Given a worldwide fistula prevalence of up to 
3,500,000(Muleta et al., 2012), and incidence up to 1 in 800 births (Vangeenderhuysen 
et al., 2001), there is clearly much to be done before we can claim to be effectively 
managing and preventing this condition.   
Hence, it appears that with more widespread understanding of the causes of obstetric 
fistulae in LMICs, and increasing rates of caesarean section, there is an increase in VVF 
and ureterovaginal fistulae that may be at least in part iatrogenic in nature.  We have 
also provided evidence to support the possibility of an increase in the incidence of 
iatrogenic (post-hysterectomy) fistulae in HICs, which coincides with a decrease in the 
number of hysterectomies carried out.  In the first case this may reflect the amount of 
training, supervision and support provided to trainees; in the second it may reflect the 
amount of surgical experience accrued in training and workload in independent 
practice.  In both situations it behoves governments and educational authorities to 
invest in training and workforce planning, and to facilitate audit and operational 
research, so that an appropriately trained and supervised medical workforce is 
maintained in the correct working environment.  Alternatively, so that the right 
people, do the right thing, at the right time, and in the right place (NHS England, 
2014a).   
  
 152 
  
 153 
References 
Abrams, P., de Ridder, D., de Vries, C., Elneil, S., Esegbona, G., Mouread, S. and Muleta, M. 
(2012) ICUD-SIU 1st International Consultation on Obstetric Fistula in the Developing World. 
Montreal, Canada: Societe Internationale d'Urologie. 
Abrams, P. and Hilton, P. (2002) 'Discussion on Urogenital Fistulae', in Maclean, A. and 
Cardozo, L. (eds.) Incontinence in Women - proceedings of the 42nd RCOG Study Group. 
London: RCOG, pp. 199-201. 
Abrams, P. and Khoury, S. (2010) 'International Consultation on Urological Diseases: 
Evidence-based medicine overview of the main steps for developing and grading 
guideline recommendations', Neurourology & Urodynamics, 29(1), pp. 116-118. 
Adam, R.A., Graves, A., Ni, S. and McPheeters, M. (2015) 'Time trends in post-
hysterectomy vesicovaginal fistula and lower urinary tract injury', Journal of Minimally 
Invasive Gynecology, 22, pp. S7-S8 (abstract). 
Adler, A.J., Ronsmans, C., Calvert, C. and Filippi, V. (2013) 'Estimating the prevalence of 
obstetric fistula: a systematic review and meta-analysis', BMC Pregnancy Childbirth, 13, p. 
246. 
Aimakhu, V.E. (1974) 'Reproductive functions after the repair of obstetric vesicovaginal 
fistulae', Fertility & Sterility, 25(7), pp. 586-591. 
Altman, D., Forsgren, C., Hjern, F., Lundholm, C., Cnattingius, S. and Johansson, A.L. 
(2010) 'Influence of hysterectomy on fistula formation in women with diverticulitis', Br J 
Surg, 97(2), pp. 251-7. 
Bangser, M., Mehta, M., Singer, J., Daly, C., Kamugumya, C. and Mwangomale, A. (2011) 
'Childbirth experiences of women with obstetric fistula in Tanzania and Uganda and their 
implications for fistula program development', International Urogynecology Journal & 
Pelvic Floor Dysfunction, 22(1), pp. 91-98. 
Barone, M.A., Widmer, M., Arrowsmith, S., Ruminjo, J., Seuc, A., Landry, E., Barry, T.H., 
Danladi, D., Djangnikpo, L., Gbawuru-Mansaray, T., Harou, I., Lewis, A., Muleta, M., 
Nembunzu, D., Olupot, R., Sunday-Adeoye, I., Wakasiaka, W.K., Landoulsi, S., Delamou, A., 
 154 
Were, L., Frajzyngier, V., Beattie, K. and Gulmezoglu, A.M. (2015) 'Breakdown of simple 
female genital fistula repair after 7 day versus 14 day postoperative bladder 
catheterisation: a randomised, controlled, open-label, non-inferiority trial', Lancet, 
386(9988), pp. 56-62. 
Bazi, T. (2007) 'Spontaneous closure of vesicovaginal fistulas after bladder drainage 
alone: Review of the evidence', International Urogynecology Journal & Pelvic Floor 
Dysfunction, 18(3), pp. 329-333. 
Bird, G.C. (1967) 'Obstetric vesicovaginal and allied fistulae: a report on 70 cases', Journal 
of Obstetrics Journal of Obstetrics & Gynaecology of the British Commonwealth, 74, pp. 749-
752. 
Bodner-Adler, B., Hanzal, E., Pablik, E., Koelbl, H. and Bodner, K. (2017) 'Management of 
vesicovaginal fistulas (VVFs) in women following benign gynaecologic surgery: A 
systematic review and meta-analysis', PLoS One, 12(2), p. e0171554. 
Brandes, S., Coburn, M., Armenakas, N. and McAninch, J. (2004) 'Diagnosis and 
management of ureteric injury: an evidence-based analysis', BJU International, 94(3), pp. 
277-89. 
Bristol Urological Institute (2014) International Concultation on Incontinence Modular 
Questionnaire (ICIQ). Available at: http://www.iciq.net (Accessed: 4/5/2014). 
Brookes, S., Donovan, J., Wright, M., Jackson, S. and Abrams, P. (2004) 'A scored form of 
the Bristol Lower Urinary Tract Symptoms questionnaire: data from a randomized 
controlled trial of surgery for women with stress incontinence', American Journal of 
Obstetrics & Gynecology, 191(1), pp. 73-82. 
Browning, A. and Menber, B. (2008) 'Women with obstetric fistula in Ethiopia: a 6-month 
follow up after surgical treatment', BJOG: an International Journal of Obstetrics & 
Gynaecology, 115(12), pp. 1564-1569. 
Cavallaro, F.L., Cresswell, J.A., Franca, G.V., Victora, C.G., Barros, A.J. and Ronsmans, C. 
(2013) 'Trends in caesarean delivery by country and wealth quintile: cross-sectional 
surveys in southern Asia and sub-Saharan Africa', Bulletin of the World Health 
Organisation, 91(12), pp. 914-922D. 
 155 
Chilopora, G., Pereira, C., Kamwendo, F., Chimbiri, A., Malunga, E. and Bergstrom, S. 
(2007) 'Postoperative outcome of caesarean sections and other major emergency 
obstetric surgery by clinical officers and medical officers in Malawi', Human Resources for 
Health, 5, p. 17. 
Danso, K.A., Martey, J.O., Wall, L.L. and Elkins, T.E. (1996) 'The epidemiology of 
genitourinary fistulae in Kumasi, Ghana, 1977-1992', International Urogynecology Journal & 
Pelvic Floor Dysfunction, 7(3), pp. 117-120. 
de Bernis, L. (2007) 'Obstetric fistula: guiding principles for clinical management and 
programme development, a new WHO guideline', International Journal of Gynaecology & 
Obstetrics, 99 Suppl 1, pp. S117-21. 
de Ridder, D., Abubakar, A., Raassen, T., Tafesse, B. and Waaldijk, K. (2012) 'Surgical 
treatment of obstetric fistula', in Abrams, P., de Ridder, D., de Vries, C., Elneil, S., 
Esegbona, G., Mouread, S. and Muleta, M. (eds.) ICUD-SIU 1st International Consultation on 
Obstetric Fistula in the Developing World. Montreal, Canada: Societe Internationale 
d'Urologie, pp. 87-122. 
de Ridder, D., Hilton, P., Mourad, S., Pickard, R.S., Rovner, E.S. and Stanford, E. (2013) 
'Fistulae', in Abrams, P., Cardozo, L.D. and Wein, A. (eds.) Incontinence – ICUD-EAU 5th  
International Consultation on Incontinence. Geneva, Switzerland: EAU Publications, pp. 
1527-1579. 
de Vries, C., Emasu, A., Bangser, M., Cochran, S., Lengmang, S., Lusi, L. and Kirya, F. (2012) 
'Vesicovaginal fistula prevention', in Abrams, P., de Ridder, D., de Vries, C., Elneil, S., 
Esegbona, G., Mouread, S. and Muleta, M. (eds.) ICUD-SIU 1st International Consultation on 
Obstetric Fistula in the Developing World. Montreal, Canada: Societe Internationale 
d'Urologie, pp. 41-58. 
Demographic and Health Surveys (2018) The DHS Program. Available at: 
http://dhsprogram.com (Accessed: 07/09/2018). 
Department of Health (2018) 'Hospital Episode Statistics'. 3/5/2018. Department of Health. 
Available at: https://digital.nhs.uk/data-and-information/data-tools-and-services/data-
services/hospital-episode-statistics#section-3. 
 156 
Desalliers, J., Pare, M.E., Kouraogo, S. and Corcos, J. (2017) 'Impact of surgery on quality 
of life of women with obstetrical fistula: a qualitative study in Burkina Faso', Int 
Urogynecol J, 28(7), pp. 1091-1100. 
Dolan, L., Easwaran, S. and Hilton, P. (2004) 'Congenital vesicovaginal fistula in 
association with hypoplastic kidney and uterus didelphys', Urology, 63(1), pp. 175-177. 
Dolan, L.M. and Hilton, P. (2010) 'Obstetric risk factors and pelvic floor dysfunction 20 
years after first delivery', International Urogynecology Journal & Pelvic Floor Dysfunction, 
21(5), pp. 535-544. 
Donnelly, K., Oliveras, E., Tilahun, Y., Belachew, M. and Asnake, M. (2015) 'Quality of life of 
Ethiopian women after fistula repair: implications on rehabilitation and social 
reintegration policy and programming', Cult Health Sex, 17(2), pp. 150-64. 
Duong, T.H. and Patterson, T.M. (2014) 'Lower urinary tract injuries during hysterectomy 
in women with a history of two or more cesarean deliveries: a secondary analysis', 
International Urogynecology Journal & Pelvic Floor Dysfunction, 25(8), pp. 1037-1040. 
Duong, T.H., Taylor, D.P. and Meeks, G.R. (2011) 'A multicenter study of vesicovaginal 
fistula following incidental cystotomy during benign hysterectomies', International 
Urogynecology Journal, 22(8), pp. 975-9. 
Ekwedigwe, K.C., Isikhuemen, M.E., Sunday-Adeoye, I., Yakubu, E.N. and Eliboh, M.O. 
(2017) 'Bladder spasm following urogenital fistula repair', Int J Gynaecol Obstet, 138(3), pp. 
299-303. 
Elkadry, E.A., Kenton, K.S., FitzGerald, M.P., Shott, S. and Brubaker, L. (2003) 'Patient-
selected goals: a new perspective on surgical outcome', American Journal of Obstetrics & 
Gynecology, 189(6), pp. 1551-7. 
Evans, A.S. (1976) 'Causation and disease: the Henle-Koch postulates revisited', Yale 
Journal of  Biology and  Medicine, 49(2), pp. 175-195. 
Evans, A.S. (1978) 'Causation and disease: a chronological journey. The Thomas Parran 
Lecture', American Journal of Epidemiology, 108(4), pp. 249-258. 
 157 
Feezer, L.W. (1921) 'Theories concerning the casusation of disease', American Journal of 
Public Health, 11(10), pp. 908-912. 
Fistula Foundation, Direct Relief and UNFPA (2018) Global Fistula Map. Available at: 
https://www.globalfistulamap.org (Accessed: 28/8/2018). 
Forsgren, C. and Altman, D. (2010) 'Risk of pelvic organ fistula in patients undergoing 
hysterectomy', Current Opinion in Obstetrics & Gynecology, 22(5), pp. 404-7. 
Forsgren, C., Lundholm, C., Johansson, A.L., Cnattingius, S. and Altman, D. (2009) 
'Hysterectomy for benign indications and risk of pelvic organ fistula disease', Obstetrics & 
Gynecology, 114(3), pp. 594-9. 
Goh, J., Stanford, E.J. and Genadry, R. (2009) 'Classification of female genito-urinary tract 
fistula: a comprehensive review', International Urogynecology Journal & Pelvic Floor 
Dysfunction, 20(5), pp. 605-610. 
Goh, J.T., Browning, A., Berhan, B. and Chang, A. (2008) 'Predicting the risk of failure of 
closure of obstetric fistula and residual urinary incontinence using a classification system', 
International Urogynecology Journal & Pelvic Floor Dysfunction, 19(12), pp. 1659-1662. 
Goh, J.T., Krause, H., Tessema, A.B. and Abraha, G. (2013) 'Urinary symptoms and 
urodynamics following obstetric genitourinary fistula repair', Int Urogynecol J, 24(6), pp. 
947-51. 
Goh, J.T.W. (2004) 'A New Classification for female genital tract fistula', Australian & New 
Zealand Journal of Obstetrics & Gynaecology, 44, pp. 502-504. 
Gray, P.H. (1970) 'Obstetric vesicovaginal fistulas', American Journal of Obstetrics & 
Gynecology, 107(6), pp. 898-901. 
Hadley, R., Myers, R.C. and Ruckle, H.C. (1994) 'Do unplanned cystotomies during vaginal 
operative procedures lead to vesicovaginal fistulae or other complications?', International 
Urogynecology Journal & Pelvic Floor Dysfunction, 5(2), pp. 66-68. 
Halm, E.A., Lee, C. and Chassin, M.R. (2002) 'Is volume related to outcome in health care? 
A systematic review and methodologic critique of the literature', Annals of Internal 
Medicine, 137(6), pp. 511-20. 
 158 
Harkki-Siren, P., Sjoberg, J. and Tiitinen, A. (1998) 'Urinary tract injuries after 
hysterectomy', Obstetrics & Gynecology, 92, pp. 113-118. 
Hillary, C.J., Osman, N.I., Hilton, P. and Chapple, C.R. (2016) 'The aetiology, treatment and 
outcome of urogenital fistulae managed in well- and low-resourced countries: a 
systematic review', European Urology, 70(3), pp. 478-492. 
Hilton, P. (1990) 'Female urethral pressure profilometry', in O'Reilly, P.H., George, N.J.R. 
and Weiss, R.M. (eds.) Diagnostic Techniques in Urology. Pennsylvania: W.B.Saunders, pp. 
309-335. 
Hilton, P. (1997) 'Debate: 'Post-operative urinary fistulae should be managed by 
gynaecologists in specialist centres'', British Journal of Urology Supplement, 80(1), pp. 35-
42. 
Hilton, P. (2001) 'Surgical fistulae', in Cardozo, L. and Staskin, D. (eds.) Female Urology and 
Urogynaecology. 1st edn. London: Isis Medical Media, pp. 691-709. 
Hilton, P. (2002) 'Trials of surgery for stress incontinence - thoughts on the 'Humpty 
Dumpty principle'', BJOG: an International Journal of Obstetrics & Gynaecology, 109, pp. 
1081-1088. 
Hilton, P. (2003) 'Vesico-vaginal fistulas in developing countries', International Journal of 
Gynaecology & Obstetrics, 82(3 - World Report on Women's Health), pp. 285-295. 
Hilton, P. (2008) 'Long-term follow up studies in pelvic floor dysfunction: the Holy Grail or 
a realistic aim?', BJOG: an International Journal of Obstetrics & Gynaecology, 115(2), pp. 135-
143. 
Hilton, P. (2012) 'Urogenital fistula in the UK - a personal case series managed over 25 
years', BJU International, 110(1), pp. 102-110. 
Hilton, P. (2016) 'Trends in the aetiology of urogenital fistula: a case of 'retrogressive 
evolution'?', Int Urogynecol J, 27(6), pp. 831-7. 
Hilton, P., Armstrong, N., Brennand, C., Howel, D., Shen, J., Bryant, A., Tincello, D.G., 
Lucas, M.G., Buckley, B.S., Chapple, C.R., Homer, T., Vale, L., McColl, E. and on behalf of 
the INVESTIGATE studies group (2015) 'INVESTIGATE-I (INVasive Evaluation before 
 159 
Surgical Treatment of Incontinence Gives Added Therapeutic Effect?): a mixed methods 
study to assess the feasibility of a future randomised controlled trial of invasive 
urodynamic testing prior to surgery for stress urinary incontinence in women', Health 
Technology Assessment Journal, 19(15). 
Hilton, P. and Cromwell, D. (2012) 'The risk of vesicovaginal and urethrovaginal fistula 
after hysterectomy performed in the English National Health Service  - a retrospective 
cohort study examining patterns of care between 2000 and 2008', BJOG: an International 
Journal of Obstetrics & Gynaecology, 119(12), pp. 1447-1454. 
Hilton, P. and Robinson, D. (2011) 'Defining cure', Neurourology & Urodynamics, 30(5), pp. 
741-745. 
Hilton, P. and Rose, K. (2016) 'The "learning curve" for retropubic mid-urethral sling 
procedures: a retrospective cohort study', International Urogynecology Journal & Pelvic 
Floor Dysfunction, 27(4), pp. 565-70. 
Hilton, P. and Ward, A. (1998) 'Epidemiological and surgical aspects of urogenital fistulae: 
a review of 25 years' experience in southeast Nigeria', International Urogynecology Journal 
& Pelvic Floor Dysfunction, 9(4), pp. 189-194. 
Holmgren, C., Nilsson, S., Lanner, L. and Hellberg, D. (2005) 'Long-term results with 
tension-free vaginal tape on mixed and stress urinary incontinence', Obstet Gynecol, 
106(1), pp. 38-43. 
Howick, J., Chalmers, I., Glasziou, P., Greenhalgh, T., Heneghan, C., Liberati, A., Moschetti, 
I., Phillips, B. and Thornton, H. (2011a) The 2011 Oxford CEBM Levels of Evidence 
(Introductory Document). Available at: https://www.cebm.net/index.aspx?o=5653. 
Howick, J., Chalmers, I., Glasziou, P., Greenhalgh, T., Heneghan, C., Liberati, A., Moschetti, 
I., Phillips, B. and Thornton, H. (2011b) Explanation of the 2011 Oxford Centre for Evidence-
Based Medicine (OCEBM) Levels of Evidence (Background Document). Available at: 
https://www.cebm.net/index.aspx?o=5653. 
Ibrahim, T., Sadiq, A. and Daniel, S. (2000) 'Characteristics of VVF patients as seen at the 
specialist hospital Sokoto, Nigeria.', West African Medical Journal, 19(1), pp. 59-63. 
 160
Imoto, A., Matsuyama, A., Ambauen-Berger, B. and Honda, S. (2015) 'Health-related 
quality of life among women in rural Bangladesh after surgical repair of obstetric fistula', 
Int J Gynaecol Obstet, 130(1), pp. 79-83. 
Jackson, S., Donovan, J., Brookes, S., Eckford, S., Swithinbank, L. and Abrams, P. (1996) 
'The Bristol Female Lower Urinary Tract Symptoms Questionnaire: Development and 
psychometric testing', BJU International, 77, pp. 805-812. 
Johnson, K. and Peterman, A. (2008) Incontinence data from the Demographic and Health 
Surveys: comparative analysis of a proxy measurement of vaginal fistula and 
recommendations for future population-based data collection. Calverton, Maryland, USA: 
Macro International Inc. 
Johnston, T.A., Paterson-Brown, S. and Guidelines Committee of the RCOG (2011) Placenta 
Praevia, Placenta Praevia Accreta and Vasa Praevia: Diagnosis and Management.  Green-top 
Guideline no. 27. London: RCOG. [Online]. Available at: 
https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_27.pdf. 
Kalilani-Phiri, L.V., Umar, E., Lazaro, D., Lunguzi, J. and Chilungo, A. (2010) 'Prevalence of 
obstetric fistula in Malawi', International Journal of Gynaecology & Obstetrics, 109(3), pp. 
204-8. 
Kelly, J. and Kwast, B. (1993a) 'Epidemiologic study of vesico-vaginal fistula in Ethiopia', 
International Urogynecology Journal & Pelvic Floor Dysfunction, 4, pp. 278-281. 
Kelly, J. and Kwast, B. (1993b) 'Obstetric vesicovaginal fistulas: Evaluation of failed 
repairs', International Urogynecology Journal & Pelvic Floor Dysfunction, 4, pp. 271-273. 
Kruk, M.E., Pereira, C., Vaz, F., Bergstrom, S. and Galea, S. (2007) 'Economic evaluation of 
surgically trained assistant medical officers in performing major obstetric surgery in 
Mozambique', BJOG: an International Journal of Obstetrics & Gynaecology, 114(10), pp. 1253-
1260. 
Kuuva, N. and Nilsson, C.G. (2002) 'A nationwide analysis of complications associated with 
the tension-free vaginal tape (TVT) procedure', Acta Obstetrica et Gynecologica 
Scandinavica, 81(1), pp. 72-7. 
 161 
Langkilde, N.C., Pless, T.K., Lundbeck, F. and Nerstrom, B. (1999) 'Surgical repair of 
vesicovaginal fistulae--a ten-year retrospective study', Scandinavian Journal of Urology & 
Nephrology, 33(2), pp. 100-103. 
Lawson, J.B. (1968) 'Birth canal injuries', Proceedings of the Royal Society of Medicine, 61, 
pp. 22-24. 
Lawson, J.B. (1978) 'The management of genito-urinary fistulae', Clinics in Obstetrics and 
Gynaecology, 6, pp. 209-236. 
Lebret, T., Lugagne, P.M., Herve, J.M., Barre, P., Orsoni, J.L., Yonneau, L., Saporta, F. and 
Botto, H. (2001) 'Evaluation of tension-free vaginal tape procedure. Its safety and efficacy 
in the treatment of female stress urinary incontinence during the learning phase', 
European Urology, 40(5), pp. 543-547. 
Lee, R.A., Symmonds, R.E. and Williams, T.J. (1988) 'Current status of genitourinary 
fistula', Obstetrics & Gynecology, 72(3 Pt 1), pp. 313-9. 
Leonard, T.M. (2006) Encyclopedia of the Developing World. (3 vols). New York: Taylor & 
Francis. 
Likic, I.S., Kadija, S., Ladjevic, N.G., Stefanovic, A., Jeremic, K., Petkovic, S. and Dzamic, Z. 
(2008) 'Analysis of urologic complications after radical hysterectomy', American Journal 
of Obstetrics & Gynecology, 199(6), pp. 644.e1-3. 
Loposso, M.N., Ndundu, J., De Win, G., Ost, D., Punga, A.M. and De Ridder, D. (2015) 
'Obstetric fistula in a district hospital in DR Congo: Fistula still occur despite access to 
caesarean section', Neurourology & Urodynamics, 34(5), pp. 434-437. 
Maguire, T., Mayne, C.J., Terry, T. and Tincello, D.G. (2013) 'Analysis of the surgical 
learning curve using the cumulative sum (CUSUM) method', Neurourology & Urodynamics, 
32(7), pp. 964-7. 
Malde, S., Spilotros, M., Wilson, A., Pakzad, M., Hamid, R., Ockrim, J., Shah, P.J. and 
Greenwell, T. (2017) 'The uses and outcomes of the Martius fat pad in female urology', 
World Journal of Urology, 35(3), pp. 473-478. 
 162 
Mann, S., Dahiya, P., Mann, A. and Madan, S. (2013) 'Uterovesicovaginal fistula following 
placenta percreta: case review and management options', Urogynaecologia, 27, p. e2. 
Manuel, G. and Posluns, M. (1974) The Fourth World: An Indian Reality. University of 
Michigan, Free Press. 
Mathevet, P., Valencia, P., Cousin, C., Mellier, G. and Dargent, D. (2001) 'Operative injuries 
during vaginal hysterectomy', European Journal of Obstetrics, Gynecology, & Reproductive 
Biology, 97(1), pp. 71-5. 
McCord, C., Mbaruku, G., Pereira, C., Nzabuhakwa, C. and Bergstrom, S. (2009) 'The 
quality of emergency obstetrical surgery by assistant medical officers in Tanzanian district 
hospitals', Health Affairs, 28(5), pp. 876-885. 
McLennan, M.T. and Melick, C.F. (2005) 'Bladder perforation during tension-free vaginal 
tape procedures: analysis of learning curve and risk factors', Obstetrics & Gynecology, 
106(5 Pt 1), pp. 1000-4. 
McPherson, K., Metcalfe, M.A., Herbert, A., Maresh, M., Casbard, A., Hargreaves, J., 
Bridgman, S. and Clarke, A. (2004) 'Severe complications of hysterectomy: the VALUE 
study', BJOG, 111(7), pp. 688-94. 
Meeks, G.R., Sams, J.O., Field, K.W., Fulp, K.S., Margolis, M.T. and Schneider, G.T. (1997) 
'Formation of vesicovaginal fistula: The role of suture placement into the bladder during 
closure of the vaginal cuff after transabdominal hysterectomy', American Journal of 
Obstetrics and Gynecology, 177(6), pp. 1298-1304. 
Mehra, S., Bokaria, R., Gujral, A., Bhat, V. and Hotchandani, M. (1996) 'Experience in 
laparoscopic hysterectomy: analysis of three hundred cases', Annals of the Academy of 
Medicine, Singapore, 25(5), pp. 660-664. 
Moir, J.C. (1967) The vesico-vaginal fistula. 2nd edn. London: Balliere. 
Moir, J.C. (1973) 'Vesico-vaginal fistulae as seen in Britain', BJOG: an International Journal 
of Obstetrics & Gynaecology, 80(7), pp. 598-602. 
Mourad, S., Haruna, M., Hilton, P., Saafan, A., Shaker, H. and Vasan, S. (2012) 
'Complications of fistula surgery', in Abrams, P., de Ridder, D., de Vries, C., Elneil, S., 
 163 
Esegbona, G., Mouread, S. and Muleta, M. (eds.) ICUD-SIU 1st International Consultation on 
Obstetric Fistula in the Developing World. Montreal, Canada: Societe Internationale 
d'Urologie, pp. 123-176. 
Mukwege, D. and Berg, M. (2016) 'A Holistic, Person-Centred Care Model for Victims of 
Sexual Violence in Democratic Republic of Congo: The Panzi Hospital One-Stop Centre 
Model of Care', PLoS Med, 13(10), p. e1002156. 
Mukwege, D.M., Mohamed-Ahmed, O. and Fitchett, J.R. (2010) 'Rape as a strategy of war 
in the Democratic Republic of the Congo', Int Health, 2(3), pp. 163-4. 
Mukwege, D.M. and Nangini, C. (2009) 'Rape with extreme violence: the new pathology 
in South Kivu, Democratic Republic of Congo', PLoS Med, 6(12), p. e1000204. 
Muleta, M., Ahmed, S., Arrowsmith, S. and Kiserud, T. (2012) 'Epidemiology of obstetric 
fistula', in Abrams, P., de Ridder, D., de Vries, C., Elneil, S., Esegbona, G., Mouread, S. and 
Muleta, M. (eds.) ICUD-SIU 1st International Consultation on Obstetric Fistula in the 
Developing World. Montreal, Canada: Societe Internationale d'Urologie, pp. 1-40. 
Muleta, M., Fantahun, M., Tafesse, B., Hamlin, E.C. and Kennedy, R.C. (2007) 'Obstetric 
fistula in rural Ethiopia', East African Medical Journal, 84(11), pp. 525-33. 
Muleta, M., Rasmussen, S. and Kiserud, T. (2010a) 'Obstetric fistula in 14,928 Ethiopian 
women', Acta Obstetricia et Gynecologica Scandinavica, 89(7), pp. 945-51. 
Muleta, M., Tafesse, B. and Aytenfisu, H.G. (2010b) 'Antibiotic use in obstetric fistula 
repair: single blinded randomized clinical trial', Ethiop Med J, 48(3), pp. 211-7. 
Mullan, F. and Frehywot, S. (2007) 'Non-physician clinicians in 47 sub-Saharan African 
countries', Lancet, 370(9605), pp. 2158-2163. 
Murphy, M. (1981) 'Social consequences of vesico-vaginal fistula in Northern Nigeria', 
Journal of Biosocial Sciences, 13, pp. 139-150. 
Murray, C., Goh, J.T., Fynes, M. and Carey, M.P. (2002) 'Urinary and faecal incontinence 
following delayed primary repair of obstetric genital fistula', BJOG : an international 
journal of obstetrics and gynaecology, 109(7), pp. 828-832. 
 164
Nardos, R., Menber, B. and Browning, A. (2012) 'Outcome of obstetric fistula repair after 
10-day versus 14-day Foley catheterization', International Journal of Gynaecology & 
Obstetrics, 118(1), pp. 21-23. 
National Oesophago-Gastric Cancer Audit (2010) Third Annual Report. Leeds: NHS 
Information Centre. 
Ndiaye, P., Amoul Kini, G., Adama, F., Idrissa, A. and Tal-Dia, A. (2009) '[Obstetric 
urogenital fistula (OUGF): cost analysis at the Niamey National Hospital (Niger)]', Revue d 
Epidemiologie et de Sante Publique, 57(5), pp. 374-9. 
Neuman, M. (2004) 'Tension-free vaginal tape bladder penetration and long-lasting 
transvesical prolene material', Journal of Pelvic Medicine & Surgery, 10(6), pp. 307-309. 
NHS England (2013) NHS Standard contract for complex gynaecology: urinary fistulae. NHS 
Commissioning Board (now NHS England). Available at: https://www.england.nhs.uk/wp-
content/uploads/2013/06/e10-comp-gynae-urin-fistulae.pdf (Accessed: 23/08/2018). 
NHS England (2014a) Commissioning for carers: Principles and resources to support 
effective commissioning for adult and young carers. Leeds: NHS England. [Online]. 
Available at: https://www.england.nhs.uk/commissioning/wp-
content/uploads/sites/12/2014/12/comm-carers-princ-091214.pdf. 
NHS England (2014b) Five year forward view. UK: NHS England. [Online]. Available at: 
https://www.england.nhs.uk/wp-content/uploads/2014/10/5yfv-web.pdf (Accessed: 
23/8/2018). 
Nieboer, T.E., Johnson, N., Lethaby, A., Tavender, E., Curr, E., Garry, R., van Voorst, S., 
Mol, B.W. and Kluivers, K.B. (2009) 'Surgical approach to hysterectomy for benign 
gynaecological disease', Cochrane Database Syst Rev, (3), p. CD003677. 
Ockrim, J.L., Greenwell, T.J., Foley, C.L., Wood, D.N. and Shah, P.J. (2009) 'A tertiary 
experience of vesico-vaginal and urethro-vaginal fistula repair: factors predicting success', 
BJU Int, 103(8), pp. 1122-6. 
 165 
Oliphant, S.S., Bochenska, K., Tolge, M.E., Catov, J.M. and Zyczynski, H.M. (2014) 
'Maternal lower urinary tract injury at the time of Cesarean delivery', International 
Urogynecology Journal & Pelvic Floor Dysfunction, 25(12), pp. 1709-1714. 
Onolemhemhen, D.O. and Ekwempu, C.C. (1999) 'An investigation of sociomedical risk 
factors associated with vaginal fistula in northern Nigeria', Women & Health, 28(3), pp. 
103-116. 
Onsrud, M., Sjoveian, S., Luhiriri, R. and Mukwege, D. (2008) 'Sexual violence-related 
fistulas in the Democratic Republic of Congo', Int J Gynaecol Obstet, 103(3), pp. 265-9. 
Onsrud, M., Sjoveian, S. and Mukwege, D. (2011) 'Cesarean delivery-related fistulae in the 
Democratic Republic of Congo', International Journal of Gynaecology & Obstetrics, 114(1), 
pp. 10-14. 
Pushkar, D.Y., Dyakov, V.V. and Kasyan, G.R. (2009) 'Management of radiation-induced 
vesicovaginal fistula', European Urology, 55(1), pp. 131-137. 
Raassen, T.J., Ngongo, C.J. and Mahendeka, M.M. (2014) 'Iatrogenic genitourinary fistula: 
an 18-year retrospective review of 805 injuries', International Urogynecology Journal & 
Pelvic Floor Dysfunction, 25(12), pp. 1699-1706. 
Rangnekar, N.P., Imdad, A.N., Kaul, S.A. and Pathak, H.R. (2000) 'Role of the martius 
procedure in the management of urinary-vaginal fistulas', Journal of the American College 
of Surgeons, 191, pp. 259-263. 
Reid, P.C. and Mukri, F. (2005) 'Trends in number of hysterectomies performed in England 
for menorrhagia: examination of health episode statistics, 1989 to 2002-3', BMJ, 
330(7497), pp. 938-939. 
Riemsma, R., Hagen, S., Kirschner-Hermanns, R., Norton, C., Wijk, H., Andersson, K.E., 
Chapple, C., Spinks, J., Wagg, A., Hutt, E., Misso, K., Deshpande, S., Kleijnen, J. and 
Milsom, I. (2017) 'Can incontinence be cured? A systematic review of cure rates', BMC 
Medicine, 15(1), p. 63. 
Safan, A., Shaker, H., Abdelaal, A., Mourad, M.S. and Albaz, M. (2009) 'Fibrin glue versus 
martius flap interpositioning in the repair of complicated obstetric vesicovaginal fistula. A 
 166
prospective multi-institution randomized trial', Neurourology & Urodynamics, 28(5), pp. 
438-41. 
Sand, P.K. and Ostergard, D.R. (1995) 'Urethrovaginal fistulas', in  Urodynamics and the 
evaluation of female incontinence: a practical guide. London: Springer-Verlag, pp. 94-95. 
Schleicher, D.J., Ojengbede, O.H.A. and Elkins, T.E. (1993) 'Urologic evaluation after 
closure of vesicovaginal fistulas', International Urogynecology Journal & Pelvic Floor 
Dysfunction, 4, pp. 262-265. 
Schraffordt Koops, S.E., Bisseling, T.M., Heintz, A.P. and Vervest, H.A. (2005) 'Prospective 
analysis of complications of tension-free vaginal tape from The Netherlands Tension-free 
Vaginal Tape study', American Journal of Obstetrics & Gynecology, 193(1), pp. 45-52. 
Shah, A., Fawole, B., M'Imunya J, M., Amokrane, F., Nafiou, I., Wolomby, J.J., Mugerwa, 
K., Neves, I., Nguti, R., Kublickas, M. and Mathai, M. (2009) 'Cesarean delivery outcomes 
from the WHO global survey on maternal and perinatal health in Africa', International 
Journal of Gynaecology & Obstetrics, 107(3), pp. 191-197. 
Shaker, H., Saafan, A., Yassin, M., Idrissa, A. and Mourad, M.S. (2011) 'Obstetric vesico-
vaginal fistula repair: should we trim the fistula edges? A randomized prospective study', 
Neurourology & Urodynamics, 30(3), pp. 302-5. 
Silver, R.M., Landon, M.B., Rouse, D.J., Leveno, K.J., Spong, C.Y., Thom, E.A., Moawad, 
A.H., Caritis, S.N., Harper, M., Wapner, R.J., Sorokin, Y., Miodovnik, M., Carpenter, M., 
Peaceman, A.M., O'Sullivan, M.J., Sibai, B., Langer, O., Thorp, J.M., Ramin, S.M., Mercer, 
B.M., National Institute of Child Health and Human Development Maternal-Fetal Medicine 
Units Network (2006) 'Maternal morbidity associated with multiple repeat cesarean 
deliveries', Obstetrics & Gynecology, 107(6), pp. 1226-1232. 
Summerton, D.J., Kitrey, N.D., Lumen, N., Serafetinidis, E. and Djakovic, N. (2012) 'EAU 
guidelines on iatrogenic trauma', European Urology, 62(4), pp. 628-639. 
Tahzib, F. (1983) 'Epidemiological determinants of vesicovaginal fistulas', British  Journal 
of Obstetrics and Gynaecology, 90, pp. 387-391. 
 167 
Thaddeus, S. and Maine, D. (1991) 'Too far to walk: maternal mortality in context', Newsl 
Womens Glob Netw Reprod Rights, (36), pp. 22-4. 
Tomlinson, A.J. and Thornton, J.G. (1998) 'A randomised controlled trial of antibiotic 
prophylaxis for vesico-vaginal fistula repair', BJOG : an international journal of obstetrics 
and gynaecology, 105, pp. 397-399. 
Umoiyoho, A.J., Inyang-Etoh, E.C., Abah, G.M., Abasiattai, A.M. and Akaiso, O.E. (2011) 
'Quality of life following successful repair of vesicovaginal fistula in Nigeria', Rural Remote 
Health, 11(3), p. 1734. 
United Nations (2015) The Millennium Development Goals Report. New York, USA: United 
Nations. 
United Nations Department of Economic and Social Affairs - Development Policy and 
Analysis Division (2018) LDC identification criteria & indicators. Available at: 
https://www.un.org/development/desa/dpad/least-developed-country-category/ldc-
criteria.html. 
United Nations Development Programme (1990) Human Development Report 1990 (ISBN 
0-19-506481-X). New York: Oxford University Press. [Online]. Available at: 
http://hdr.undp.org/sites/default/files/reports/219/hdr_1990_en_complete_nostats.pdf. 
United Nations Development Programme (2016) Human Development Report 2016: Human 
Development for Everyone. New York, NY, USA: United Nations Development Programme. 
[Online]. Available at: 
http://hdr.undp.org/sites/default/files/HDR2016_EN_Overview_Web.pdf (Accessed: 
25/07/2018). 
United Nations General Assembly (2000) United Nations Millennium Declaration. New 
York, USA: United Nations. [Online]. Available at: 
http://www.un.org/millennium/declaration/ares552e.pdf (Accessed: 07/09/2018). 
United Nations Statistics Division (2017) Millennium development indicators: world and 
regional groupings. Available at: https://unstats.un.org/unsd/mi/worldmillennium.htm  
 168
Vangeenderhuysen, C., Prual, A. and Ould el Joud, D. (2001) 'Obstetric fistulae: incidence 
estimates for sub-Saharan Africa', International Journal of Gynaecology & Obstetrics, 73(1), 
pp. 65-6. 
Waaldijk, K. (1989) The surgical management of bladder fistula in 775 women in Northern 
Nigeria. MD thesis. Amsterdam. 
Waaldijk, K. (1997) 'Immediate indwelling bladder catheterisation at postpartum urine 
leakage - personal experience of 1200 patients', Tropical Doctor, 27, pp. 227-228. 
Waaldijk, K. (2004) 'The immediate management of fresh obstetric fistulas', American 
Journal of Obstetrics & Gynecology, 191(3), pp. 795-9. 
Waaldijk, K. (2008) Obstetric fistula: art and science. 1st edn. Katsina, Nigeria. 
Waaldijk, K. (2009) 'Prevention of post IIAa fistula repair incontinence: a prospective 
study of 845 consecutive patients', International Society of Obstetric Fistula Surgeons. 
Nairobi. 
Waaldijk, K. (2018) Obstetric trauma surgery: art and science - setting standards by 
evidence-based practice. Katsina, Nigeria. 
Wall, L.L. and Arrowsmith, S.D. (2007) 'The "continence gap": a critical concept in 
obstetric fistula repair', International Urogynecology Journal & Pelvic Floor Dysfunction, 
18(8), pp. 843-844. 
Walz, N.K., Faroqul, M., Begum, A., Sultana, N., Sarker, S. and Faisel, A.J. (2003) Situation 
analysis of obstetric fistula in Bangladesh. Dhaka: Engender Health. 
Ward, K.L. and Hilton, P. (2002) 'Prospective multicentre randomised trial of tension-free 
vaginal tape and colposuspension as primary treatment for stress incontinence', British 
Medical Journal, 325, pp. 67-70. 
Ward, K.L. and Hilton, P. (2004) 'A prospective multicenter randomized trial of tension-
free vaginal tape and colposuspension for primary urodynamic stress incontinence: two-
year follow-up', American Journal of Obstetrics & Gynecology, 190(2), pp. 324-31. 
 169 
Ward, K.L. and Hilton, P. (2008) 'Tension-free vaginal tape versus colposuspension for 
primary urodynamic stress incontinence: 5-year follow up', BJOG: an International Journal 
of Obstetrics & Gynaecology, 115(2), pp. 226-33. 
WHO, UNFPA, UNICEF and Averting Maternal Death and Disability (AMDD) (2009) 
Monitoring emergency obstetric care: a handbook. Geneva: World Health Organisation. 
Wikipedia (2018) Human Development Index. Available at: 
https://en.wikipedia.org/wiki/Human_Development_Index. 
Wilson, A., Lissauer, D., Thangaratinam, S., Khan, K.S., MacArthur, C. and Coomarasamy, 
A. (2011) 'A comparison of clinical officers with medical doctors on outcomes of caesarean 
section in the developing world: meta-analysis of controlled studies', BMJ, 342, p. d2600. 
World Health Organisation (2015) WHO statement on caesarean section rates. [Online]. 
Available at: http://apps.who.int/iris/bitstream/10665/161442/1/WHO_RHR_15.02_eng.pdf. 
(Accessed: 07/09/2018). 
World Health Organization (2018) WHO recommendation on duration of bladder 
catheterization after surgical repair of simple obstetric urinary fistula (Licence: CC BY-NC-SA 
3.0 IGO). Geneva: World Health Organization. [Online]. Available at: 
http://apps.who.int/iris/bitstream/handle/10665/259818/9789241550192-
eng.pdf;jsessionid=57EE47E6F6A4B352F3DAEF4BB9E789FB?sequence=1. 
Wright, J., Ayenachew, F. and Ballard, K.D. (2016) 'The changing face of obstetric fistula 
surgery in Ethiopia', International Journal of Women’s Health, 8, pp. 243-248. 
Zuarez-Easton, S., Shalev, E. and Salim, R. (2015) 'Trend in major neonatal and maternal 
morbidities accompanying the rise in the cesarean delivery rate', Nature: Scientific 
Reports, 5, p. 12565. 
 
  
 170 
  
 171 
 
Appendices 
  
 172 
  
 173 
Appendix A: Group II-a publications 
(Other works put forward as evidence of the scope of the candidate's contribution to the 
specific field of study in which the primary submissions lie - i.e. urogenital fistula4) 
 
 
Table 6: Group II-a publications listed by format 
 
  
                                               
4 The candidate’s publications are categorised as group I, IIa and IIb, as follows: 
Group I - Works upon which a candidate primarily bases his claim to have satisfied the 
standards for the award of the degree (see Chapter 2); 
Group II - Other works put forward as evidence of the scope of the candidate's 
contribution: 
IIa - to the specific field of study in which the primary submissions lie - i.e. 
urogenital fistula (Appendix A); 
IIb - to the broader field of study - i.e. urogynaecology (see Appendix B). 
 
Format No.
Chapters and narrative reviews 21
Peer-reviewed original papers 13
Published abstracts 6
Systematic reviews 4
Letters 2
Audio-visual materials 2
Total 48
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Luesley D, Monga A, published by Elsevier Science Ltd Edinburgh pp 874-895. 
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31. Hilton P. (2011) Fistula repair. In: An Atlas of Gynecological Oncology – 
investigation and surgery. (3rd edition) Edited by Smith RJ, del Priore G, Curtin 
J, Monaghan JM. Published by Taylor & Francis Medical Books, London pp 236-
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2011; available from: 
http://www.bjui.org/ContentFullItem.aspx?id=764&SectionType=1&title=Intrav
esical-herniation-of-small-bowel:-a-very-rare-complication-of-bladder-
perforation#comment.  (peer-reviewed case report) 
33. Hilton P. Urogenital fistula in the UK – a personal case series managed over 25 
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vesicovaginal fistula. BJUI Website 2012; available from: 
http://www.bjui.org/ContentFullItem.aspx?id=814&SectionType=1&title=Classic
al-Hodgkin’s-lymphoma-presenting-as-vesicovaginal-fistula (peer-reviewed case 
report) 
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hysterectomy performed in the English National Health Service – a 
retrospective cohort study examining patterns of care between 2000 and 
2008. BJOG 2012; 119(12): 1447-1454. (peer-reviewed paper - included in 
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36. Mourad S, Haruna M, Hilton P, Saafan A, Shaker H, Vasan S. (2012) 
Complications of fistula surgery. In: Abrams P, editor. ICUD-SIU – 1st 
International Consultation on Obstetric Fistula in the Developing World. 
Societé Internationale d’Urologie, Montreal, Canada pp. 123-176. (systematic 
review) 
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Abrams P, Cardozo L, Wein A (eds) Geneva. EAU publications pp. 1527-1579. 
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English National Health Service hospitals between 2000 and 2009. BJU Int 
2013; 111(4b): E257-E262. available from: 
http://onlinelibrary.wiley.com/doi/10.1111/j.1464-410X.2012.11483.x/pdf (peer-
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39. Kiran A, Hilton P, Cromwell DA. The risk of ureteric injury after hysterectomy 
performed in the English National Health Service – a retrospective cohort 
study examining patterns of care between 1998 and 2010. Int Urogynecol J & 
Pelvic Floor Dysfunct. 2014; 25(suppl.1): S143-S144. (published conference 
abstract) 
40. Kiran A, Hilton P, Cromwell DA. The risk of ureteric injury after hysterectomy 
performed in the English National Health Service – a retrospective cohort 
study examining patterns of care between 1998 and 2010. Female Pelvic Med 
& Reconst Surg. 2014; 20(4, suppl.1): S82-S83 (published conference abstract) 
41. Kiran A, Hilton P, Cromwell DA. The risk of ureteric injury after hysterectomy 
performed in the English National Health Service: a 10-year retrospective 
cohort study. BJOG 2016; 123(7); 1184-1191. (peer-reviewed paper - included in 
submitted work) 
42. Hillary C, Osman N, Chapple CR, Hilton P. The aetiology, treatment and 
outcome of urogenital fistulae managed in well- and low-resourced countries: 
a systematic review. Eur Urol 2016; 70(3): 478-492. (systematic review – 
included in submitted work) 
43. Hilton P. Trends in the aetiology of urogenital fistula: a case of ‘retrogressive 
evolution’? Int Urogynecol J & Pelvic Floor Dysfunct 2016; 27.6: 831-837. Open 
access available from: http://rd.springer.com/article/10.1007/s00192-015-2919-y 
(‘special contribution’) 
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Urogynecol J & Pelvic Floor Dysfunct 2016; 27(9): 1445. Open access, available 
from: http://link.springer.com/article/10.1007/s00192-016-3083-8. (letter) 
45. Hilton P, MacLaren E, Doshani, A. Urogynaecology (2017).  In: RCOG Essential 
Gynaecological Skills: Supporting best practice in women's health – Training 
& facilitators’ manuals.  RCOG Global Health Unit, London pp 119-126 (Training 
manual) & 107-126 (Facilitators’ manual). (chapter) 
46. Hilton P. (2018) Fistula repair. In: An Atlas of Gynecological Oncology – 
investigation and surgery. (4th edition) Edited by Smith RJ, del Priore G, 
Coleman RL, Monaghan JM. Published by Taylor & Francis Medical Books, 
London. London.  Pp 237-252. (chapter) 
47. Hilton P. (2018) Operations for the repair of urinary fistulae. In: Bonney’s 
Gynaecological Surgery. (12th edition) Edited by Lopes A, Spirtos N, Hilton P, & 
Monaghan JM. Wiley-Blackwell, London. Pp 231-265. (chapter) 
48. Gurland B, d’Hoore A, Hilton P. (2018) Gynaecological considerations and 
urogenital fistulas. In: Surgery of the Anus, Rectum and Colon. (4th edition). 
Edited by Keighley MRB, Williams N. CRC Press/Taylor & Francis, London. Pp 
1477-1487. (chapter) 
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Appendix B: Group II-b publications 
(Other works put forward as evidence of the scope of the candidate's contribution to the 
broader field of study - i.e. urogynaecology5) 
 
Table 7: Group II-b publications listed by format (above); total publications (below) 
  
                                               
5 Group I - Works upon which a candidate primarily bases his claim to have satisfied 
the standards for the award of the degree (see Chapter 2); 
Group II - Other works put forward as evidence of the scope of the candidate's 
contribution: 
IIa - to the specific field of study in which the primary submissions lie - i.e. 
urogenital fistula (see Appendix A); 
IIb - to the broader field of study - i.e. urogynaecology (Appendix B). 
 
Format No.
Peer-reviewed original papers 93
Chapters and narrative reviews 64
Published abstracts 50
Editorial comments & letters 15
Edited books & monographs 13
Systematic reviews 13
Audio-visual materials 10
Group IIb total 248
Group I + group IIa publications 48
Other non-included publications 14
Groups I + II total 310
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1. Hilton P, Stanton SL. Suprapubic catheterisation. BMJ 1980; 281: 1261-1263. 
(review) 
2. Hilton P, Stanton SL. Algorithmic method for assessing urinary incontinence in 
elderly women. BMJ 1980; 282: 940-942. (peer-reviewed paper) 
3. Hilton P. (1981) Urethral pressure measurement by microtransducer: 
observations on methodology, the pathophysiology of genuine stress 
incontinence & the effects of its treatment in the female. MD thesis. 
Newcastle University – available from British Library EThOS ID: 
uk.bl.ethos.257745. (thesis) 
4. Hilton P, Stanton SL. (1981) Suprapubic catheterisation. In: Procedures in 
Practice. Published by The British Medical Journal; pp 27-29. (review) 
5. Suprapubic catheterisation. Hilton P, Stanton SL. BMJ (1981) 282:479-480. 
(letter) 
6. Assessing elderly incontinent patients. Hilton P, Stanton SL. BMJ 1981; 
282:1706. (letter) 
7. Hilton P, Stanton SL. The use of Desmopressin (DDAVP) in nocturnal urinary 
frequency in the female. BJU Int 1982; 54: 252-255. (peer-reviewed paper) 
8. Hilton P. Urethral pressure measurement at rest: an analysis of variance. 
Neurourol Urodynam 1982; 1: 303-311. (peer-reviewed paper; work included in 
MD thesis) 
9. Stanton SL, Hilton P, Norton C, Cardozo LD. Clinical and urodynamic effects of 
the anterior colporrhaphy and vaginal hysterectomy for prolapse with or 
without incontinence. BJOG 1982; 89: 459-463. (peer-reviewed paper) 
10. Hilton P. Bladder function simply tested. General Practitioner (1982). (review) 
11. Stanton SL, Hilton P, Hertogs K. (1982) Preliminary clinical and urodynamic 
results of the 'Marlex' sling procedure for stress incontinence. BJOG 89:775. 
(published abstract) 
12. Hilton P, Stanton SL. Urethral pressure measurement by micro-transducer: the 
results in symptom-free women and those with genuine stress incontinence. 
BJOG 1983; 90: 919-933. (peer-reviewed paper; work included in MD thesis) 
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13. Hilton P, Stanton SL. A clinical and urodynamic evaluation of the Burch 
colposuspension in genuine stress incontinence. BJOG 1983; 90: 934-939. 
(peer-reviewed paper; work included in MD thesis) 
14. Hilton P, Stanton SL. The use of intra-vaginal oestrogen cream in genuine 
stress incontinence. BJOG 1983; 90: 940-944. (peer-reviewed paper; work 
included in MD thesis) 
15. Hilton P, Spathis GS, Stanton SL. Transient autonomic/sensory neuropathy in 
newly diagnosed insulin dependent diabetes mellitus. BMJ 1983; 286: 686. 
(peer-reviewed paper – case report) 
16. Hilton P, Hertogs K, Stanton SL. The use of Desmopressin for nocturia in 
women with multiple sclerosis. J Neurol, Neurosurg & Psych 1983; 46: 854-855. 
(peer-reviewed paper) 
17. Hilton P. Urethral pressure measurement on stress: an analysis of profiles 
obtained on coughing and straining. Neurourol Urodynam 1983; 2: 55-62. (peer-
reviewed paper; work included in MD thesis) 
18. Hilton P, Stanton SL. A clinical and urodynamic evaluation of the polypropylene 
(Marlex) sling for genuine stress incontinence. Neurourol Urodynam 1983; 2: 
145-153. (peer-reviewed paper; work included in MD thesis) 
19. Stanton SL, Ozsoy C, Hilton P. Voiding difficulties in the female: prevalence, 
clinical and urodynamic review. Obstet Gynecol 1983; 61: 144-147. (peer-
reviewed paper) 
20. Hilton P. (1984) Urethral pressure measurement. In: Clinical Gynecologic 
Urology. Edited by Stanton SL; Published by C V Mosby, St Louis pp 110-126. 
(chapter) 
21. Hilton P, Varma TR. (1984) The menopause. In: Clinical Gynecologic Urology. 
Edited by Stanton SL: Published by C V Mosby, St Louis pp 343-353. (chapter) 
22. Hilton P, Millard P. (1984) The elderly. In: Clinical Gynecologic Urology. Edited 
by Stanton SL; Published by C V Mosby, St Louis pp 354-363. (chapter) 
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23. Hilton P. A clinical and urodynamic comparison of the sub-urethral sling and 
Stamey endoscopic bladder neck suspension in the treatment of genuine 
stress incontinence. Blair-Bell Research Society, Glasgow. BJOG 1985; 93: 291-
292. (published abstract) 
24. Hilton P, Stanton SL (1986) Urinary incontinence in the female: Part I –
Anatomy, physiology & investigation. Graves Medical Audio-Visual, 
Chelmsford, Essex. (tape-slide presentation) 
25. Stanton SL, Hilton P (1986) Urinary incontinence in the female: Part II -
Methods of treatment. Graves Medical Audio-Visual, Chelmsford, Essex. (tape-
slide presentation) 
26. Hilton P. Clinical algorithms: Urinary incontinence in women. BMJ 1987; 295: 
425-432. (peer-reviewed paper) 
27. Hilton P. (1987) The mechanism of continence. In: Surgery for Female Urinary 
Incontinence. Edited by Stanton SL, Tanagho EA; Published by Springer-Verlag, 
Berlin pp 1-21. (chapter) 
28. Hilton P. (1987) Catheters and drains. In: Principles of Gynaecological Surgery. 
Edited by Stanton SL; Published by Springer-Verlag, Berlin pp 257-283. (chapter) 
29. Hilton P. (1987) Surgery for urinary stress incontinence. In: Operative Surgery: 
Gynaecology and Obstetrics. 4th Edition, edited by Monaghan J; Published by 
Butterworths Scientific, London pp 105-126. (chapter) 
30. Mayne CJ, Hilton P. A comparison of the distal urethral electrical conductance 
(DUEC) test with weighed pads during standardised exercise test. Neurourol 
Urodynam 1987; 6.3: 167-168. (published abstract) 
31. Hilton P. Urinary incontinence during sexual intercourse: a common but rarely 
volunteered symptom. BJOG 1988; 95: 377-381. (peer-reviewed paper) 
32. Hilton P. Unstable urethral pressure - towards a more relevant definition. 
Neurourol Urodynam 1988; 6: 411-418. (peer-reviewed paper) 
33. Hilton P. Bladder drainage: a survey of practices among gynaecologists in the 
British Isles. BJOG 1988; 95: 1178-1189. (peer-reviewed paper) 
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34. Hilton P. Surgical drains: a survey of practices among gynaecologists in the 
British Isles. BJOG 1988; 95: 1063-1069. (peer-reviewed paper) 
35. Mayne CJ, Hilton P. The distal urethral electrical conductance (DUEC) test: 
standardisation of method and clinical reliability. Neurourol Urodynam 1988; 7: 
55-60. (peer-reviewed paper) 
36. Mayne CJ, Hilton P. The short pad test: standardisation of method and a 
comparison with the one-hour test. Neurourol Urodynam 1988; 7: 443-445. 
(peer-reviewed paper) 
37. Hilton P. (1988) Suprapubic catheterisation. In: Procedures in Practice. 2nd 
Edition. Published by The British Medical Journal pp 140-150. (chapter) 
38. Hilton P, Mayne CJ. (1988) Urethral pressure variations: the correlation 
between pressure measurement and electrical conductance in genuine stress 
incontinence. Neurourol Urodynam 7.3: 175-176. (published abstract) 
39. Mayne CJ, Hilton P. A comparison of urethral electrical conductance and 
perineometry during pelvic floor exercises for genuine stress incontinence. 
Neurourol Urodynam 1988; 7.3: 264-269. (published abstract) 
40. Hilton P, Tweddell AL, Mayne CJ. The effect of oral and intra-vaginal 
oestrogens and their influence on alpha-adrenoreceptor stimulation in genuine 
stress incontinence. Int Urogynecol J & Pelvic Floor Dysfunct 1988; 1.1: 36. 
(published abstract) 
41. Hilton P. A clinical and urodynamic study comparing the Stamey bladder neck 
suspension and sub-urethral sling procedures in the treatment of genuine 
stress incontinence. BJOG 1989; 96: 213-220. (peer-reviewed paper) 
42. Hilton P. Sexuality and urinary incontinence. Brit J Sex Med 1989; 16: 230-233. 
(review) 
43. Hilton P, Mayne CJ. Urethral pressure measurement: comparison of profiles 
obtained by conventional and fibre-optic transducers. Neurourol Urodynam 
1989; 8: 481-489. (peer-reviewed paper) 
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44. Hilton P. (1989) Urinary incontinence in women: general management 1; 
general management 2; surgical treatment. In: Clinical Algorithms in 
Gynaecology. Published by The British Medical Journal pp 55-61. (chapter) 
45. Hilton P, Laor D. Voiding symptoms in the female: the correlation with 
urodynamic voiding characteristics. Neurourol Urodynam 1989; 8.4: 308-310. 
(published abstract) 
46. Hilton P, Mayne CJ. The Stamey endoscopic bladder neck suspension: a clinical 
and urodynamic evaluation including actuarial follow-up of 4 years. Neurourol 
Urodynam 1989; 8.4: 336-337. (published abstract) 
47. Hilton P, Tweddell AL, Mayne CJ. Oral and intra-vaginal oestrogens alone and in 
combination with adrenergic stimulant drugs in genuine stress incontinence. 
Int Urogynecol J & Pelvic Floor Dysfunct 1990; 1: 80-86. (peer-reviewed paper) 
48. Drife JO, Hilton P, Stanton SL, Hilton P. (editors) (1990). Micturition - 
Proceedings of the 21st RCOG Study Group; ISBN 978-1-4471-1782-7.  Published 
by Springer-Verlag, London. (edited book) 
49. Hilton P. (1990) Anatomy of the lower urinary tract and pathophysiology of 
incontinence. In: Practical Urodynamics. Edited by Jarvis G; Published by 
RCOG, London pp 1-13. (chapter) 
50. Hilton P. (1990) Surgery for genuine stress incontinence: which operation and 
for which patient? In: Micturition - Proceedings of the 21st RCOG Study Group. 
Edited by Drife JO, Hilton P, Stanton SL. Published by Springer-Verlag, London; 
pp 225-246. (chapter) 
51. Hilton P. (1990) Female urethral pressure profilometry. In: Diagnostic 
Techniques in Urology. Edited by O'Reilly PH, George NJR and Weiss RM; 
Published by W.B. Saunders, Pennsylvania pp 309-335. (chapter) 
52. Clancy S, Hilton P. The prevalence of sexual problems in women attending for 
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Appendix C: Candidate’s complete cohort of patients with 
urogenital fistulae referred and managed in UK 
i.e. updated from included paper 3, to cover the period 1985 to 2015. 
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0.6%malignant
10.6%
Aetiology - miscellaneous
69.3%
10.0%
9.4%
0.6%
10.6%miscellaneous
Aetiology - surgery
Surgery 69.3%
10.0%
9.4%
0.6%
10.6%
Route of primary fistula surgery
51% 
10% 
4% 
6% 
0% 
17% 
6% 
5% 1% Vaginal layer dissection 
Vaginal + Martius graft
Urethral reconstruction
Colpocleisis
Urethrocleisis + SPC
Transperitoneal +/- omentum
Transvesical
Ureteric re-implantation/stent
Primary urinary diversion
Vaginal layer dissection 
Vaginal + Martius graft
Urethral reconstruction
Colpocleisis
Urethrocleisis + SPC
Transperitoneal +/- omentum
Transvesical
Ureteric re-implantation/stent
Primary urinary diversion
Route of primary fistula surgery
29% abdominal
71% vaginal
(24% with exclusions)
(76% excl. diversion 
&  re-implantations)
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Newcastle fistula data 1985 - 2015
3
Results of surgery - overall
2% 
1% 
7% 
9% 
Closed at 1st operation
Closed at 2nd operation
Closed at 3rd operation
Urinary diversion
Spontaneous closure
Declined surgery *
*	Genuinely	declined	treatment
Telephone	advice	only
Dry	on	medical	treatment
Deceased	before	Rx
80%	closed	at	1st	operation
(96.6%	of	those	operated)
Results of surgery - by procedure
* Hilton & Ward, 1998
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Results of surgery – other variables
(p=0.015)
(p=0.0001)
(p=0.207)
(p=0.104)
(p=0.460)
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No surgery - other reasons (9.4%)
Healed spontaneously (6.8%)
Results of surgery – by aetiology
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Results of surgery – by aetiology
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Results of surgery – by aetiology
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Closed with residual incont. (5.8%)
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